(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ☐ No ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of ~~May~~October 31, 2019: 1,688,219 shares of common stock, no par value, were outstanding.

	March 31, 2019			December 31, 2018			September 30, 2019			December 31, 2018
ASSETS
Current assets:
Cash	$	1,533		$	2,407		$	3,421		$	2,407
Restricted cash		1,100			1,411			1,119			1,411
Accounts receivable, net of allowance of $42 and $1,356		1,001			971
Accounts receivable, net of allowance of $721 and $1,356								912			971
Prepaid expenses and other		669			472			277			472
Notes receivable		667			610			687			610
Assets of disposal group held for sale		—			2,204			—			2,204
Total current assets		4,970			8,075			6,416			8,075
Restricted cash		2,640			2,668			2,550			2,668
Property and equipment, net		76,422			77,237			55,512			77,237
Intangible assets - bed licenses		2,471			2,471			2,471			2,471
Intangible assets - lease rights, net		825			906			584			906
Right-of-use operating lease assets		39,805			—			38,133			—
Goodwill		2,105			2,105			1,585			2,105
Lease deposits and other deposits		518			402			517			402
Straight-line rent receivable		6,731			6,301			6,376			6,301
Notes receivable		273			331			153			331
Other assets		74			74			74			74
Total assets	$	136,834		$	100,570		$	114,371		$	100,570
LIABILITIES AND EQUITY
Current liabilities:
Current portion of notes payable and other debt	$	25,733		$	26,397		$	1,747		$	26,397
Accounts payable		4,229			4,361			3,405			4,361
Accrued expenses and other		3,336			4,461			2,867			4,461
Operating lease obligation		6,033			—			6,093			—
Liabilities of disposal group held for sale		—			1,491			—			1,491
Total current liabilities		39,331			36,710			14,112			36,710
Notes payable and other debt, net of current portion:
Senior debt, net		47,977			48,317			47,251			48,317
Bonds, net		6,372			6,599			6,281			6,599
Other debt, net		14			—			502			—
Operating lease obligation		35,515			—			33,961			—
Other liabilities		1,219			2,793			1,247			2,793
Deferred tax liabilities		44			—			44			—
Total liabilities		130,472			94,419			103,398			94,419
Commitments and contingencies (Note 13)
Stockholders’ equity:
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 1,688 and 1,688 issued and outstanding at March 31, 2019 and December 31, 2018, respectively		61,927			61,900
Preferred stock, no par value; 5,000 shares authorized; 2,812 and 2,812 shares issued and outstanding, redemption amount $70,288 and $70,288 at March 31, 2019 and December 31, 2018, respectively		62,423			62,423
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 1,688 issued and outstanding at September 30, 2019 and December 31, 2018								61,970			61,900
Preferred stock, no par value; 5,000 shares authorized; 2,812 shares issued and outstanding, redemption amount $70,288 at September 30, 2019 and December 31, 2018								62,423			62,423
Accumulated deficit		(117,988	)		(118,172	)		(113,420	)		(118,172	)
Total stockholders’ equity		6,362			6,151			10,973			6,151
Total liabilities and stockholders’ equity	$	136,834		$	100,570		$	114,371		$	100,570

	Three Months Ended March 31,						Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018			2019			2018
Revenues:
Rental revenues	$	5,138		$	5,705		$	4,590		$	4,972		$	14,746		$	15,706
Management fees		239			234			239			235			716			703
Other revenues		47			48			1			49			93			148
Total revenues		5,424			5,987			4,830			5,256			15,555			16,557
Expenses:
Facility rent expense		1,726			2,171			1,640			2,171			5,006			6,512
Cost of management fees		159			157			148			137			467			448
Depreciation and amortization		1,023			1,221			797			1,126			2,661			3,507
General and administrative expense		926			879			730			984			2,551			2,751
Provision for doubtful accounts		(172	)		1,938			32			(48	)		(214	)		3,934
Other operating expenses		408			343			191			255			821			823
Total expenses		4,070			6,709			3,538			4,625			11,292			17,975
Income (loss) from operations		1,354			(722	)		1,292			631			4,263			(1,418	)
Other expense:
Other (income) expense:
Interest expense, net		1,654			1,275			1,157			1,783			4,535			4,595
Loss on extinguishment of debt		333			441			924			3,514			2,478			3,955
Gain on disposal of Assets		(690	)		—
Other expense		7			9
Total other expense, net		1,304			1,725
Gain on disposal of assets								(6,451	)		—			(7,141	)		—
Other (income) expense								(48	)		—			6			10
Total other (income) expense, net								(4,418	)		5,297			(122	)		8,560
Income (loss) from continuing operations before income taxes		50			(2,447	)		5,710			(4,666	)		4,385			(9,978	)
Income tax expense		44			26			—			—			44			33
Income (loss) from continuing operations		6			(2,473	)		5,710		$	(4,666	)	$	4,341		$	(10,011	)
Income (loss) from discontinued operations, net of tax		178			(55	)		101			157			411			(242	)
Net Income (loss)		184			(2,528	)
Preferred stock dividends - declared		—			—
Net income (loss)								5,811			(4,509	)		4,752			(10,253	)
Preferred stock dividends - undeclared		(2,249	)		(1,912	)		(2,250	)		(1,912	)		(6,748	)		(5,736	)
Net loss attributable to Regional Health Properties, Inc. common stockholders	$	(2,065	)	$	(4,440	)
Net loss (income) per share of common stock attributable to Regional Health Properties, Inc.
Net income (loss) attributable to Regional Health Properties, Inc. common stockholders							$	3,561		$	(6,421	)	$	(1,996	)	$	(15,989	)
Net income (loss) per share of common stock attributable to Regional Health Properties, Inc.
Basic and diluted:
Continuing operations	$	(1.33	)	$	(2.66	)	$	2.05		$	(3.93	)	$	(1.42	)	$	(9.45	)
Discontinued operations		0.11			(0.04	)	$	0.06		$	0.09		$	0.24			(0.15	)
	$	(1.22	)	$	(2.70	)	$	2.11		$	(3.84	)	$	(1.18	)	$	(9.60	)
Weighted average shares of common stock outstanding:
Basic and diluted		1,688			1,647			1,688			1,688			1,688			1,665

	Shares of Common Stock		Shares of Preferred Stock		Common Stock and Additional Paid-in Capital		Preferred Stock		Accumulated Deficit			Total
For the Nine Months ended September 30, 2019														Shares of Common Stock		Shares of Preferred Stock		Common Stock and Additional Paid-in Capital		Preferred Stock		Accumulated Deficit			Total
Balances, December 31, 2018		1,688		2,812	$	61,900	$	62,423	$	(118,172	)	$	6,151		1,688		2,812	$	61,900	$	62,423	$	(118,172	)	$	6,151
Stock-based compensation		—		—		27		—		—			27		—		—		27		—		—			27
Net income		—		—		—		—		184			184		—		—		—		—		184			184
Balances, March 31, 2019		1,688		2,812	$	61,927	$	62,423	$	(117,988	)	$	6,362		1,688		2,812		61,927		62,423		(117,988	)		6,362
Stock-based compensation															—		—		21		—		—			21
Net loss															—		—		—		—		(1,243	)		(1,243	)
Balances, June 30, 2019															1,688		2,812		61,948		62,423		(119,231	)		5,140
Stock-based compensation															—		—		22		—		—			22
Net income															—		—		—		—		5,811			5,811
Balances, September 30, 2019															1,688		2,812	$	61,970	$	62,423	$	(113,420	)	$	10,973

For the Nine Months ended September 30, 2018	Shares of Common Stock		Shares of Preferred Stock		Common Stock and Additional Paid-in Capital		Preferred Stock		Accumulated Deficit			Total
Balances, December 31, 2017		1,647		2,812	$	61,724	$	62,423	$	(106,277	)	$	17,870
Stock-based compensation		—		—		31		—		—			31
Net loss		—		—		—		—		(2,528	)		(2,528	)
Balances, March 31, 2018		1,647		2,812		61,755		62,423		(108,805	)		15,373
Stock-based compensation		—		—		45		—		—			45
Issuance of restricted stock, net of forfeitures		41		—		—		—		—			—
Net loss		—		—		—		—		(3,216	)		(3,216	)
Balances, June 30, 2018		1,688		2,812		61,800		62,423		(112,021	)		12,202
Stock-based compensation		—		—		50		—		—			50
Net loss		—		—		—		—		(4,509	)		(4,509	)
Balances, September 30, 2018		1,688		2,812	$	61,850	$	62,423	$	(116,530	)	$	7,743

	Three Months Ended March 31,						Nine Months Ended September 30,
	2019			2018			2019			2018
Cash flows from operating activities:
Net income (loss)	$	184		$	(2,528	)	$	4,752		$	(10,253	)
Income (loss) from discontinued operations, net of tax		(178	)		55
(Income) loss from discontinued operations, net of tax								(411	)		242
Income (loss) from continuing operations		6			(2,473	)		4,341			(10,011	)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:
Depreciation and amortization		1,023			1,221			2,661			3,507
Interest paid in kind		178			—
Stock-based compensation expense		27			31			70			126
Rent expense in excess of cash paid		75			113			252			301
Rent revenue in excess of cash received		(428	)		(683	)		(1,124	)		(1,784	)
Amortization of deferred financing costs, debt discounts and premiums		53			195			166			698
Loss on debt extinguishment		333			441			2,478			3,955
Gain on disposal of assets		(690	)		—			(7,141	)		—
Bad debt (benefit) expense		(172	)		1,938			(214	)		3,934
Deferred tax expense		44			—			44			—
Changes in operating assets and liabilities:
Accounts receivable		346			(271	)		578			(349	)
Prepaid expenses and other		50			(22	)		326			239
Other assets		(155	)		33			(57	)		35
Accounts payable, and accrued expenses and other		(566	)		209
Accounts payable and accrued expenses								(376	)		663
Other liabilities		(7	)		—			161			7
Net cash provided by operating activities - continuing operations		117			732			2,165			1,321
Net cash used in operating activities - discontinued operations		(282	)		(735	)		(980	)		(1,264	)
Net cash used in operating activities		(165	)		(3	)
Net cash provided by operating activities								1,185			57
Cash flows from investing activities:
Proceeds from disposal of assets, net		1,192			—
Proceeds from disposal of lease assets, net								1,192			—
Proceeds from the sale of property and equipment, net								2,687			—
Purchase of property and equipment		(87	)		(163	)		(243	)		(266	)
Net cash provided by (used in) investing activities - continuing operations		1,105			(163	)		3,636			(266	)
Net cash provided by (used in) investing activities		1,105			(163	)		3,636			(266	)
Cash flows from financing activities:
Proceeds from debt issuance		—			2,397			—			2,397
Repayment on notes payable		(1,410	)		(503	)		(2,585	)		(1,546	)
Repayment on bonds payable		(243	)		—			(344	)		(95	)
Debt forbearance costs		(466	)		—
Debt extinguishment, forbearance and issuance costs								(1,254	)		(95	)
Net cash (used in) provided by financing activities - continuing operations		(2,119	)		1,894			(4,183	)		661
Net cash used in financing activities - discontinued operations		(34	)		(90	)		(34	)		(188	)
Net cash (used in) provided by financing activities		(2,153	)		1,804			(4,217	)		473
Net change in cash and restricted cash		(1,213	)		1,638			604			264
Cash and restricted cash, beginning		6,486			5,359			6,486			5,359
Cash and restricted cash, ending	$	5,273		$	6,997		$	7,090		$	5,623

	Three Months Ended March 31,					Nine Months Ended September 30,
	2019		2018			2019			2018
Supplemental disclosure of cash flow information:
Interest paid	$	1,434	$	755
Cash interest paid						$	4,105		$	3,775
Cash income taxes paid						$	—		$	33
Supplemental disclosure of non-cash activities:
Non-cash payments of short-term debt						$	(24,637	)	$	—
Non-cash payments of long-term debt	$	—	$	(8,744	)	$	—		$	(8,744	)
Non-cash payments of convertible debt		—		(1,500	)		—			(1,500	)
Non-cash payments of professional liability settlements from financing		—		(2,371	)		—			(2,371	)
Non-cash debt issuance costs and prepayment penalties		—		(1,238	)
Non-cash debt extinguishment, issuance costs and prepayment penalties							(1,036	)		(1,238	)
Non-cash surrender of security deposit							(140	)		—
Non-cash payments of professional liability settlements from prior insurer		—		(2,850	)		—			(2,850	)
Net payments through escrow	$	—	$	(16,703	)	$	(25,813	)	$	(16,703	)

Non-cash proceeds from sale of property and equipment							25,813			—
Non-cash proceeds from financing		—		13,853			—			13,853
Non-cash proceeds from prior insurer for professional liability settlements		—		2,850			—			2,850
Net proceeds through escrow	$	—	$	16,703		$	25,813		$	16,703

Non-cash deferred financing	$	—	$	488		$	—		$	3,352
Surrender of security deposit	$	—	$	245		$	—		$	305
Non-cash proceeds from vendor-financed insurance	$	246	$	194		$	250		$	198
Non-cash proceeds from finance lease to purchase fixed assets	$	26	$	—		$	26		$	—

AdCare Health Systems, Inc. (“AdCare”) is the former parent of, and the predecessor issuer to, Regional Health Properties, Inc. (“Regional Health” or “Regional” and, together with its subsidiaries, the “Company” or “we”). On September 29, 2017, AdCare merged (the “Merger”) with and into Regional Health, a Georgia corporation and wholly owned subsidiary of AdCare formed for the purpose of the Merger, with Regional Health continuing as the surviving corporation in the Merger. The Company now has many of the characteristics of a real estate investment trust and is focused on the ownership, acquisition and leasing of healthcare related properties. For a description of the Merger, see Part II, Item 8, “Financial Statements and Supplemental Data”, Note 1 – Summary of Significant Accounting Policies included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the Securities and Exchange Commission (“SEC”) on May 17, 2019 (the “Annual Report”).

Regional Health is a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. The Company’s business primarily consists of leasing and subleasing healthcare facilities to third-party tenants, which operate the facilities. The operators of the Company’s facilities provide a range of healthcare services to their patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for both long-term and short-stay patients and residents.

As of ~~March 31,~~September 30, 2019, the Company owned, leased, or managed for third parties 2824 facilities, primarily in the Southeast United States. Of the 2824 facilities, the Company: (i) leased 1410 owned facilities and subleased 9nine leased skilled nursing facilities to third-party tenants; (ii) leased two owned assisted living facilities to third-party tenants; and (iii) managed on behalf of third-party owners two skilled nursing facilities and one independent living ~~facility (see~~facility. See Note 7 – Leases, ~~to the Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”, of this Quarterly Report on Form 10-Q (this “Quarterly Report”),~~herein, and Note 7 – Leases located in Part II, Item 8, “Financial Statements and Supplemental Data” in the Annual Report for a more detailed description of the Company’s ~~leases)~~leases.

Pursuant to the Purchase and Sale Agreement, dated April 15, 2019, as subsequently amended from time to time (the “PSA”), between certain subsidiaries of the Company and MED Healthcare Partners LLC (“MED”), the Company sold to affiliates of MED Healthcare Partners LLC (“MED”) four skilled nursing facilities (collectively, the “PSA Facilities”), together with substantially all of the fixtures, equipment, furniture, leases and other assets relating to such PSA Facilities (the “Asset Sale”). Under the PSA, the Company sold: (i) on August 28, 2019, the 100-bed skilled nursing facility commonly known as Northwest Nursing Center located in Oklahoma City, Oklahoma (the “Northwest Facility”); and (ii) on August 1, 2019, the following three facilities, (a) the 182-bed skilled nursing facility commonly known as Attalla Health & Rehab located in Attalla, Alabama (the “Attalla Facility”), (b) the 100-bed skilled nursing facility commonly known as Healthcare at College Park located in College Park, Georgia (the “College Park Facility”), and (c) the 118-bed skilled nursing facility commonly known as Quail Creek Nursing Home located in Oklahoma City, Oklahoma (the “Quail Creek Facility”).

In connection with the Asset Sale: (i) MED paid to the Company a cash purchase price for the PSA Facilities equal to $28.5 million in the aggregate; (ii) the Company incurred approximately $0.4 million in sales commission expenses and $0.1 million for a building improvement credit; and (iii) the Company transferred approximately $0.1 million in lease security deposits to MED.

On ~~April 15,~~August 1, 2019, the Company ~~entered into~~used a ~~purchase~~portion of the proceeds from the Asset Sale to repay approximately $21.3 million to Pinecone Realty Partners II, LLC (“Pinecone”) to extinguish all indebtedness owed by the Company under a loan agreement, dated February 15, 2018, as amended from time to time with an original aggregate principal amount of $16.25 million which refinanced existing mortgage debt (the “Pinecone Credit Facility”), and ~~sale~~to repay approximately $3.8 million to Congressional Bank to extinguish all indebtedness owed by the Company under a term loan agreement, ~~with respect~~dated September 27, 2013, as amended from time to ~~four (4) owned skilled nursing facilities, with a scheduled closing date, subject to satisfaction or waiver of customary terms~~time, between the Company and ~~conditions, of August 1, 2019, but may be extended by up to fifteen (15) days.~~Congressional Bank (the “Quail Creek Credit Facility”). For further information, see Note 159 – Notes Payable and Other Debt and Note 10 – ~~Subsequent Events~~Discontinued Operations and Dispositions.

The Company leases its currently-owned healthcare properties, and subleases its currently-leased healthcare properties, on a triple-net basis, meaning that the lessee (i.e., the third-party operator of the property) is obligated under the lease or sublease, as applicable, for all costs of operating the property, including insurance, taxes and facility maintenance, as well as the lease or sublease payments, as applicable. These leases are generally long-term in nature with renewal options and annual rent escalation clauses.

When used in this Quarterly Report on Form 10-Q (this “Quarterly Report”), unless otherwise specifically stated or the context otherwise requires, the terms:

~~For the three months ended and as~~As of ~~March 31,~~September 30, 2019, we had negative working capital of approximately ~~$34.3 million.~~$1.6 million, which excludes $6.1 million of current operating lease obligation (with the corresponding right of use asset classified as long term). At ~~March 31,~~September 30, 2019, we had ~~$1.5~~$3.4 million in unrestricted cash and ~~$80.1~~$55.8 million in indebtedness, including current maturities of ~~$25.7~~$1.7 million. The current portion of such indebtedness is comprised of: (i) $19.4 million of long term-debt (including a $0.5 million “tail fee” and a $0.5 million “repayment or acceleration fee”) under a debt refinancing facility dated February 15, 2018, as amended from time to time, betweenOn August 1, 2019, the Company and Pinecone Realty Partners II, LLC (“Pinecone”), with an original aggregate principal amount of $16.25 million which refinanced existing mortgage debt (the “Pinecone Credit Facility”), classified as currentfully repaid the amounts due ~~to the Company’s short-term forbearance agreement regarding the Company’s noncompliance with certain covenants~~ under the Pinecone Credit Facility ~~pursuant to which Pinecone may exercise its default-related rights~~ and ~~remedies, including~~ the ~~acceleration~~Quail Creek Credit Facility using the proceeds from the sale of three of the ~~maturity~~Company’s facilities. On September 30, 2019, the Company and Pinecone entered into a waiver and release agreement and the Company paid approximately $0.4 million to Pinecone to fully extinguish the surviving obligations and provisions (the “Surviving Obligations”) of the ~~debt, upon~~Pinecone Credit Facility, which included (i) a right of first refusal to provide first mortgage financing for any acquisition of a healthcare facility by the ~~termination~~Company for a period of three months following the above repayment, and (ii) an exclusive option to refinance the Company’s existing first mortgage loan (the “Pinecone Financing Option”), with a balance of $5.3 million at June 30, 2019, on the Company’s 124-licensed bed skilled nursing facility located in Alabama known as Coosa Valley Health Care, in each case subject to the terms and conditions of the ~~forbearance period under such forbearance agreement (as further discussed below in this note and Note 3 –~~ ~~Liquidity); (ii) $4.0 million of mortgage indebtedness under~~Pinecone Credit Facility.

Prior to August 1, 2019, the Company’s credit facility with Housing & Healthcare Funding, LLC (the “Quail Creek Credit Facility”) maturing in June 2019; and (iii) other debt of approximately $2.3 million, which includes senior debt and bond and mortgage indebtedness.

~~The~~ continuation of our business iswas dependent upon our ability: (i) to comply with the terms and conditions under the Pinecone Credit Facility and the second new amended and restated forbearance agreement, dated March 29, 2019, between the Company and certain of its subsidiaries and Pinecone (the “Second A&R Forbearance Agreement”); as amended on June 13, 2019; and (ii) to refinance or obtain further debt maturity extensions on the Quail Creek Credit Facility, neither of which iswas entirely within the Company’s control. These factors ~~create~~had created substantial doubt about the Company’s ability to continue as a going concern.

~~The~~ However, the Company ~~is pursuing a strategy to repay~~repaid the Pinecone Credit Facility and Quail Creek Credit Facility ~~within~~on August 1, 2019 and fully extinguished the ~~next few months.~~Surviving Obligations on September 30, 2019. If ~~these~~ efforts ~~are~~to make such repayment had been unsuccessful, the Company ~~may be~~would have been required to seek relief through ~~a number of~~ other available alternatives, ~~which may include~~including a filing under the U.S. Bankruptcy Code. The consolidated financial statements do not include any adjustments that might behave been necessary if the Company iswas unable to continue as a going concern. See Note – 1510 ~~Subsequent Events~~Discontinued Operations and Dispositions for ~~details on a purchase and sale agreement,~~information with respect to the PSA, with respect to the sale of ~~certain~~the PSA Facilities and the repayment of all amounts due under the ~~Company’s facilities,~~Pinecone Credit Facility and the Quail Creek Credit Facility, which ~~transaction, if successfully completed, is intended to address~~have addressed certain factors ~~creating~~that had created substantial doubt regarding the Company’s ability to continue as a going concern. ~~There~~

As a result of such repayments, the Company is ~~no assurance, however,~~able to conclude that ~~these efforts, including~~it is probable that the ~~asset sale contemplated by such purchase and sale agreement,~~Company will be ~~successful.~~able to meet its obligations arising within one year of the date of issuance of these consolidated financial statements within the parameters set forth in the accounting guidance. For additional information, see Note 3 – Liquidity.

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations for the periods presented have been included. Operating results for the three and nine months ended ~~March 31,~~September 30, 2019 and 2018 are not necessarily indicative of the results that may be expected for the fiscal year. The consolidated balance sheet at December 31, 2018 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the unaudited consolidated financial statements in this Quarterly Report together with the historical audited consolidated financial statements of the Company for the year ended December 31, 2018, included in the Annual Report. See Part II, Item 8, “Financial Statements and Supplementary Data”, Note 1 – Summary of Significant Accounting Policies included in the Annual Report, for a description of all significant accounting policies. During the three and nine months ended ~~March 31,~~September 30, 2019, there were no material changes to the Company’s policies, except as noted below in RecentlyAdopted Standards.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

On December 27, 2018, the Board authorized a reverse stock split of the issued and outstanding shares of the common stock, at a ratio of one-for-twelve shares (the “Reverse Stock Split”). Shareholder approval for the Reverse Stock Split was obtained at the Company’s annual meeting of shareholders on December 27, 2018 and the Reverse Stock Split became effective on December 31, 2018. At the effective date, every ~~twelve~~12 shares of the common stock that were issued and outstanding were automatically combined into one issued and outstanding share of the common stock. Shareholders did not receive fractional shares in connection with the Reverse Stock Split and instead, received an additional whole share of the common stock in lieu thereof. The authorized number of shares, and the par value per share, of the common stock was not affected by the Reverse Stock Split. The Reverse Stock Split also correspondingly affected all outstanding Regional Health equity awards. The Reverse

Stock Split was implemented for the purpose of complying with the NYSE American LLC (“NYSE American” or the “Exchange”) continued listing standards regarding low selling price.

All authorized, issued and outstanding stock and per share amounts contained in the accompanying consolidated financial statements have been adjusted to reflect the Reverse Stock Split for all prior periods presented.

Triple-Net Leased Properties. The Company’s triple-net leases provide for periodic and determinable increases in rent. The Company recognizes rental revenues under these leases on a straight-line basis over the applicable lease term when collectability is probable. Recognizing rental income on a straight-line basis generally results in recognized revenues during the first half of a lease term exceeding the cash amounts contractually due from our tenants, creating a straight-line rent receivable that is included in straight-line rent receivable on our consolidated balance sheets. In the event the Company cannot reasonably estimate the future collection of rent from one or more tenant(s) of the Company’s facilities, rental income for the affected facilities is thus recognized only upon cash collection, and any accumulated straight-line rent receivable is thus reversed in the period in which the Company deems rent collection to no longer be probable. Rental revenues for five facilities located in Ohio (until operator transition on December 1, 2018) ~~and~~, one facility in North Carolina (until operator transition on March 1, 2019) and four facilities held for sale since April 15, 2019 (until the sale of such facilities, which occurred on August 1, 2019 (three facilities) and August 28, 2019 (one facility)) were recorded on a cash basis during the year ended December 31, 2018, ~~and~~the three months ended March ~~31.~~31, 2019 and until the sale of such facilities, respectively. For additional information with respect to such facilities, see Note 7 – Leasesand Note 10 – Discontinued Operations and Dispositions.

Revenue from Contracts with Customers. The Company recognizes management fee revenues as services are provided. The Company has one contract to manage three facilities (the “Management Contract”), with payment for each month of service received in full on a monthly basis. The maximum penalty for service contract nonperformance under the Management Contract is $50,000 per year, payable after the end of the year. Further, the Company recognizes interest income from loans and investments, using the effective interest method when collectability is probable. The Company applies the effective interest method on a loan-by-loan basis.

Allowances. The Company assesses the collectability of its rent receivables, including straight-line rent receivables and working capital loans to tenants. The Company bases its assessment of the collectability of rent receivables and working capital loans to tenants on several factors, including payment history, the financial strength of the tenant and any guarantors, the value of the underlying collateral, and current economic conditions. If the Company’s evaluation of these factors indicates it is probable that the Company will be unable to receive the rent payments or payments on a working capital loan, then the Company provides a reserve against the recognized straight-line rent receivable asset or working capital loan for the portion that we estimate may not be recovered. Payments received on impaired loans are applied against the allowance. If the Company changes its assumptions or estimates regarding the collectability of future rent payments required by a lease or required from a working capital loan to a tenant, then the Company may adjust its reserve to increase or reduce the rental revenue or interest revenue from working capital loans to tenants recognized in the period the Company makes such change in its assumptions or ~~estimates (see~~estimates. See Note 7 – Leases).

As of ~~March 31,~~September 30, 2019 and December 31, 2018, the Company reserved for approximately ~~$0.05~~$0.7 million and $1.4 million, respectively, of gross patient care related receivables arising from its legacy operations. Allowances for patient care receivables are estimated based on an aged bucket method as well as additional analyses of remaining balances incorporating different payor types. Any changes in patient care receivable allowances are recognized as a component of discontinued operations. All uncollected ~~patient care receivables were fully reserved at March 31, 2019 and December 31, 2018.~~receivables. Accounts receivable, net, totaled ~~$1.0~~$0.9 million at ~~March 31,~~September 30, 2019 and $1.0 million at December 31, 2018.

The Company recognizes extinguishment of debt when the criteria for a troubled debt restructure are not met and the change in the debt terms is considered substantial. The Company calculates the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt (including deferred finance fees) and recognizes a gain or loss on the income statement of the period of extinguishment.

As of ~~March 31,~~September 30, 2019 and December 31, 2018, the Company had ~~$0.7~~$0.3 million and $0.5 million, respectively, in pre-paid expenses and other, primarily for directors’ and officers’ insurance and mortgage insurance premiums.

The Company ~~was~~has self-insured against professional and general liability claims since it discontinued its healthcare operations during 2014 and 2015 in connection with its transition from an owner and operator of healthcare properties to a healthcare property holding and leasing company (the “Transition”)~~, see~~. See Part II, Item 8, “Financial Statements and Supplementary Data”, Note 15 – Commitments and Contingencies in the Annual Report for more information. The Company evaluates quarterly the adequacy of its self-insurance reserve based on a number of factors, including: (i) the number of actions pending and the relief sought; (ii) analyses provided by defense counsel, medical experts or other information which comes to light during discovery; (iii) the legal fees and other expenses anticipated to be incurred in defending the actions; (iv) the status and likely success of any mediation or settlement discussions, including estimated settlement amounts and legal fees and other expenses anticipated to be incurred in such settlement, as applicable; and (v) the venues in which the actions have been filed or will be adjudicated. The Company believes that most of the professional and general liability actions are defensible and intends to defend them through final judgment unless settlement is more advantageous to the Company. Accordingly, the self-insurance reserve reflects the Company’s estimate of settlement amounts for the pending actions, if applicable, and legal costs of settling or litigating the pending actions, as applicable. Because the self-insurance reserve is based on estimates, the amount of the self-insurance reserve may not be sufficient to cover the settlement amounts actually incurred in settling the pending actions, or the legal costs actually incurred in settling or litigating the pending actions. See Note 8 – Accrued Expenses and Other.

In addition, the Company maintains certain other insurance programs, including commercial general liability, property, casualty, directors’ and officers’ liability, crime and employment practices liability.

On January 1, 2019, the Company adopted Accounting Standards Update (“ASU”) ASU 2016-02, Leases, as codified in Accounting Standards Codification (“ASC”) 842, using the non-comparative transition option pursuant to ASU 2018-11. Therefore we have not restated comparative period financial information for the effects of ASC 842, and we have not made the new required lease disclosures for comparative periods beginning before January 1, 2019. The Company recognized both right of use assets and lease liabilities for leases in which we lease land, real property or other equipment, electing the practical expedient to maintain the prior operating lease classification. Effective January 1, 2019, we will assess any new contracts or modification of contracts in accordance with ASC 842 to determine the existence of a lease and its classification. We are reporting revenues and expenses for real estate taxes and insurance, prospectively where the lessee has not made those payments directly to a third party in accordance with their respective leases with us. ~~For the three months ended March 31, 2019, we recorded $0.1 million of rental revenues and the corresponding $0.1 million of~~

The following table summarizes real estate tax ~~expense within~~ ~~“Other operating expense”~~recognized on our consolidated statement of ~~operations. We have elected~~operations for the ~~practical expedient to account for our leases as a single lease component.~~ three and nine months ended September 30, 2019 and 2018:

Also, we now expense certain leasing costs, other than leasing commissions, as they are incurred. Current GAAP provides for the deferral and amortization of such costs over the applicable lease term. Adoption of ASU 2016-02 has not had a material effect on the Company’s consolidated financial statements, other than the initial balance sheet impact of recognizing the right-of-use assets and the right-of-use lease liabilities. ~~As of March 31, 2019,~~Upon adoption, we recognized operating lease assets of $39.8 million on our consolidated balance sheet for the period ended March 31, 2019, which represents the present value of minimum lease payments associated with such leases. Also upon adoption, we recognized operating lease liabilities of $41.5 million, instead of $1.7 million of previously recorded deferred rent recorded in “Other Liabilities” on our consolidated balance sheet for the period ended March 31, 2019. The present value of minimum lease payments was calculated on each lease using a discount rate that ~~approximates~~approximated our incremental borrowing rate and the current lease ~~term. As of the March 31, 2019,~~term and upon adoption we utilized a discount rate of 7.98% for the Company’s leases. See Note 7– Leases for the Company’s operating leases.

See Part II, Item 8, “Financial Statements and Supplementary Data”, Note 1 – Summary of Significant Accounting Policies included in the Annual Report, for a description of the other accounting pronouncements the Company is currently evaluating.

Basic earnings per share is computed by dividing net income or loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the respective period. Diluted earnings per share is similar to basic earnings per share ~~except: (i)~~except that the net income or loss is adjusted by the impact of the ~~assumed conversion of convertible debt into shares of common stock; and (ii) the~~ weighted-average number of shares of common stock outstanding ~~includes~~including potentially dilutive securities (such as options, warrants and non-vested common ~~stock and additional shares of common stock issuable under convertible debt outstanding during the period)~~stock) when such securities are not anti-dilutive. Potentially dilutive securities from options, warrants and unvested restricted shares are calculated in accordance with the treasury stock method, which assumes that proceeds from the exercise of all options and warrants with exercise prices exceeding the average market value are used to repurchase common stock at market value. The incremental shares remaining after the proceeds are exhausted represent the potentially dilutive effect of the securities. ~~Potentially dilutive securities from convertible debt are calculated based on the~~

~~assumed issuance at the beginning of the period, as well as any adjustment to income that would result from their assumed issuance.~~ For the three and nine months ended ~~March 31,~~September 30, 2019 and 2018, approximately 0.1 million and 0.1 million shares, respectively, of potentially dilutive securities were excluded from the diluted loss per share calculation because including them would have been anti-dilutive for such periods.

The following tables provide a reconciliation of net income (loss) for continuing and discontinued operations and the number of shares of common stock used in the computation of both basic and diluted earnings per share:

	Three Months Ended March 31,						Three Months Ended September 30,						Nine Months Ended September 30,
(Amounts in 000’s, except per share data)	2019			2018			2019			2018			2019			2018
Numerator:
Income (loss) from continuing operations	$	6		$	(2,473	)	$	5,710		$	(4,666	)	$	4,341		$	(10,011	)
Preferred stock dividends - declared		—			—
Preferred stock dividends - undeclared ⁽¹⁾		(2,249	)		(1,912	)		(2,250	)		(1,912	)		(6,748	)		(5,736	)
Basic and diluted loss from continuing operations		(2,243	)		(4,385	)
Basic and diluted income (loss) from continuing operations								3,460			(6,578	)		(2,407	)		(15,747	)
Income (loss) from discontinued operations, net of tax		178			(55	)		101			157			411			(242	)
Net loss attributable to Regional Health Properties, Inc. common stockholders	$	(2,065	)	$	(4,440	)
Net income (loss) attributable to Regional Health Properties, Inc. common stockholders							$	3,561		$	(6,421	)	$	(1,996	)	$	(15,989	)
Denominator:
Basic - weighted average shares		1,688			1,647			1,688			1,688			1,688			1,665
Diluted - adjusted weighted average shares ⁽²⁾		1,688			1,647			1,688			1,688			1,688			1,665
Basic and diluted loss per share:
Loss from continuing operations attributable to Regional Health	$	(1.33	)	$	(2.66	)
Income (loss) from discontinued operations		0.11			(0.04	)
Loss attributable to Regional Health Properties, Inc. common stockholders	$	(1.22	)	$	(2.70	)
Basic and diluted income (loss) per share:
Income (loss) from continuing operations attributable to Regional Health							$	2.05		$	(3.93	)	$	(1.42	)	$	(9.45	)
Income (loss) from discontinued operations, net of tax								0.06			0.09			0.24			(0.15	)
Net income (loss) attributable to Regional Health Properties, Inc. common stockholders							$	2.11		$	(3.84	)	$	(1.18	)	$	(9.60	)

	March 31,				September 30,
(Share amounts in 000’s)	2019		2018		2019		2018
Stock options		15		15		15		15
Warrants - employee		49		49		49		49
Warrants - non employee		36		36		36		36
Shares issuable upon conversion of convertible debt		—		—
Total anti-dilutive securities		100		100		100		100

~~For the three months ended and as~~As of ~~March 31,~~September 30, 2019, we had negative working capital of ~~$34.3 million.~~approximately $1.6 million which excludes $6.1 million of current operating lease obligation (with the corresponding right of use asset classified as long term). At ~~March 31,~~September 30, 2019, we had ~~$1.5~~$3.4 million in unrestricted cash and ~~$80.1~~$55.8 million in indebtedness, including current maturities of ~~$25.7~~$1.7 million. The current portion of such indebtedness is comprised ~~of: (i) $19.4 million~~ of long term-debt (including a $0.5 million “tail fee” and a $0.5 million “repayment or acceleration fee”) under the Pinecone Credit Facility, classified as current due to the Company’s short-term forbearance agreement regarding the Company’s noncompliance with certain covenants under the Pinecone Credit Facility, pursuant to which Pinecone may exercise its default-related rights and remedies, including the acceleration of the maturity of the debt, upon the termination of the forbearance period under such forbearance agreement (as further discussed below in this note); (ii) $4.0 million of mortgage indebtedness under the Quail Creek Credit Facility maturing in June 2019; and (iii) other debt of approximately $2.3 million, which includes senior debt and bond and mortgage indebtedness. On August 1, 2019, the Company fully repaid the amounts due under the Pinecone Credit Facility and the Quail Creek Credit Facility using the proceeds from the Asset Sale.

~~The~~Prior to August 1, 2019, the continuation of our business iswas dependent upon our ability: (i) to comply with the terms and conditions under the Pinecone Credit Facility and the Second A&R Forbearance Agreement ~~(see Note -15~~ ~~Subsequent Events~~ ~~for details of an amendment to the Second A&R Forbearance Agreement);~~as amended on June 13, 2019; and (ii) to refinance or obtain further debt maturity extensions on the Quail Creek

Credit Facility, neither of which iswas entirely within the Company’s control. These factors ~~create~~had created substantial doubt about the Company’s ability to continue as a going concern.

The Company ~~is pursuing a strategy to repay~~repaid the Pinecone Credit Facility and Quail Creek Credit Facility ~~within the next few months.~~on August 1, 2019. If ~~these~~ efforts ~~are~~to make such repayments had been unsuccessful, the Company ~~may be~~would have been required to seek relief through a number of other available alternatives ~~which may include~~including a filing under the U.S. Bankruptcy Code. The consolidated financial statements do not include any adjustments that might behave been necessary if the Company iswas unable to continue as a going concern. See Note – 1510 ~~Subsequent Events~~Discontinued Operations and Dispositions ~~for details~~. The Asset Sale on ~~a purchase~~August 1, 2019, and ~~sale agreement, with respect to~~ the ~~sale~~repayment of ~~certain of~~all amounts due under the ~~Company’s facilities, which transaction, if successfully completed, is intended to address~~Pinecone Credit Facility and the Quail Creek Credit Facility, have addressed certain factors ~~creating~~that had created substantial doubt regarding the Company’s ability to continue as a going concern. ~~There~~As a result of such repayment, the Company is ~~no assurance, however,~~able to conclude that ~~these efforts, including~~it is probable that the ~~asset sale contemplated by such purchase and sale agreement,~~Company will be ~~successful.~~able to meet its obligations arising within one year of the date of issuance of these consolidated financial statements within the parameters set forth in the accounting guidance.

The Company is undertaking measures to grow its operations, streamline its cost infrastructure and otherwise increase liquidity by: (i) refinancing or repaying debt ~~which is classified as current and longer term debt~~ to reduce interest costs and mandatory principal repayments, with such repayment to be funded through potentially expanding borrowing arrangements with certain lenders or raising capital through the ~~sale~~issuance of ~~assets;~~securities after restructuring of the Company’s capital structure; (ii) increasing future lease revenue through acquisitions and investments in existing properties; (iii) modifying the terms of existing leases; (iv) replacing certain tenants who default on their lease payment terms; and (v) reducing other and general and administrative expenses.

Management anticipates access to several sources of liquidity, including cash on hand, cash flows from operations, and debt refinancing during the twelve months from the date of this filing. At ~~March 31,~~September 30, 2019, the Company had ~~$1.5~~$3.4 million in unrestricted cash. During the ~~three~~nine months ended ~~March 31,~~September 30, 2019, the Company generated positive operating cash flow from continuing operations of ~~$0.1~~$2.2 million.

On June 8, 2018, the Board indefinitely suspended quarterly dividend payments with respect to the Series A Preferred Stock. Such dividends are currently in arrears with respect to the fourth quarter of 2017, all quarters of 2018, and the first, ~~quarter~~second and third quarters of 2019. The Board plans to revisit the dividend payment policy with respect to the Series A Preferred Stock on an ongoing basis. The Board believes that the dividend suspension will provide the Company with additional funds to meet its ongoing liquidity needs. As the Company has failed to pay cash dividends on the outstanding Series A Preferred Stock in full for more than four dividend periods, the annual dividend rate on the Series A Preferred Stock for the fifth and future missed dividend periods has increased to 12.875%, which is equivalent to $3.22 per share each year, commencing on the first day after the missed fourth quarterly payment (October 1, 2018) and continuing until the second consecutive dividend payment date following such time as the Company has paid all accumulated and unpaid dividends on the Series A Preferred Stock in full in cash.

As of ~~March 31,~~September 30, 2019, the Company had total current liabilities of ~~$39.3~~$14.1 million and total current assets of ~~$5.0~~$6.4 million, resulting in a working capital deficit of approximately ~~$34.3 million.~~$1.6 million after excluding $6.1 million of current operating lease obligation (with the corresponding right of use asset classified as long term). Included in current liabilities at ~~March 31,~~September 30, 2019 is the ~~$25.7~~$1.7 million ~~(net of $0.1 million of deferred financing)~~ current portion of the Company’s ~~$80.1~~$55.8 million in indebtedness. The current portion of such indebtedness is comprised ~~of: (i) $19.4 million~~ of long term-debt (including a $0.5 million “tail fee” and a $0.5 million “repayment or acceleration fee” ) under the Pinecone Credit Facility, classified as current due to the Company’s short-term forbearance agreement with Pinecone regarding the Company’s noncompliance with certain covenants under the Pinecone Credit Facility pursuant to which Pinecone may exercise its default-related rights and remedies, including the acceleration of the maturity of the debt, upon the termination of the forbearance period under such forbearance agreement (as further discussed below in this note); (ii) $4.0 million mortgage indebtedness under the Quail Creek Credit Facility maturing in June 2019; and (iii) other debt of approximately $2.3 million, which includes senior debt, ~~and~~ bond and mortgage ~~indebtedness.~~indebtedness and other debt. The Company anticipates net principal repayments of approximately ~~$25.8~~$1.7 million during the next twelve-month period, which includes ~~the $19.4 million debt under the Pinecone Credit Facility,~~ approximately ~~$4.0 million of payments under the Quail Creek Credit Facility,~~ $1.5 million of routine debt service amortization, ~~approximately $0.8~~$0.1 million payments on other non-routine debt and a $0.1 million payment of bond debt.

On ~~February 15, 2018 (the “Closing Date”),~~August 1, 2019, the Company entered into the Pinecone Credit Facility with Pinecone, with an aggregate principal amount of $16.25 million, which refinanced existing mortgage debt in an aggregate amount of $8.7 million on three skilled nursing properties known as Attalla, College Park and Northwest (the “Facilities”), and provided additional surplus cash flow of $6.3 million for general corporate needs (see Note 9 ~~– Notes Payable and Other Debt) after deducting approximately $1.25 million in debt issuance costs and prepayment penalties. Regional Health is~~used a ~~guarantor~~portion of the proceeds from the Asset Sale to repay approximately $21.3 million to Pinecone ~~Credit Facility. Certain of~~to extinguish all indebtedness owed by the ~~notes~~Company under the Pinecone Credit Facility, ~~are also guaranteed by certain wholly-owned subsidiaries of Regional Health. The surplus cash flow from the Pinecone Credit Facility was used~~and to ~~fund $2.4 million of self-insurance reserves for professional and general liability claims with respect to 25 professional and general liability actions, and~~

~~to fund repayment of $1.5 million in convertible debt. The remaining $2.4 million in surplus cash proceeds from the Pinecone Credit Facility was used for general corporate purposes.~~

On May 10, 2018, Pinecone notified the Company in writing (the “Default Letter”) that the Company was in default under certain financial covenants of the Loan Agreement dated as of February 15, 2018, among the Company and certain of its subsidiaries and Pinecone (the “Loan Agreement”) and other loan documents evidencing the Pinecone Credit Facility (collectively, the “Pinecone Loan Documents”). On May 18, 2018, the Company and certain of its subsidiaries entered into a Forbearance Agreement with Pinecone with respect to the specified events of default set forth therein (the “Original Forbearance Agreement”), pursuant to which, among other things, additional fees in the amount of $0.4 million were added to the outstanding principal balance under the Pinecone Credit Facility. The forbearance period under the Original Forbearance Agreement terminated on July 6, 2018 because the Company did not satisfy conditions in the Original Forbearance Agreement that required the Company to enter into an agreement with Pinecone to support a transaction or series of transactions to remedy the defaults specified in the Default Letter and the Original Forbearance Agreement.

On September 6, 2018, the Company and certain of its subsidiaries entered into a new Forbearance Agreement (the “New Forbearance Agreement”) with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the New Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to specified events of default (such events of default as set forth in the Company’s forbearance agreement with Pinecone as in effect from time to time, the “Specified Defaults”) under the Pinecone Loan Documents.

Pursuant to the New Forbearance Agreement, the Company and Pinecone amended certain provisions of the Pinecone Loan Documents. Such amendments, among other things: (i) removed the restriction on prepaying the loans during the thirteen (13) month-period after the Closing Date; (ii) provided a thirty (30)-day cure period for certain events of default and a fifteen (15)-day cure period for certain failures to provide information or materials pursuant to the Pinecone Loan Documents; (iii) increased the finance fee payable on repayment or acceleration of the loans, depending on the time at which the loans are repaid ($0.25 million prior to December 31, 2018 and $0.5 million thereafter); and (iv) increased the outstanding principal balance owed by (a)repay approximately ~~$0.7~~$3.8 million to ~~reimburse Pinecone for its accrued and unpaid expenses and~~Congressional Bank to pay outstanding interest payments for prior interest periods and (b) $1.5 million fee described as a non-refundable payment of additional interest. During the forbearance period under the New Forbearance Agreement, the interest rate reverted from the default rate of 18.5% per annum to the ongoing rate of 13.5% per annum.

~~The New Forbearance Agreement terminated on December 31, 2018 because the Company did not satisfy certain conditions set forth therein.~~

On December 31, 2018, the Company and certain of its subsidiaries entered into a new amended and restated Forbearance Agreement (the “A&R New Forbearance Agreement”) with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the A&R New Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to the Specified Defaults under the Loan Agreement.

Pursuant to the A&R New Forbearance Agreement, the Company and Pinecone amended certain provisions of the Loan Agreement. In addition Pinecone consented to the termination, effective January 15, 2019, of the Company’s lease and sublease of two skilled nursing facilities, an 115-bed skilled nursing facility located in East Point, Georgia and an 184-bed skilled nursing facility located in Atlanta, Georgia (the “Omega Facilities”), by mutual consent of the Company and the lessor (affiliate of Omega Healthcare) and the sublessees (affiliates of Wellington Health Services) of each of the Omega Facilities (the “Omega Lease Termination”). The leases of the Omega Facilities were to expire in August 2025, and the A&R New Forbearance Agreement required that the Omega Lease Termination be completed by February 1, 2019.

Pursuant to the A&R New Forbearance Agreement, the Company paid Pinecone approximately $1.4 million, of which: (i) $0.2 million was paid to Pinecone on January 4, 2019 for Pinecone’s expenses; and (ii) $1.2 million was paid to Pinecone on January 28, 2019, of which (a) $0.3 million was for Pinecone’s expenses (including a 1% prepayment penalty) and (b) $0.9 million was applied to pay down the principal amount of Pinecone’s loan to AdCare Property Holdings, LLC (the “AdCare Holdco Loan”), which at March 31, 2019 was approximately $4.5 million. The Company funded such payments to Pinecone using the gross proceeds realizedextinguish all indebtedness owed by the Company ~~from the Omega Lease Termination, including a $1.2 million termination fee paid by the lessor to the Company, which fee approximated future forgone cash flow from the Company’s related sublease.~~

The A&R New Forbearance Agreement amended the Loan Agreement to, among other things: (i) add a $0.35 million fee (paid in kind) to the loans on a pro rata basis; (ii) provide for additional payment in kind interest at a rate of 3.5% (the “PIK Rate”), with such interest to be paid in kind in arrears by increasing the outstanding principal amount of loans held by the Pinecone on

the first (1st) day of each month; provided that interest accruing at the PIK Rate on each loan and any overdue interest on each loan was paid in cash (a) on the maturity of the loans, whether by acceleration or otherwise, or (b) in connection with any repayment or prepayment of the loans; and (iii) modify the default rate of interest to add an additional 2.5% to the PIK Rate, in addition to the ongoing rate of 13.5%. During the forbearance period under the ~~A&R New Forbearance Agreement, the interest rate paid in cash on the first (1st) day of each month was the ongoing rate of 13.5% per annum. See~~Quail Creek Credit Facility. For further information, see Note – 9 Notes Payable and Other debt and Note – 10 Discontinued Operations and ~~dispositions~~Dispositions for further information on the Omega Lease Termination and subsequent AdCare Holdco Loan partial repayment completed on January 28, 2019. The forbearance period under the A&R New Forbearance Agreement expired according to its terms on March 14, 2019.

On March 29, 2019, the Company and certain of its subsidiaries entered into the Second A&R Forbearance Agreement with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the Second A&R Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to the Specified Defaults under the Loan Agreement. The forbearance period under the Second A&R Forbearance Agreement commenced on March 29, 2019 and may extend as late as October 1, 2019, unless the forbearance period is earlier terminated as a result of specified termination events, including a default or event of default under the Loan Agreement (other than any Specified Defaults) or any failure by the Company or its subsidiaries to comply with the terms of the Second A&R Forbearance Agreement, including, without limitation, the Company’s obligation to progress with an Asset Sale (as defined below) in accordance with the timeline specified therein (see Note -15 ~~Subsequent Events~~ ~~for details of an amendment to the Second A&R Forbearance Agreement with respect to such timeline)~~. ~~Accordingly, the forbearance period under the Second A&R Forbearance Agreement may terminate at any time and there is no assurance such period will extend through October 1, 2019.~~

Pursuant to the Second A&R Forbearance Agreement, the Company and Pinecone amended certain provisions of the Loan Agreement. The Second A&R Forbearance Agreement requires, among other things (i) that the Company pursue and complete an asset sale (the “Asset Sale”) which would result in the repayment in full of all of the Company’s indebtedness to Pinecone and, in connection therewith, the Company pay not less than $0.3 million and not more than $0.55 million in forbearance fees, as well as certain other expenses of Pinecone, or (ii) Pinecone’s other disposition of the Loan Agreement as contemplated by the Second A&R Forbearance Agreement. Additionally the Second A&R Forbearance Agreement accelerates the previously disclosed 3% finance “tail fee”, 1% prepayment penalty, and 1% break up fee so that such fees and penalties became part of the principal as of April 15, 2019.

Upon the occurrence of an event of default (other than the Specified Defaults), or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement, Pinecone may declare the entire unpaid principal balance under the Pinecone Credit Facility, together with all accrued interest and other amounts payable to Pinecone thereunder, immediately due and payable. Subject to the terms of the Pinecone Loan Documents, Pinecone may foreclose on the collateral securing the Pinecone Credit Facility (the “Collateral”). The Collateral includes, among other things, the Facilities and all assets of the borrowers owning the Facilities, the leases associated with the Facilities and all revenue generated by the Facilities, and rights under a promissory note in the amount of $4.5 million, issued by Regional Health pursuant to the Pinecone Credit Facility in favor of one of its subsidiaries, which subsidiary is a borrower and guarantor under the Pinecone Credit Facility.

In addition, the equity interests in substantially all of Regional Health’s direct and indirect, wholly-owned subsidiaries (the “Pledged Subsidiaries”) have been pledged to Pinecone as part of the Collateral. The assets and operations of the Pledged Subsidiaries constitute substantially all of the Company’s assets and operations. Upon the occurrence of an event of default (other than the Specified Defaults) or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement, Pinecone may, in addition to its other rights and remedies, remove any or all of the managers of the Pledged Subsidiaries and appoint its own representatives as managers of such Pledged Subsidiaries. If Pinecone elects to appoint its own representatives as managers of the Pledged Subsidiaries, then such managers would control such subsidiaries and their assets and operations and could potentially restrict or prevent such subsidiaries from paying dividends or distributions to Regional Health. As a holding company with no significant operations, Regional Health relies primarily on dividends and distributions from the Pledged Subsidiaries to meet its obligations and pay dividends on its capital stock (when and as declared by the Board.)

The Pinecone Loan Documents provide that Pinecone’s rights and remedies upon an event of default are cumulative, and that Pinecone may exercise (although it is not obligated to do so) all or any one or more of the rights and remedies available to it under the Pinecone Loan Documents or applicable law. The Company does not know which rights and remedies, if any, Pinecone may choose to exercise under the Pinecone Loan Documents upon the occurrence of an event of default (other than the Specified Defaults) or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement. If Pinecone elects to appoint its own representatives as managers of the Pledged Subsidiaries, to accelerate the indebtedness under the Pinecone Credit Facility, or to foreclose on significant assets of the Company (such as the Facilities and/or the equity interests in the Pledged Subsidiaries), then it will have a material adverse effect on the Company’s liquidity, cash flows, financial condition and results of operations, and on the Company’s ability to continue as a going concern.

The forbearance period under the Second A&R Forbearance Agreement commenced on March 29, 2019 and may extend as late as October 1, 2019, unless earlier terminated upon the occurrence of specified termination events under the Second A&R Forbearance Agreement. As of such date or earlier termination, Pinecone will no longer be required to forbear from exercising its default-related rights and remedies with respect to the Specified Defaults and may exercise all of its rights and remedies with respect to the Pinecone Loan Documents at that time.

As of ~~March 31,~~September 30, 2019, the Company ~~is in compliance with its debt covenants other than those in the Quail Creek Credit Facility. The Company~~ was ~~not~~ in compliance with the monthly operator minimum EBITDAR required under the Quail Creek Credit Facility as of March 31, 2019. The Quail Credit Facility requires the Company maintain an operator minimum EBITDAR of $400 thousand, andvarious covenants for the Company’s operator minimum EBITDAR was equal to $294 thousand as of March 31, 2019. The Company is currently in the process to obtain a waiver for such violation in anticipation of the sale of the Company’s 118-bed skilled nursing facility commonly known as Quail Creek Nursing & Rehabilitation Center located in Oklahoma City, Oklahoma (the “Quail Creek Facility”), the sale of which is contemplated by the purchase and sale agreement disclosed in Note 15 – ~~Subsequent Events. The Quail Creek Credit Facility is secured by the Quail Creek Facility.~~

On ~~January 15, 2019, but effective February~~August 1, 2019 ~~the Company agreed to a 10% reduction in base rent, or an aggregate average of approximately $31,000 per month cash rent reduction for the year ending December 31, 2019,~~ and $48,000 per month decrease in straight-line revenue, respectively, for two of the Company’s eight facilities located in Georgia, which are subleased to affiliates of Wellington Health Services (the “Wellington Sublessees”) under agreements dated January 31, 2015, as subsequently amended (the “Wellington Subleases”). The Wellington Subleases due to expire August 31, 2027, relate to the Company’s 134-bed skilled nursing facility located in Thunderbolt, Georgia (the “Tara Facility”) and an 208-bed skilled nursing facility located in Powder Springs, Georgia (the “Power Springs Facility”). Additionally, the Company modified the annual rent escalator to 1% per year from the prior scheduled increase from 1% to 2% previously due to commence on the 1st day of the sixth lease year.

On August 28, 2018, the Company received a deficiency letter from NYSE American stating that the Company was not in compliance with the continued listing standards as set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “Company Guide”). Specifically, the letter informed the Company that the Exchange determined that shares of the Company’s securities were selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the Company Guide, the Company’s continued listing was predicated on the Company effecting a reverse stock split of the common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the Exchange determined to be no later than February 27, 2019.

~~On February~~ 28, 2019 the Company ~~regained compliance with~~completed the ~~continued listing standards set forth in the Company Guide regarding the low selling price by completing the Reverse Stock Split.~~Asset Sale. The ~~proposal to amend the Charter to effect a reverse stock split~~sale of the ~~common stock at a ratio of between one-for-six and one-for-twelve, as determined by~~Quail Creek Facility, the ~~Board in its sole discretion, was approved at the Company’s 2018 annual meeting of shareholders,~~Attalla Facility and the ~~Reverse Stock Split became effective~~College Park Facility occurred on ~~December 31, 2018. If~~August 1, 2019, and the ~~Company is again determined to be noncompliant with any~~sale of the ~~continued listing standards of the NYSE American within twelve months of February~~Northwest Facility occurred on August 28, 2019, the Exchange will examine the relationship between the Company’s previous noncompliance with the continued listing standards with respect to the low selling price and such new event of noncompliance in accordance with Section 1009(h) of the Company Guide.2019. In connection with ~~such new event of noncompliance,~~ the ~~Exchange may, among other things, truncate~~Asset Sale: (i) MED paid to the ~~compliance procedures described~~Company a cash purchase price for the PSA Facilities equal to $28.5 million in the ~~continued listing standards or initiate immediate delisting proceedings.~~

~~On April 17, 2019,~~aggregate; (ii) the Company ~~received~~incurred approximately $0.4 million in sales commission expenses and $0.1 million for a ~~letter from NYSE American stating that the Company was not~~building improvement credit; and (iii) transferred approximately $0.1 million in ~~compliance with the Exchange’s continued listing standards under the timely filing criteria outlined in Section 1007 of the Company Guide because the Company failed~~lease security deposits to ~~timely file its Annual Report on Form 10-K~~MED. The expected 2019 annualized rent receivable, for the ~~period ended December 31, 2018. As a result, the Company became subject to the procedures~~PSA Facilities was approximately $3.0 million and requirements set forth in Section 1007 of the Company Guide. The Company was provided a six-month cure period (until October 17, 2019) during which the Exchange would monitor the Company and the status of the initial delinquent report and any subsequent delinquent reports.

~~On May 17,~~estimated 2019 the Company received a letter from NYSE American stating that the Company had regained compliance with the Exchange’s continued listing standards set forth in Part 10 of the Company Guide. Specifically, the Company resolved the continued listing deficiency with respect to sections 134 and 1011 of the Company Guide since the Company filed its Annual Report Form 10-Kannualized interest expense for the ~~period ended December 31, 2018 with the SEC~~Pinecone Credit Facility and Quail Creek Credit Facility, repaid on ~~May 17, 2019.~~

~~On May 21,~~August 1, 2019 ~~the Company received a letter of noncompliance~~ from the NYSE American stating that the Company is not in compliance with the Exchange’s continued listing standards under the timely filing criteria outlined in Section 1007 of the Company Guide because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2019 (the "Delayed Form 10-Q"), whichAsset Sale proceeds, was due to be filed with the SEC no later than May 20, 2019 (the “Filing Delinquency”). As a result of the foregoing, the Company has become subject to the procedures and requirements of Section 1007 of the Company Guide. During the six-month period from the date of the Filing Delinquency (the “Initial Cure Period”), the Exchange will monitor the Company and the status of the Delayed Form 10-Q and any subsequent reports until the Filing Delinquency is cured. If the Company fails to cure the Filing Delinquency within the Initial Cure Period, the Exchange may, in its sole discretion, allow the Company’s securities to be traded for up to an additional six-month period (the “Additional Cure Period”), depending on the Company’s specific circumstances. If the Exchange determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set forth in Section 1010 of the Company Guide.

~~By filing this Quarterly Report, the Company has now filed the Delayed Form 10-Q.~~

In 2016, the NYSE American notified the Company that it was not in compliance with certain NYSE American continued listing standards relating to stockholders’ equity. The Company regained compliance with such continued listing standards as a result of the Merger, but there is no assurance that the Company will be able to maintain such compliance in the future. As of March 31, 2019, the Company’s equity at $6.4 million was $0.4 million above the required minimum for compliance with certain NYSE American continued listing standards relating to stockholders’ equity. Specifically, Section 1003(a)(iii) of the Company Guide requires stockholders’ equity of $6.0 million or more if an issuer has reported losses from continuing operations and/or net losses in its five most recent fiscal years. If the Company falls below the required minimum stockholders equity, then the Company could become subject to the procedures and requirements of Section 1009 of the Company Guide and be required to submit a compliance plan describing the actions the Company is taking or would take to regain compliance with the continued listing standards. Alternatively, the Exchange may, among other things, truncate the compliance procedures described in the continued listing standards or initiate immediate delisting proceedings.

The Company’s ability to raise additional capital through the issuance of equity securities and the terms upon which we are able to raise such capital will be adversely affected if we are unable to maintain the listing of the common stock and the Series A Preferred Stock on the NYSE American.approximately $3.8 million.

Under the accounting guidance related to the presentation of financial statements, the Company is required to evaluate, on a quarterly basis, whether or not the entity’s current financial condition, including its sources of liquidity at the date that the consolidated financial statements are issued, will enable the entity to meet its obligations as they come due arising within one year of the date of the issuance of the Company’s consolidated financial statements and to make a determination as to whether or not it is probable, under the application of this accounting guidance, that the entity will be able to continue as a going concern. The Company’s consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

In applying applicable accounting guidance, management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows, and the Company’s obligations due over the next twelve months, including the Quail Creek Credit Facility maturing in June 2019, the likelihood that the Company will be able to comply with the requirements in the Pinecone Loan Documents, including the Second A&R New Forbearance Agreement, and Pinecone’s remedies in the event of non-compliance, as well as the Company’s recurring business operating expenses.

~~There is no assurance that~~As the Company will be able to repay, refinance or obtain further debt maturity extensions on the Quail Creek Credit Facility, or comply with all of the requirements under the Pinecone Loan Documents, including the Second A&R Forbearance Agreement as amended, which requires, among other things, that the Company complete the Asset Sale in accordance with the timeframe set forth therein. Such compliance depends, in part, on the Company’s ability to work with outside parties, which is not within the Company’s exclusive control. If the Company is unable to repay, refinance or obtain further debt maturity extensions on the Quail Creek Credit Facility, the Quail Creek Facility lender may exercise its default-related rights, or if the Company is unable to comply with all the requirements under the Pinecone Loan Documents, including the Second A&R Forbearance Agreement, and Pinecone were to accelerate all obligations under the Pinecone Loan Documents or otherwise exercise its default-related rights or foreclose on the Collateral, then it will have a material adverse consequence on the Company’s ability to meet its obligations arising within one year of the date of issuance of these consolidated financial statements.

~~The Company is pursuing a strategy to repay~~fully repaid the Pinecone Credit Facility and ~~the~~ Quail Creek Credit Facility ~~by means~~on August 1, 2019 from the proceeds of the Asset Sale, ~~and to streamline its cost infrastructure. See Note – 9~~ ~~Notes Payable and Other Debt~~ ~~and Note – 15~~ ~~Subsequent Events~~ for a further discussion of the conditions of the extension of the Quail Creek Credit Facility and a purchase and sale transaction to effectuate the Asset Sale, which if completed, would permit us to repay the Pinecone Credit Facility and the Quail Creek Credit Facility in full. There is no assurance that we will be able to successfully execute this strategy or otherwise repay the Pinecone Credit Facility and the Quail Creek Credit Facility. Due to the inherent risks, unknown results, and significant uncertainties associated with each of these matters along with the direct correlation between these matters and the Company’s ability to satisfy the financial obligations that may arise over the applicable one-year period, the Company is ~~unable~~able to conclude that it is probable that the Company will be able to meet its obligations arising within one year of the date of issuance of these consolidated financial statements within the parameters set forth in the accounting guidance.

These factors create substantial doubt about the Company’s ability to continue as a going concern. If the Company’s efforts to repay the Pinecone Credit Facility and the Quail Creek Facility are unsuccessful, the Company may be required to seek relief through a number of other available routes, which may include a filing under the U.S. Bankruptcy Code. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

(Amounts in 000’s)	March 31, 2019		December 31, 2018		September 30, 2019		December 31, 2018
Cash	$	1,533	$	2,407	$	3,421	$	2,407

Restricted cash:
Cash collateral		144		313		94		313
Replacement reserves		297		297		—		297
Escrow deposits		659		801		1,025		801
Total current portion		1,100		1,411		1,119		1,411

Restricted cash for debt obligations		365		365		317		365
HUD and other replacement reserves		2,275		2,303		2,233		2,303
Total noncurrent portion		2,640		2,668		2,550		2,668
Total restricted cash		3,740		4,079		3,669		4,079

Total cash and restricted cash	$	5,273	$	6,486	$	7,090	$	6,486

Cash collateral—In securing mortgage financing from certain lending institutions, the Company and certain of its wholly-owned subsidiaries are required to deposit cash to be held as collateral in accordance with the terms of such loan agreements.

Replacement reserves—Cash reserves set aside for non-critical building repairs for completion within the next 12twelve months, pursuant to loan agreements.

Escrow deposits—In connection with financing secured through the Company’s lenders, several wholly-owned subsidiaries of the Company are required to make monthly escrow deposits for taxes and insurance.

Restricted cash for other debt obligations—In compliance with certain financing and insurance agreements, the Company and certain wholly-owned subsidiaries of the Company are required to deposit cash held as collateral by the lender or in escrow with certain designated financial institutions.

HUD and other replacement reserves—The regulatory agreements entered into in connection with the financing secured through the U.S. Department of Housing and Urban Development (“HUD”) require monthly escrow deposits for replacement and improvement of the HUD project assets..

(Amounts in 000’s)	Estimated Useful Lives (Years)		March 31, 2019			December 31, 2018			Estimated Useful Lives (Years)		September 30, 2019			December 31, 2018
Buildings and improvements	5-40		$	88,764		$	88,710		5-40		$	65,679		$	88,710
Equipment and computer related	2-10			7,151			7,398		2-10			5,748			7,398
Land		—		4,130			4,131			—		2,779			4,131
Construction in process		—		26			43			—		114			43
				100,071			100,282					74,320			100,282
Less: accumulated depreciation and amortization				(23,649	)		(23,045	)				(18,808	)		(23,045	)
Property and equipment, net			$	76,422		$	77,237				$	55,512		$	77,237

During the three months ended June 30, 2019, the Company transferred $19.7 million of Property and equipment, net, to Assets held for sale and on August 1, 2019, and August 28, 2019, sold approximately $17.0 million and $2.7 million, respectively of such net assets. See Note 10 – Discontinued Operations and Dispositions.

The following table summarizes total depreciation and amortization expense for the three and nine months ended ~~March 31,~~September 30, 2019 and 2018:

	Three Months Ended March 31,				Three Months Ended September 30,				Nine Months Ended September 30,
(Amounts in 000’s)	2019		2018		2019		2018		2019		2018
Depreciation	$	731	$	808	$	571	$	788	$	1,906	$	2,394
Amortization		292		413		226		338		755		1,113
Total depreciation and amortization expense	$	1,023	$	1,221	$	797	$	1,126	$	2,661	$	3,507

(Amounts in 000’s)	Bed licenses (included in property and equipment)^(a)			Bed Licenses - Separable		Lease Rights			Total			Bed licenses (included in property and equipment)^(a)			Bed Licenses - Separable		Lease Rights			Total
Balances, December 31, 2018
Gross	$	22,811		$	2,471	$	5,015		$	30,297		$	22,811		$	2,471	$	5,015		$	30,297
Accumulated amortization		(4,849	)		—		(4,109	)		(8,958	)		(4,849	)		—		(4,109	)		(8,958	)
Net carrying amount	$	17,962		$	2,471	$	906		$	21,339		$	17,962		$	2,471	$	906		$	21,339
Acquisitions		—			—		40			40			—			—		43			43
Assets sold
Gross													(8,535	)		—		—			(8,535	)
Accumulated amortization													2,003			—		—			2,003
Fully amortized asset adjustments
Gross													—			—		(300	)		(300	)
Accumulated amortization													—			—		300			300
Amortization expense		(171	)		—		(121	)		(292	)		(390	)		—		(365	)		(755	)
Balances, March 31, 2019
Balances, September 30, 2019
Gross		22,811			2,471		5,055			30,337			14,276			2,471		4,758			21,505
Accumulated amortization		(5,020	)		—		(4,230	)		(9,250	)		(3,236	)		—		(4,174	)		(7,410	)
Net carrying amount	$	17,791		$	2,471	$	825		$	21,087		$	11,040		$	2,471	$	584		$	14,095

The following table summarizes amortization expense for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 and 2018:

	Three Months Ended March 31,				Three Months Ended September 30,				Nine Months Ended September 30,
(Amounts in 000’s)	2019		2018		2019		2018		2019		2018
Bed licenses	$	171	$	171	$	104	$	171	$	390	$	512
Lease rights		121		242		122		167		365		601
Total amortization expense	$	292	$	413	$	226	$	338	$	755	$	1,113

Expected amortization expense for all definite-lived intangibles for each of the years ended December 31 is as follows:

(Amounts in 000’s)	Bed Licenses		Lease Rights		Bed Licenses		Lease Rights
2019^(a)	$	512	$	367	$	104	$	122
2020		683		303		414		304
2021		683		23		414		24
2022		683		23		414		24
2023		683		23		414		23
Thereafter		14,547		86		9,280		87
Total expected amortization expense	$	17,791	$	825	$	11,040	$	584

(Amounts in 000’s)	March 31, 2019			December 31, 2018			September 30, 2019			December 31, 2018
Goodwill	$	2,945		$	2,945
Accumulated impairment losses		(840	)		(840	)
Goodwill - balances, December 31, prior year							$	2,105		$	2,105
Assets sold								(520	)		—
Net carrying amount	$	2,105		$	2,105		$	1,585		$	2,105

The Company does not amortize indefinite-lived intangibles, which consist of separable bed licenses and goodwill.

The Company leases nine skilled nursing facilities from unaffiliated owners under non-cancelable leases, all of which have rent escalation clauses and provisions requiring payment of real estate taxes, insurance and maintenance costs by the lessee. Each of the skilled nursing facilities that are leased by the Company are subleased to and operated by third-party tenants. The Company also leases certain office space located in Atlanta and Suwanee, Georgia. The Atlanta office space is subleased to a third-party entity.

As of ~~March 31,~~September 30, 2019, the Company is in compliance with all operating lease financial covenants.

The weighted average remaining lease term for our nine subleased facilities is ~~8.6~~8.1 years.

Foster Prime Lease. Eight of the Company’s skilled nursing facilities (collectively, the “Georgia Facilities”) are leased under a single master indivisible arrangement (as amended), by and between the Company and William M. Foster, with a lease termination date of August 31, 2027 (the “Prime Lease”). Under the Prime Lease, a default related to an individual facility may cause a default of the entire Prime Lease. The Company is responsible for the cost of maintaining the Georgia Facilities. On August 14, 2015, the lessor consented to the Company’s sublease of the Georgia Facilities to a third-party tenant. Commencing on July 1, 2016, annual rent increases at 2.0% annually for the remainder of the lease term.

Covington Prime Lease. One of the Company’s facilities is leased under an agreement dated August 26, 2002, as subsequently amended (the “Covington Prime Lease”), by and between the Company and Covington Realty, LLC (“Covington”). On January 11, 2019 the Company and Covington entered into a forbearance agreement (the “Covington Forbearance Agreement”), whereby the Company and Covington agreed ~~that (a)~~that: (i) the term of the lease shall be extended from April 30, 2025 until April 30, 2029 (the “Term”); ~~(b)~~(ii) the base rent was reduced by approximately $0.8 million over the remainder of the prior lease term; and ~~(c)~~(iii) the Company shall receive relief from approximately $0.5 million of outstanding lease amounts (the “Rent Due”) as of December 31, 2018. Without waiving any default by the Company or Covington’s rights and remedies, and subject to specified terms and conditions for so long as the Company or the Company’s subtenant are not in default under the lease and the proposed sublease, as the case may ~~be.~~be, Covington (including its subsidiaries, affiliates, successors and assigns) will forbear from pursuing its rights against the Company for so long as neither the Company nor its subtenant is not in default under the existing lease, as amended on January 11, 2019, or the new sublease, on the final day of the third, fourth and fifth years following the execution of the new sublease. Covington will release and forever quit claim specified portions of the Rent Due as follows: one-third ~~(1/3)~~at the end of year

three of the new sublease, one-third at the end of year ~~3 of the new sublease, one-third (1/3) at the end of year 4~~four of the new sublease, and one-third ~~(1/3)~~ at the end of year 5five of the new sublease. The forbearance period under the Covington Forbearance Agreement shall terminate as of the expiration of the Term. At Covington’s option in its sole and absolute business discretion, the Covington Forbearance Agreement and the forbearance period thereunder can be terminated upon the occurrence of certain specified events such as, the Company files a petition for bankruptcy or takes advantage of any other debtor relief law, or an involuntary petition for bankruptcy is filed against the Company, or any other judicial action is taken with respect to the Company by any creditor of the Company or the Company breaches or defaults in performance of any covenant or agreement contained in the Covington Forbearance Agreement. Upon termination of the forbearance period under the Covington Forbearance Agreement, for any reason, Covington may take all steps it deems necessary or desirable to enforce its lease rights as permitted by law or equity.

Bonterra/Parkview Master Lease. The Company and certain of its subsidiaries entered into a forbearance agreement with Pinecone with respect to the Pinecone Credit Facility on December 31, 2018 (the “A&R New Forbearance Agreement”). Pursuant to the A&R New Forbearance Agreement, Pinecone consented to the termination, of the Company’s lease and sublease of two skilled nursing facilities, an 115-bed skilled nursing facility located in East Point, Georgia and an 184-bed skilled nursing facility located in Atlanta, Georgia (the “Omega Facilities”), by mutual consent of the Company and the lessor (affiliate of Omega Healthcare) and the sublessees (affiliates of Wellington Health Services) of each of the Omega Facilities (the “Omega Lease Termination”). Prior to the Omega Lease Termination which was effective January 15, 2019, the Omega Facilities were leased under a single indivisible agreement (the “Bonterra/Parkview Master Lease”), which leases were due to expire August 2025 and which Omega Facilities the Company subleased to third party subtenants. Effective January 15, 2019, pursuant to the Omega Lease Termination and as contemplated by the A&R New Forbearance Agreement, the Company’s leases for the Omega Facilities were terminated by mutual consent of the Company and the lessor of the Omega Facilities.

In connection with the Omega Lease Termination, the Company transferred approximately $0.4 million of all its integral physical fixed assets in the Omega Facilities to the lessor and on January 28, 2019 received from the lessor gross proceeds of approximately $1.5 million, consisting of (i) a termination fee in the amount of $1.2 million and (ii) approximately $0.3 million to satisfy other net amounts due to the Company under the leases. The Company paid $1.2 million of such Omega Lease Termination proceeds to Pinecone on January 28, 2019, as required by the A&R New Forbearance Agreement, to reimburse Pinecone for approximately $0.3 million of certain unpaid expenses and partially prepay $0.9 million of the principal amount of Pinecone’s loan to AdCare Property Holdings, LLC (the “AdCare Holdco ~~Loan.~~Loan”). The Omega Lease Termination contributed approximately $0.7 million income recorded in "Net loss attributable to Regional Health Properties, Inc. common stockholders" reported in the consolidated statement of operations for the period ended March 31, 2019. For further information, see Note 10 - Discontinued Operations and Dispositions.

Wellington. Two of the Company’s eight Georgia Facilities, leased under the Prime Lease, are subleased to ~~the~~affiliates of Wellington ~~Sublessees~~Health Services under ~~the~~ agreements dated January 31, 2015, as subsequently amended (the “Wellington Subleases”). The Wellington Subleases, which are due to expire August 31, 2027, ~~comprising the Tara Facility~~relate to the Company’s 134-bed skilled nursing facility located in Thunderbolt, Georgia (the “Tara Facility”) and ~~the Power~~an 208-bed skilled nursing facility located in Powder Springs, ~~Facility.~~ Georgia (the “Powder Springs Facility”). Effective February 1, 2019, the Company agreed to a 10% reduction in base rent, or in aggregate approximately an average $31,000 per month cash rent reduction for the year ended December 31, 2019, and $48,000 per month decrease in straight-line revenue, respectively for the Tara Facility and the ~~Power~~Powder Springs Facility combined. Additionally the Company modified the annual rent escalator to 1% per year from the prior scheduled increase from 1% to 2% previously due to commence of the 1^s^tst day of the sixth lease year.

Future minimum lease payments for each of the next five years ending December 31, are as follows:

(Amounts in 000’s)	Future rental payments		Accretion of lease liability ⁽¹⁾			Operating lease obligation		Future rental payments		Accretion of lease liability ⁽¹⁾			Operating lease obligation
2019 ⁽²⁾	$	4,712	$	(153	)	$	4,559	$	1,584	$	(20	)	$	1,564
2020		6,390		(623	)		5,767		6,390		(389	)		6,001
2021		6,551		(1,091	)		5,460		6,551		(869	)		5,682
2022		6,691		(1,540	)		5,151		6,691		(1,331	)		5,360
2023		6,823		(1,972	)		4,851		6,823		(1,775	)		5,048
Thereafter		26,790		(11,030	)		15,760		26,790		(10,391	)		16,399
Total	$	57,957	$	(16,409	)	$	41,548	$	54,829	$	(14,775	)	$	40,054

~~The~~As of September 30, 2019, the Company ~~leases~~leased or ~~subleases 25~~subleased 21 facilities ~~(16~~(12 owned by the Company and 9nine leased to the Company), to third-party tenants on a triple net basis, meaning that the lessee (i.e., the third-party tenant of the property) is obligated under the lease or sublease, as applicable, for all costs of operating the property, including insurance, taxes and facility maintenance, as well as the lease or sublease payments, as applicable. The weighted average remaining lease term for our facilities is ~~8.6~~8.2 years.

Beacon. On August 1, 2015, the Company entered into a lease inducement fee agreement with certain affiliates (collectively, the "Beacon Affiliates") of Beacon Health Management, LLC (“Beacon”), pursuant to which the Company paid a fee of $0.6 million as a lease inducement for certain Beacon Affiliates to enter into sublease agreements and to commence such subleases and transfer operations thereunder (the “Beacon Lease Inducement”). As of December 31, 2017, the balance of the Beacon Lease Inducement was approximately $0.5 million. On April 24, 2018, five Beacon affiliates (the “Ohio Beacon Affiliates”) informed the Company in writing that they would no longer be operating five (four owned and one leased by the Company) of the Company’s facilities located in Ohio (the “Ohio Beacon Facilities”), whose leases were set to expire in 2025, and that they would surrender operation of such facilities to the Company on June 30, 2018. On November 30, 2018, the Ohio Beacon Affiliates, who were ten months in arrears on rental payments, surrendered possession of the Ohio Beacon Facilities and the lease was terminated by mutual consent. Pursuant to such termination, on November 30, 2018, the Company and the Ohio Beacon Affiliates entered into a termination agreement (the “Ohio Beacon Termination Agreement”), whereby the Ohio Beacon Affiliates agreed to pay a $0.675 million termination fee, payable in 18 monthly installments of $37,500 commencing January 3, 2019 in full satisfaction of the $0.5 million Beacon Lease Inducement and approximately $2.5 million in rent in arrears and approximately $0.6 million of other receivables, such as property taxes and capital expenditures, which discharges each tenant from any and all claims upon completion of the payment plan. The Company intends to enforce its rights under the Ohio Beacon Termination Agreement. As of the date of filing this Quarterly Report, ~~six~~11 such installment payments have been received, but there is no assurance that the Company will be able to obtain payment of the outstanding unpaid termination fee from the Ohio Beacon Affiliates. During the year ended December 31, 2018, the Company recognized revenue on a cash basis with respect to the Ohio Beacon Facilities. During the first quarter of 2018, the Company expensed approximately $0.7 million straight-line rent asset, recorded an allowance of $0.5 million against the Beacon Lease Inducement and recorded approximately $0.3 million allowance for other receivables. During the three months ended September 30, 2019,the Company released approximately $0.3 million of the provision of doubtful accounts as the Company has assessed the collectability of the remaining $0.3 million termination fee is more probable than not.

Aspire. On November 30, 2018, the Company subleased the Ohio Beacon Facilities to affiliates (collectively, “Aspire Sublessees”) of Aspire Regional Partners, Inc. (“Aspire”) management formerly affiliated with MSTC Development Inc., pursuant to separate sublease agreements (the “Aspire Subleases”), whereby the Aspire Sublessees took possession of, and commenced operating, the Ohio Beacon Facilities (under Aspire’s operation, the “Aspire Facilities”) as subtenant. The Aspire Subleases became effective on December 1, 2018 and are structured as triple net leases. The Aspire Facilities are comprised of: (i) a 94-bed skilled nursing facility located in Covington, Ohio (the “Covington Facility”); (ii) an 80-bed assisted living facility located in Springfield, Ohio (the “Eaglewood ALF Facility”); (iii) a 99-bed skilled nursing facility located in Springfield, Ohio (the “Eaglewood Care Center Facility”); (iv) a 50-bed skilled nursing facility located in Greenfield, Ohio (the “H&C of Greenfield Facility”); and (v) a 50-bed skilled nursing facility located in Sidney, Ohio (the “Pavilion Care Facility”). Under the Aspire Subleases, a default related to an individual facility may cause a default under all the Aspire Subleases. All Subleases are for an initial term of ~~ten~~10 years, with renewal options, except with respect to term for the H&C of Greenfield Facility, which has an initial five year term, and set annual rent increases generally commencing in the third lease year; from month seven of the Aspire Subleases monthly rent amounts may increase based on each facility’s prior month occupancy, with minimum annual rent escalations of at least 1% generally commencing in the third lease year. Minimum rent receivable for the Covington Facility, the Eaglewood ALF Facility, the Eaglewood Care Center Facility, the H&C of Greenfield Facility and the Pavilion Care Facility for the year ending December 31, 2019 is $0.4 million, $0.5 million, $0.4 million, $0.2 million and $0.2 million per annum, respectively. Additionally, the Company agreed to indemnify Aspire against any and all liabilities imposed on them

as arising from the former operator, capped at $8.0 million. The Company has assessed the fair value of the indemnity agreements as not material to the financial statements at ~~March 31,~~September 30, 2019.

Symmetry. Affiliates (the “Symmetry Tenants”) of Healthcare Management, LLC (“Symmetry” or “Symmetry Healthcare”) leased the following facilities from the Company, pursuant to separate lease agreements which expire in 2030 (the “Symmetry Leases”): (i) the Company’s ~~106 bed,~~106-bed, skilled nursing facility located in Sylvia, North Carolina (the “Mountain Trace Facility”); (ii) the Company’s 96-bed, skilled nursing facility located in Sumter, South Carolina (the “Sumter Facility”); and (iii) the Company’s 84-bed, skilled nursing facility located in Georgetown, South Carolina (the “Georgetown Facility”). On June 27, 2018, the Company notified Blue Ridge of Sumter, LLC, the tenant with respect to the Sumter Facility (the “Sumter Tenant”), and Blue Ridge on the Mountain, LLC, the tenant with respect to the Mountain Trace Facility (the “Mountain Trace Tenant”), that continued breach of the payment terms of the applicable Symmetry Lease would constitute an event of default. The Symmetry Tenants had alleged that the Company was in material breach of each of the Symmetry Leases with regard to deferred maintenance and were withholding rental payments on the basis of such allegations.

Prior to September 20, 2018, the Mountain Trace Tenant had not paid approximately $0.2 million in rent owed for April through August 2018, the Sumter Tenant had not paid approximately $0.3 million in rent owed for May through August 2018, and Blue Ridge in Georgetown, LLC, the tenant with respect to the Georgetown Facility (the “Georgetown Tenant”), had not paid $0.05 million in rent owed for July and August 2018.

On September 20, 2018, the Company reached an agreement with the Symmetry Tenants with respect to the Symmetry Leases, pursuant to which the Symmetry Tenants agreed to a payment plan for the rent arrears and the Company agreed to a reduction in annualized rent of approximately $0.6 million, or 5.3% of the total expected 2018 annual cash rent, and waived approximately $0.2 million in rent arrears, upon which the Symmetry Tenants recommenced monthly rent payments of $0.1 million starting with the September 1, 2018 amounts due under the Symmetry Leases. There is no assurance that the Company will be able to obtain payment of all unpaid rents and the collection of approximately ~~$1.2~~$1.3 million ~~(of~~(comprised of approximately $0.9 million straight-line rent asset and approximately $0.4 million of payment plan receivables) of asset balances ~~shown in the table below)~~ could be at risk. During the three months ended September 30, 2019, the Company expensed approximately $0.4 million allowance against the outstanding balance of payment plan receivables. On February 28, 2019 the Company completed a mutual lease termination with the Mountain Trace Tenant and operations at the facility were transferred to Vero Health X, LLC (‘(“Vero Health”).

~~Balances, net of allowances as of March 31, 2019 and annualized cash rent under the lease agreements for the Symmetry affiliated facilities is shown below:~~

Vero Health. On February 28, 2019, the Company entered into a lease agreement (the “Vero Health Lease”) with Vero Health, providing that Vero Health would take possession of and operate the Mountain Trace Facility located in North Carolina. The Vero Health Lease became effective, upon the termination of the prior Mountain Trace Tenant mutual lease termination on March 1, 2019. The Vero Health Lease is for an initial term of 10 years, with renewal options, is structured as a triple net lease and rent for the Mountain Trace Facility is approximately $0.5 million per year, with an annual 2.5 % rent escalation clause.

Peach Health. On June 18, 2016, the Company entered into a master sublease agreement, as amended on March 30, 2018, (the “Peach Health Sublease”) with affiliates (collectively, “Peach Health Sublessee”) of Peach Health Group, LLC (“Peach Health”), providing that Peach Health Sublessee would take possession of and operate three facilities located in Georgia (the “Peach Facilities”) as subtenant. The Peach Facilities are comprised of: (i) an 85-bed skilled nursing facility located in Tybee Island, Georgia (the “Oceanside Facility”); (ii) a 50-bed skilled nursing facility located in Tybee Island, Georgia (the “Savannah Beach Facility”); and (iii) a 131-bed skilled nursing facility located in Jeffersonville, Georgia (the “Jeffersonville Facility”).

In connection with the Peach Health Sublease, the Company extended a line of credit to Peach Health Sublessee for up to $1.0 million for operations at the Peach Facilities (the “Peach Line”), with an initial interest rate of 13.5% per annum, which increases by 1% per annum. The Peach Line had a maturity date one year from the date of the first disbursement and is secured by a first priority security interest in Peach Health Sublessee’s assets and accounts receivable. On April 6, 2017, the Company modified certain terms of the Peach Line in connection with Peach Health Sublessee securing a $2.5 million revolving working capital loan from a third party lender (the “Peach Working Capital Facility”), subsequently capped at $1.75 million, which matures April 5, 2020. The Peach Working Capital Facility is secured by Peach Health Sublessee’s eligible accounts receivable, and all collections on the eligible accounts receivable are remitted to a lockbox controlled by the lender. The modifications of the Peach Line include: (i) reducing the loan balance to $0.8 million and restricting further borrowings; (ii) extending the maturity date to October 1, 2020 and adding a six month extension option by Peach Health Sublessee, subject to certain conditions; (iii) increasing the interest rate from 13.5% per annum by 1% per annum; and (iv) establishing a four-year amortization schedule. Payment of principal and interest under the Peach Line is governed by certain financial covenants limiting distributions under the Peach Working Capital Facility. Furthermore, the Company guaranteed Peach Health Sublessee’s borrowings under the Peach Working Capital Facility subject to certain burn-off provisions (i.e., the Company’s obligations under such guaranty cease after the later of 18 months or achievement of a certain financial ratio by Peach Health Sublessee). The Company is obligated to pay the outstanding balance on the Peach Working Capital Facility (after application of all eligible accounts receivable collections by the lender) if Peach Health Sublessee fails to comply with the Peach Working Capital Facility obligations and covenants. Fair value of the liability using the expected present value approach is immaterial.

At ~~March 31,~~September 30, 2019, there was approximately ~~$1.1~~$1.2 million outstanding on the Peach Line.

C.R. Management. On March 21, 2018, C. R. of Attalla, LLC (the “Attalla ~~Operator”~~Tenant”), affiliated with C-Ross Management, filed a voluntary chapter 11 bankruptcy petition in the state of Alabama, due to unpaid back taxes owed to the Internal Revenue Services (the “IRS”) and a large professional and general liability judgement (the “Attalla PLGL Claim”) imposed against it, in order to be granted an automatic stay from any IRS recoupments and any collection attempts from the Attalla PLGL Claim. The Attalla ~~Operator~~Tenant continued to pay its monthly rent obligations under its lease agreement to the Company pursuant to the April 16, 2018, court approved motion for the Attalla ~~Operator~~Tenant to formally assume the Attalla lease. As of December 31, 2018, the Company had recorded a straight-line rent receivable of approximately $0.6 million. On January 8, 2019, the Attalla ~~Operator~~Tenant bankruptcy filing was dismissed per filing with the bankruptcy court. On August 1, 2019, the Company sold the facility leased to the Attalla Tenant and the College Park Facility as part of the Asset Sale and leased to another tenant affiliated with C-Ross Management and assigned the associated leases, which were set to expire in 2030, pursuant to the Asset Sale. See Note – 10 Discontinued Operations and Dispositions for further information.

Southwest LTC. As part of the Asset Sale,on August 1, 2019 the Company sold the Quail Creek Facility and on August 28, 2019 the Company sold the Northwest Facility, assigning both associated leases which were set to expire in 2025. The tenants of such facilities were affiliated with Southwest LTC and were our only tenants associated with Southwest LTC. See Note – 10 Discontinued Operations and Dispositions for further information.

Future minimum lease receivables, At September 30, 2019, from the Company’s facilities leased and subleased to third party tenants for each of the next five years ending December 31, are as follows:

	(Amounts in 000's)		(Amounts in 000's)
2019 ^(a)	$	13,802	$	3,874
2020		18,752		15,716
2021		19,202		16,100
2022		20,442		17,272
2023		20,828		17,587
Thereafter		83,654		70,758
Total	$	176,680	$	141,307

For further details regarding the Company’s leased and subleased facilities to third-party operators, including a full summary of the Company’s leases to third-parties and which comprise the future minimum lease receivables of the Company, see Part II, Item 8, “Financial Statements and Supplementary Data”, Note 7 - Leases and Note 10 – Acquisitions and Dispositions included in the Annual Report.

(Amounts in 000’s)	March 31, 2019		December 31, 2018		September 30, 2019		December 31, 2018
Accrued employee benefits and payroll-related	$	334	$	326	$	197	$	326
Real estate and other taxes		737		851		788		851
Self-insured reserve ⁽¹⁾		955		1,435		804		1,435
Accrued interest		419		419		212		419
Unearned rental revenue		40		138		40		138
Other accrued expenses		851		1,292		826		1,292
Total accrued expenses and other	$	3,336	$	4,461	$	2,867	$	4,461

See Part II, Item 8, “Financial Statements and Supplementary Data”, Note 9 – Notes Payable and Other Debt included in the Annual Report for a detailed description of all the Company’s debt facilities.

(Amounts in 000’s)	March 31, 2019			December 31, 2018			September 30, 2019			December 31, 2018
Senior debt—guaranteed by HUD	$	32,645		$	32,857		$	32,215		$	32,857
Senior debt—guaranteed by USDA ^(a)		13,619			13,727			13,411			13,727
Senior debt—guaranteed by SBA ^(b)		664			668			655			668
Senior debt—bonds		6,717			6,960			6,616			6,960
Senior debt—other mortgage indebtedness		27,285			28,139			3,812			28,139
Other debt		844			664			618			664
Subtotal		81,774			83,015			57,327			83,015
Deferred financing costs		(1,518	)		(1,535	)		(1,393	)		(1,535	)
Unamortized discount on bonds		(160	)		(167	)		(153	)		(167	)
Total debt		80,096			81,313			55,781			81,313
Less: current portion of debt		25,733			26,397			1,747			26,397
Notes payable and other debt, net of current portion	$	54,363		$	54,916		$	54,034		$	54,916

The following is a detailed listing of the debt facilities that comprise each of the above categories:

(Amounts in 000’s)
Facility	Lender	Maturity	Interest Rate ^(a)			March 31, 2019		December 31, 2018		Lender	Maturity	Interest Rate ^(a)			September 30, 2019		December 31, 2018
Senior debt - guaranteed by HUD^(b)
The Pavilion Care Center	Red Mortgage	12/01/2027	Fixed	4.16	%	$	1,191	$	1,219	Red Mortgage	12/01/2027	Fixed	4.16	%	$	1,134	$	1,219
Hearth and Care of Greenfield	Red Mortgage	08/01/2038	Fixed	4.20	%		2,044		2,061	Red Mortgage	08/01/2038	Fixed	4.20	%		2,010		2,061
Woodland Manor	Midland State Bank	10/01/2044	Fixed	3.75	%		5,186		5,216	Midland State Bank	10/01/2044	Fixed	3.75	%		5,125		5,216
Glenvue	Midland State Bank	10/01/2044	Fixed	3.75	%		8,053		8,099	Midland State Bank	10/01/2044	Fixed	3.75	%		7,957		8,099
Autumn Breeze	KeyBank	01/01/2045	Fixed	3.65	%		7,000		7,041	KeyBank	01/01/2045	Fixed	3.65	%		6,918		7,041
Georgetown	Midland State Bank	10/01/2046	Fixed	2.98	%		3,543		3,564	Midland State Bank	10/01/2046	Fixed	2.98	%		3,501		3,564
Sumter Valley	KeyBank	01/01/2047	Fixed	3.70	%		5,628		5,657	KeyBank	01/01/2047	Fixed	3.70	%		5,570		5,657
Total						$	32,645	$	32,857						$	32,215	$	32,857
Senior debt - guaranteed by USDA ^(c)
Coosa	Metro City	09/30/2035	Prime + 1.50%	7.00	%		5,344		5,388	Metro City	09/30/2035	Prime + 1.50%	7.00	%		5,257		5,388
Mountain Trace	Community B&T	01/24/2036	Prime + 1.75%	7.25	%		4,103		4,135	Community B&T	01/24/2036	Prime + 1.75%	7.25	%		4,044		4,135
Southland	Bank of Atlanta	07/27/2036	Prime + 1.50%	7.00	%		4,172		4,204	Bank of Atlanta	07/27/2036	Prime + 1.50%	7.00	%		4,110		4,204
Total						$	13,619	$	13,727						$	13,411	$	13,727
Senior debt - guaranteed by SBA ^(d)
Southland	Bank of Atlanta	07/27/2036	Prime + 2.25%	7.75	%		664		668	Bank of Atlanta	07/27/2036	Prime + 2.25%	7.75	%		655		668
Total						$	664	$	668						$	655	$	668

(Amounts in 000’s)
Facility	Lender	Maturity	Interest Rate ^(a)			March 31, 2019		December 31, 2018		Lender	Maturity	Interest Rate ^(a)			September 30, 2019		December 31, 2018
Senior debt - bonds ^(b)
Eaglewood Bonds Series A	City of Springfield, Ohio	05/01/2042	Fixed	7.65	%	$	6,379	$	6,610	City of Springfield, Ohio	05/01/2042	Fixed	7.65	%	$	6,379	$	6,610
Eaglewood Bonds Series B	City of Springfield, Ohio	05/01/2021	Fixed	8.50	%		338		350	City of Springfield, Ohio	05/01/2021	Fixed	8.50	%		237		350
Total						$	6,717	$	6,960						$	6,616	$	6,960

(Amounts in 000’s)
Facility		Lender	Maturity	Interest Rate (a)			March 31, 2019		December 31, 2018			Lender	Maturity	Interest Rate (a)			September 30, 2019		December 31, 2018
Senior debt - other mortgage indebtedness	Senior debt - other mortgage indebtedness										Senior debt - other mortgage indebtedness
Quail Creek ^(c)		Congressional Bank	06/30/2019	LIBOR + 4.75%	7.24	%	$	3,981	$	4,059		Congressional Bank	06/30/2019	LIBOR + 4.75%	7.15	%	$	—	$	4,059
Meadowood		Exchange Bank of Alabama	05/01/2022	Fixed	4.50	%		3,882		3,918		Exchange Bank of Alabama	05/01/2022	Fixed	4.50	%		3,812		3,918
College Park(c)		Pinecone ^(b)	08/15/2020	Fixed	13.50	%		2,872		2,846		Pinecone ^(b)	08/15/2020	Fixed	13.50	%		—		2,846
Northwest(c)		Pinecone ^(b)	08/15/2020	Fixed	13.50	%		2,830		2,803		Pinecone ^(b)	08/15/2020	Fixed	13.50	%		—		2,803
Attalla(c)		Pinecone ^(b)	08/15/2020	Fixed	13.50	%		9,171		9,089		Pinecone ^(b)	08/15/2020	Fixed	13.50	%		—		9,089
Adcare Property Holdings(c)		Pinecone ^(b)	08/15/2020	Fixed	13.50	%		4,549		5,424		Pinecone ^(b)	08/15/2020	Fixed	13.50	%		—		5,424
Total							$	27,285	$	28,139							$	3,812	$	28,139

(Amounts in 000’s)
Lender	Maturity	Interest Rate			March 31, 2019		December 31, 2018		Maturity	Interest Rate			September 30, 2019		December 31, 2018
Other debt
First Insurance Funding	03/01/2020	Fixed	6.19	%	$	246	$	20	03/01/2020	Fixed	6.19	%	$	103	$	20
Key Bank	08/02/2019	Fixed	0.00	%		495		495	08/25/2021	Fixed	0.00	%		495		495
McBride Note ^(a)	09/30/2019	Fixed	4.00	%		77		115	09/30/2019	Fixed	4.00	%		—		115
South Carolina Department of Health & Human Services ^(b)	02/24/2019	Fixed	5.75	%		—		34	02/24/2019	Fixed	5.75	%		—		34
Marlin Covington Finance	03/11/2021	Fixed	20.17	%		26		—	3/11/2021	Fixed	20.17	%		20		—
Total					$	844	$	664					$	618	$	664

On February 15, 2018, the Company repaid the outstanding principal balance of $1.5 million of convertible debt issued in July 2012 bearing annual interest of 14%, to Cantone Asset Management, LLC, together with accrued interest thereon, with proceeds from the Pinecone Credit Facility.

On February 15, 2018 (the “Closing Date”), the Company entered into the Pinecone Credit Facility with ~~Pinecone. The Company borrowed~~Pinecone, with an original aggregate principal amount of $16.25 ~~million. The Pinecone Credit Facility~~million, which refinanced existing mortgage debt in an aggregate amount of $8.7 million on three skilled nursing properties, the Attalla Facility, the College Park Facility and the Northwest Facility (the “Pinecone Facilities”), and provided additional surplus cash flow of $6.3 million for general corporate needs after deducting approximately $1.25 million in debt issuance costs and prepayment penalties.

Regional Health was a guarantor of the Pinecone Credit Facility. Certain of the notes under the Pinecone Credit Facility were also guaranteed by certain wholly-owned subsidiaries of Regional Health. The surplus cash flow from the Pinecone Credit Facility was used to fund $2.4 million of self-insurance reserves for professional and general liability claims with respect to 25 professional and general liability actions, and to fund repayment of $1.5 million in convertible debt. The remaining $2.4 million in surplus cash proceeds from the ~~Facilities.~~Pinecone Credit Facility was used for general corporate purposes.

The maturity date of the Pinecone Credit Facility iswas August 15, 2020 and it originally bore interest at a fixed rate equal to 10% per annum for the first three months after the Closing Date and at a fixed rate equal to 12.5% per annum thereafter, subject to adjustment upon an event of default and specified regulatory events. The Pinecone Credit Facility iswas secured by, among other things, first priority liens on the Pinecone Facilities and all tangible and intangible assets of the borrowers owning the Pinecone Facilities, including all rent payments received from the operators thereof. Accrued and unpaid interest on the outstanding principal amount of the Pinecone Credit Facility iswas payable in consecutive monthly installments. Unless accelerated by Pinecone, the entire unpaid principal amount of the Pinecone Credit Facility iswas due on the maturity date, together with all accrued and unpaid interest and a finance fee equal to 3% of the original principal amount.

The Pinecone Credit Facility iswas subject to customary operating and financial covenants and regulatory conditions for each of the Pinecone Facilities, which ~~could result~~resulted in additional monthly interest charges during any non-compliance and cure period. The Pinecone Credit Facility iswas prepayable with a prepayment premium equal to 1% of the principal amount being repaid.

The Pinecone Credit Facility and the related documentation ~~provide~~provided for customary events of default. Upon the occurrence of certain events of default, Pinecone ~~can declare: (i) the entire unpaid principal balance under the Pinecone Credit Facility, together with all accrued interest and other amounts payable, immediately due and payable; (ii) increase~~increased the interest rate to 18.5%~~; and (iii) foreclose on~~ during periods not covered by compliance with the ~~Collateral.~~relevant forbearance agreement.

On May 10, 2018, management was notified by Pinecone that the certain events of default under the Pinecone Credit Facility had occurred and were continuing. On May 18, 2018, the Company and Pinecone entered into ~~the Original~~a forbearance agreement (the “Original Forbearance ~~Agreement,~~Agreement”), pursuant to which Pinecone agreed, subject to terms and conditions set forth in the Original Forbearance Agreement, to forbear from exercising its default-related rights and remedies with respect to specified events of default (the “Specified Defaults”) under the Pinecone Credit Facility during the forbearance period provided for therein. The Original Forbearance Agreement outlined a plan of correction whereby the Company could regain compliance under the Pinecone Credit Facility. Requirements set forth in the Original Forbearance Agreement included, among other things, the hiring of a special consultant to advise management on operational improvements and to assist in coordinating overall company strategy. Pursuant to the Original Forbearance Agreement, the Company and Pinecone agreed to amend certain provisions of the Pinecone Credit Facility. Such amendments, among other things: (i) ~~eliminate~~eliminated the Company’s obligation to complete certain lease assignments to suitably qualified replacement operators; (ii) ~~require~~required the payment of a specified “break-up fee” upon certain events, including prepayment of the Pinecone Credit Facility or a change of control; (iii) ~~increase~~increased the ongoing interest rate from 12.5% per annum to 13.5% effective May 18, 2018; and (iv) ~~increase~~increased the outstanding principal balance of the Pinecone Credit Facility by 2.5%.

The Company and certain of its subsidiaries subsequently entered into ~~the New Forbearance Agreement~~additional forbearance agreements with Pinecone with respect to the ~~Loan Agreement~~Pinecone Credit Facility on September 6, 2018 (the “New Forbearance Agreement”) and ~~into~~ the A&R New Forbearance Agreement ~~again~~ on December 31, 2018. The forbearance period under the Original Forbearance Agreement terminated on July 6, 2018 and the forbearance period under the A&R New Forbearance Agreement terminated on December 31, 2018 because the Company did not satisfy certain conditions set forth therein.

Pursuant to the New Forbearance Agreement, the Company and Pinecone agreed to amend certain provisions of the Pinecone ~~Loan Documents.~~Credit Facility. Such amendments, among other things: (i) increased the finance fee payable on repayment or acceleration of the loans, depending on the time at which the loans ~~are~~were repaid ($0.25 million prior to December 31, 2018 and $0.5 million thereafter); and (ii) increased the outstanding principal balance owed by (a) approximately $0.7 million to reimburse Pinecone for its accrued and unpaid expenses and to pay outstanding interest payments for prior interest periods and (b) $1.5 million as a non-refundable payment of additional interest. During the forbearance period under the New Forbearance Agreement, the interest rate reverted from the default rate of 18.5% per annum to the ongoing rate of 13.5% per annum.

Pursuant to the New Forbearance Agreement which amended the Pinecone ~~Loan Documents,~~Credit Facility, the Company hired a financial advisor (a “Financial Advisor”) acceptable to Pinecone to advise management and the ~~Company’s board~~Board of ~~directors~~Directors on operational improvements and to assist in coordinating overall company strategy, whose engagement ~~shall include~~included assisting the Company to obtain one or more sources of refinancing to repay the obligations under the Pinecone ~~Loan Documents.~~Credit Facility.

On December 31, 2018, the Company and certain of its subsidiaries entered into the A&R New Forbearance Agreement with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the A&R New Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to the Specified Defaults under the ~~Loan Agreement.~~Pinecone Credit Facility. The forbearance period under the A&R New Forbearance Agreement was from December 31, 2018 to March 14, 2019, and expired according to its terms.

Pursuant to the A&R New Forbearance Agreement, the Company and Pinecone amended certain provisions of the Loan Agreement, whereby Pinecone consented to the Omega Lease Termination and required the Company to pay to Pinecone approximately $1.4 million, of which $0.2 million was paid on January 4, 2019 for Pinecone’s expenses, which included a 1% prepayment penalty. On January 28, 2019, in connection with the Omega Lease Termination, the Company received gross proceeds of approximately $1.5 million, consisting of (i) a termination fee in the amount of $1.2 million and (ii) approximately $0.3 million to satisfy other net amounts due to the Company under the leases.

The Company paid $1.2 million of such Omega Lease Termination proceeds to Pinecone on January 28, 2019, as required by the A&R New Forbearance Agreement, to reimburse Pinecone for approximately $0.3 million of certain unpaid expenses and partially prepay $0.9 million of the AdCare Holdco Loan.

The A&R New Forbearance Agreement amended the Loan Agreement to, among other things: (i) add a $0.35 million fee (paid in kind) to the loans on a pro rata basis; (ii) ~~provided~~provide for ~~the PIK Rate (at~~additional payment in kind interest at a rate of 3.5% ),(the “PIK Rate”), with such interest to be paid in kind in arrears by increasing the outstanding principal amount of loans held by Pinecone on the first (1st) day of each month; provided that interest accruing at the PIK Rate on each loan and any overdue interest on each loan ~~shall~~ be paid in cash (a) on the maturity of the loans, whether by acceleration or otherwise, or (b) in connection with any repayment or prepayment of the loans; and (iii) modify the default rate of interest to add an additional 2.5% to the PIK Rate, in addition to the ongoing rate of 13.5%. During the forbearance period under the A&R New Forbearance Agreement, the interest rate to be paid in cash on the first (1st) day of each month was the ongoing rate of 13.5% per annum.

In addition, the A&R New Forbearance Agreement amended the Loan Agreement to require the Company to continue to retain the financial advisor as the Company’s chief restructuring officer (“CRO”) and hire a nationally recognized investment banker reasonably acceptable to Pinecone no later than January 7, 2019 to advise management and the Board on potential asset sale and related transactions and perform valuation debt capacity analyses. By February 28, 2019, the Company and the CRO (whose responsibilities were expanded to include all aspects of transaction planning, including a process of soliciting bids for one or more asset sale or related transactions (the “Bid Solicitation”) had to: (i) complete the Bid Solicitation; and (ii) negotiate in good faith and enter into with Pinecone an agreement that is acceptable to Pinecone, which required, among other things, that the Company engage in a process that ~~culminates~~culminated in (a) the consummation of one or more asset sales or related transactions and (b) the payment in full in cash of all obligations under the Loan Agreement with the proceeds thereof. As a condition of the A&R New Forbearance Agreement, the Company appointed a Pinecone non-voting observer to attend all meetings of the Board and each committee thereof, subject to certain exceptions described in the A&R New Forbearance Agreement.

On March 29, 2019, the Company and certain of its subsidiaries entered into the Second A&R Forbearance Agreement with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the Second A&R Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to the Specified Defaults under the Loan Agreement. The forbearance period under the Second A&R Forbearance Agreement commenced on March 29, 2019 and ~~may extend~~could have extended as late as October 1, 2019, unless the forbearance period iswas earlier terminated as a result of specified termination events, including a default or event of default under the Loan Agreement (other than any Specified Defaults) or any failure by the Company or its subsidiaries to comply with the terms of the Second A&R Forbearance Agreement, including, without limitation, the Company’s obligation to progress with an Asset Sale in accordance with the timeline specified therein (see Note -15 Subsequent Events for details of an amendment to the Second A&R Forbearance Agreement with respect to such timeline). Accordingly, the forbearance period under the Second A&R Forbearance Agreement may terminate at any time and there is no assurance such period will extend through October 1, 2019.therein.

Pursuant to the Second A&R Forbearance Agreement, the Company and Pinecone agreed to amend certain provisions of the Loan Agreement. The Second A&R Forbearance Agreement ~~requires,~~required, among other things (i) that the Company pursue and complete the Asset Sale which ~~would result~~resulted in the repayment in full of all of the Company’s indebtedness to Pinecone and, in connection therewith, the Company ~~pay~~paid not less than $0.3 million and not more than $0.55 million in forbearance fees, as well as certain other expenses of Pinecone, or (ii) Pinecone’s other disposition of the Loan Agreement as contemplated by the Second A&R Forbearance Agreement. Additionally the Second A&R Forbearance Agreement ~~accelerates~~accelerated the previously disclosed 3% finance “tail fee”, 1% prepayment penalty, and 1% break up fee so that such fees and penalties became part of the principal as of April 15, 2019.

On June 13, 2019, the Company and certain of its subsidiaries entered into an amendment with respect to the Second A&R Forbearance Agreement (the “Pinecone Amendment”), pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the Pinecone Amendment, to extend the timeline to complete the Asset Sale to August 15, 2019.

Pursuant to the Pinecone Amendment, the Company paid an additional non-refundable payment, payable in kind, on June 13, 2019, by increasing the outstanding principal amount owed to Pinecone up to approximately $0.5 million, which replaced approximately $0.2 million of payable in kind fees, under the Second A&R Forbearance Agreement.

The forbearance period under the Second A&R Forbearance Agreement remained unchanged by the Pinecone Amendment and may have continued until October 1, 2019, unless earlier terminated in accordance with the Second A&R Forbearance Agreement.

On August 1, 2019, the Company used a portion of the proceeds from the Asset Sale to repay approximately $21.3 million to Pinecone to extinguish all obligations and amounts owed under the Pinecone Credit Facility. However for a period of three months following such repayment, Pinecone continued to hold a right of first refusal to provide first mortgage financing for any acquisition of a healthcare facility by the Company and to have the Pinecone Financing Option. The repayment amount was comprised of the following amounts: (i) approximately $20.7 million in principal (net of $0.1 million loan forgiveness); (ii) $0.5 million in interest; and (iii) $0.1 million in legal expenses. See Note – 1510 ~~Subsequent Events~~Discontinued Operations and Dispositions for further information.

~~Debt Covenant Compliance~~On September 30, 2019, the Company and Pinecone entered into a waiver and release agreement, and the Company paid approximately $0.4 million to Pinecone to fully extinguish the Surviving Obligations under the Pinecone Credit Facility.

On April 30, 2019, the Company, a wholly owned subsidiary of the Company and Congressional Bank amended the terms of the Quail Creek Credit Facility, with an original aggregate principal amount of $5.0 million, to extend the maturity date of the Quail Creek Credit Facility, with a principal balance of approximately $4.0 million as of March 31, 2019, and bearing interest at LIBOR + 4.75%, to June 30, 2019 (the “Maturity Date”), with an option to further extend the Maturity Date to July 31, 2019, as discussed below. The Quail Creek Credit Facility was secured by a mortgage on the Quail Creek Facility.

As discussed above, on April 15, 2019, the Company entered into the PSA with MED, which provided for, among other things, the sale of the Quail Creek Facility to MED.

The option to further extend the Maturity Date of the Quail Creek Credit Facility to July 31, 2019 (the “Extension Option”), was subject to the Company’s satisfaction of the following conditions: (i) the Company shall have delivered to the Congressional Bank written notice of its intent to exercise the Extension Option no earlier than 45 days and no later than 30 days prior to the Maturity Date; (ii) no default or event of default shall have occurred; (iii) the closing under the PSA shall have been extended and the PSA shall otherwise still be in full force and effect (including with respect to the Quail Creek Facility); (iv) Congressional Bank shall have received such additional information or costs as Congressional Bank may request; and (v) Congressional Bank shall have approved such extension in its commercially reasonable discretion.

On August 1, 2019, the Company paid approximately $3.8 million to the Congressional Bank to extinguish all obligations and amounts owed under the Quail Creek Credit Facility. The repayment amount was comprised of $3.9 million in principal after application of approximately $0.1 million in restricted cash. See Note – 10 Discontinued Operations and Dispositions for further information.

As of September 30, 2019, the Company had ~~approximately 23~~17 credit related instruments outstanding that include various financial and administrative covenant requirements. Covenant requirements include, but are not limited to, fixed charge coverage ratios, debt service coverage ratios, minimum ~~EBITDA~~earnings before interest, taxes, depreciation, and amortization or ~~EBITDAR,~~earnings before interest, taxes, depreciation, amortization, and restructuring or rent costs, and current ratios. Certain financial covenant requirements are based on consolidated financial measurements whereas others are based on measurements at the subsidiary level (i.e., facility, multiple facilities or a combination of subsidiaries). The subsidiary level requirements are as follows: (i) financial covenants measured against subsidiaries of the Company; and (ii) financial covenants measured against third-party operator performance. Some covenants are based on annual financial metric measurements whereas others are based on monthly and quarterly financial metric measurements. The Company routinely tracks and monitors its compliance with its covenant requirements.

~~The~~As of September 30, 2019, the Company iswas in compliance with all covenant requirements under its debt covenants other than those in the Quail Creek Credit Facility. The Company was not in compliance with the monthly operator minimum EBITDAR required under the Quail Creek Credit Facility as of March 31, 2019. The Quail Creek Credit Facility requires the Company maintain an operator minimum EBITDAR of $400 thousand, and the Company’s operator minimum EBITDAR was equal to $294 thousand as of March 31, 2019, the Company is currently in the process to obtain a waiver for such violation in anticipation of the sale of the Quail Creek Facility pursuant to a purchase and sale agreement. For further information see, Note – 15 ~~Subsequent Events, “Quail Creek Credit Facility”.~~outstanding credit related instruments.

The schedule below summarizes the scheduled gross maturities for the twelve months ended ~~March 31~~September 30 of the respective year:

For the twelve months ended March 31,	(Amounts in 000’s)
For the twelve months ended September 30,				(Amounts in 000’s)
2020 ⁽¹⁾	$	25,796		$	1,747
2021		1,668			2,216
2022		1,736			5,155
2023		5,099			1,723
2024		1,748			1,811
Thereafter		45,727			44,675
Subtotal	$	81,774		$	57,327
Less: unamortized discounts		(160	)		(153	)
Less: deferred financing costs, net		(1,518	)		(1,393	)
Total notes and other debt	$	80,096		$	55,781

For discontinued operations, cost of services, primarily accruals or releases of over accruals for professional and general liability claims and bad debt expense are classified in the activities below. For a historical listing and description of the Company’s discontinued entities, see Part II, Item 8, “Financial Statements and Supplementary Data”, Note 11 – Discontinued Operations included in the Annual Report.

The following table summarizes the activity of discontinued operations for the three and nine months ended ~~March 31,~~September 30, 2019 and 2018:

	Three Months Ended March 31,						Three Months Ended September 30,						Nine Months Ended September 30,
(Amounts in 000’s)	2019			2018			2019			2018			2019			2018
Cost of services	$	(178	)	$	52		$	(101	)	$	(159	)	$	(411	)	$	235
Interest expense, net		—			3			—			2			—			7
Net income (loss)	$	178		$	(55	)	$	101		$	157		$	411		$	(242	)

The Company’s major classes of discontinued operation’s assets and liabilities included within the Company’s consolidated balance sheets at September 30, 2019 and December 31, 2018, respectively are: (i) “Accounts receivable, net of allowance” of $0.2 million and $0.1 million; (ii) “Accounts payable” of $3.0 million and $3.5 million; and (iii) “Accrued expenses and other” of $1.3 million and $2.1 million.

Effective January 15, 2019, and as contemplated by the A&R New Forbearance Agreement, the Company’s lease for the Omega Facilities, ~~(two facilities located in Georgia),~~ which leases were due to expire August 2025 and which Omega Facilities the Company subleased to third party subtenants, were terminated by mutual consent of the Company and the lessor of the Omega Facilities.

The Omega Lease Termination contributed approximately $0.7 million income recorded in "Net loss attributable to Regional Health Properties, Inc. common stockholders" reported in the consolidated statement of operations for the period ended March 31, 2019.

On April 15, 2019, certain subsidiaries of the Company entered into the PSA with MED, with respect to four skilled nursing facilities owned by the Company.

Subject to the terms of the PSA, the Company agreed to sell, and MED agreed to purchase, all of the Company’s right, title and interest in the PSA Facilities. MED’s obligation to complete such purchase and sale was subject to specified closing conditions, which included a 30 day due diligence period (the “Due Diligence Period”). In consideration therefor, MED agreed to pay to the Company the sum of approximately $28.5 million in cash.

On June 11, 2019, the Company and MED entered into an amendment (the “PSA Amendment”) to the PSA, pursuant to which the Company and MED agreed, that the Due Diligence Period expired as of June 3, 2019 and that the scheduled closing date, subject to satisfaction or waiver of customary terms and conditions, would occur on August 1, 2019. In accordance with the PSA and PSA Amendment, MED deposited the first deposit of $0.15 million and the second deposit of $0.15 million into an escrow account.

On August 1, 2019, the Company and MED completed the sale of three of the PSA Facilities, together with substantially all of the fixtures, equipment, furniture, leases and other assets relating to such facilities, pursuant to the PSA as amended, and entered into an additional amendment to the PSA on July 31, 2019 (the “PSA NW Amendment”). The aggregate purchase price paid to the Company for the three facilities was $26.1 million, net of $0.175 million from the first and second deposits held in escrow. The remaining earned $0.125 million was applied to the remaining facility sale on August 28, 2019, and the Company paid a $0.4 million sale commission. The proceeds from the sale were used to repay the Pinecone Credit Facility and Quail Creek Credit Facility in full.

The PSA NW Amendment provided for: (i) the extension of the scheduled closing date of the fourth facility, the Northwest Facility, to August 30, 2019, subject to satisfaction or waiver of customary terms and conditions, which could have been extended to September 30, 2019, for an additional non-refundable fee of $0.075 million if Buyer notified Seller in writing by August 28, 2019 at 5:00 p.m. EST; and (ii) a reduction in the purchase price of approximately $0.1 million for building improvements.

On August 28, 2019, the Company sold to MED the Northwest Facility, together with substantially all of the fixtures, equipment, furniture, leases and other assets relating to the Northwest Facility, pursuant to the PSA as amended, between Seller and Buyer. In connection with the sale, MED paid to the Company a cash purchase price for the Northwest Facility equal to $2.4 million, and the Company incurred approximately $0.1 million for a building improvement credit and sales commission expenses.

The sale of the PSA Facilities contributed approximately $4.8 million income to the Company’s “Net loss attributable to Regional Health Properties, Inc. common stockholders” for the nine months ended September 30, 2019, which was comprised of approximately $6.4 million gain on the sale of assets, approximately $0.1 million in operational net income offset by $1.7 million of expenses related to the Pinecone Credit Facility forbearance agreements and debt extinguishment, in "Net loss attributable to Regional Health Properties, Inc. common stockholders" reported in the Consolidated Statement of operations for the nine months ended September 30, 2019.

~~Assets~~The following table provides summary information regarding the leases associated with the PSA Facilities and ~~liabilities~~related licensed beds/units by operator affiliation as of the ~~disposal group at December 31, 2018, was as follows:~~disposition date:

December 31,

(Amounts in 000's)

2018

Lease deposits

$
375

Straight-line rent receivable

704

Buildings and improvements, net

352

Equipment and computer related, net

97

Intangible assets—lease rights, net

676

Assets of disposal group

$
2,204

Accounts payable

$
100

Other liabilities -lease deposits

170

Other liabilities -accrued straight-line rent

1,221

Liabilities of disposal group

$
1,491

						2019 Cash		2019 Cash
					Lease Term	Annual Rent		Annual Rent
Facility Name	Licensed Beds/Units		Location	Operator Affiliation	Expiration Date	(Amounts in 000’s)		% of Total Expected
Attalla ^(a)		182	AL	C.R. Management	8/31/2030	$	1,175		6.4	%
College Park ^(a)		100	GA	C.R. Management	3/31/2025		645		3.5	%
Quail Creek^(a)		118	OK	Southwest LTC	12/31/2025		783		4.3	%
Northwest ^(b)		100	OK	Southwest LTC	12/31/2025		379		2.1	%
Total		500				$	2,982		16.3	%

The following table provides summary information regarding the credit facilities associated with the PSA Facilities and related purchase price, debt repaid and net gain on the sale for the period ended September 30, 2019:

On August 1, 2019, the Company paid $21.3 million to Pinecone to repay all amounts owed under the Pinecone Credit Facility. The repayment amount was comprised of the following amounts: (i) approximately $20.7 million in principal (net of $0.1 million loan forgiveness); (ii) $0.5 million in interest; and (iii) $0.1 million in legal expenses. On September 30, 2019, the Company paid $0.4 million to Pinecone to terminate the Surviving Obligations.

On August 1, 2019, the Company paid approximately $3.8 million to Congressional Bank to extinguish all obligations and amounts owed under the Quail Creek Credit Facility. The repayment amount was comprised of $3.9 million in principal after application of approximately $0.1 million in restricted cash.

There were no dividends paid on the common stock during the three and nine months ended ~~March 31,~~September 30, 2019 and ~~during the three months ended March 31,~~ 2018.

No dividends were declared or paid on the Series A Preferred Stock for the three and nine months ended ~~March 31,~~September 30, 2019 and for the three and nine months ended ~~March 31,~~September 30, 2018.

As of ~~March 31,~~September 30, 2019, as a result of the suspension of the dividend payment on the Series A Preferred Stock commencing with the fourth quarter 2017 dividend period, the Company has ~~$12.1~~$16.6 million of undeclared preferred stock dividends in arrears. Holders of the Series A Preferred Stock are entitled to receive, when and as declared by the Board out of funds of the Company legally available for the payment of distributions, cumulative preferential cash dividends at an annual rate equal to 10.875% of the $25.00 per share stated liquidation preference of the Series A Preferred Stock, which is equivalent to an annual rate of $2.72 per share or $1.9 million per quarter. Dividends on the Series A Preferred Stock, when and as declared by the Board, are payable quarterly in arrears, on March 31, June 30, September 30, and December 31 of each year. On June 8, 2018, the Board determined to continue suspension of the payment of the quarterly dividend on the Series A Preferred Stock indefinitely. Under the terms of the Series A Preferred Stock, dividends on the Series A Preferred Stock shall continue to accrue and accumulate regardless of whether such dividends are declared by the Board. As the Company has failed to pay cash dividends on the outstanding Series A Preferred Stock in full for four dividends periods: (i) the annual dividend rate on the Series A Preferred Stock has increased to 12.875% ,which is equivalent to an annual rate of $3.22 or $2.2 million per quarter, commencing on the first day after the missed fourth quarterly payment (October 1, 2018) continuing until the second consecutive dividend payment date following such time as the Company has paid all accumulated and unpaid dividends on the Series A Preferred Stock in full in cash; and (ii) the holders of the Series A Preferred Stock will be entitled to vote, as a single class, for the election of two additional directors to serve on the Board, as further described in the Charter.

As of ~~March 31,~~September 30, 2019, the Company had 2,811,535 shares of the Series A Preferred Stock issued and outstanding.

The Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, by paying $25.00 per share, plus any accrued and unpaid dividends to the redemption date.

For historical information regarding the Series A Preferred Stock, the Company’s former “at-the-market” offering program and prior share repurchase programs, see Part II, Item 8, “Financial Statements and Supplementary Data”, Note 12 – Common and Preferred Stock included in the Annual Report.

As discussed in Note 1 - Summary of Significant Accounting Policies, the Reverse Stock Split became effective on December 31, 2018 for all issued and outstanding shares of the common stock. The number of shares authorized under the Company’s equity incentive plans was proportionately adjusted in connection with the Reverse Stock Split. The per share exercise price of all outstanding options and warrants was also increased proportionately and the number of shares of common stock issuable upon the exercise of such options and warrants was reduced proportionately. In addition, the conversion price of all other outstanding securities that are exercisable or exchangeable for, or convertible into, shares of common stock was increased proportionately and the number of shares of common stock issuable upon such exercise, exchange or conversion was reduced proportionally. Accordingly, all share and per share amounts have been adjusted to reflect the Reverse Stock Split for all periods presented.

For the three and nine months ended September~~March 31,~~ 30, 2019 and 2018, the Company recognized stock-based compensation expense as follows:

	Three Months Ended March 31,				Three Months Ended September 30,				Nine Months Ended September 30,
(Amounts in 000’s)	2019		2018		2019		2018		2019		2018
Employee compensation:
Restricted stock	$	—	$	3	$	—	$	4	$	—	$	11
Total employee stock-based compensation expense	$	—	$	3	$	—	$	4	$	—	$	11
Non-employee compensation:
Board restricted stock	$	27	$	28	$	22	$	46	$	70	$	115
Total non-employee stock-based compensation expense	$	27	$	28	$	22	$	46	$	70	$	115
Total stock-based compensation expense	$	27	$	31	$	22	$	50	$	70	$	126

The AdCare Health Systems, Inc. 2011 Stock Incentive Plan, as amended (the “2011 Stock Incentive Plan”), was assumed by Regional Health pursuant to the Merger. As a result of the Merger, all rights to acquire shares of AdCare common stock under any AdCare equity incentive compensation plan have been converted into rights to acquire Regional Health common stock pursuant to the terms of the equity incentive compensation plans and other related documents, if any. The 2011 Stock Incentive Plan expires March 28, 2021 and provides for a maximum of 168,950 shares of common stock to be issued. The 2011 Stock Incentive Plan permits the granting of incentive or nonqualified stock options and the granting of restricted stock. The plan is administered by the Compensation Committee of the Board (the “Compensation Committee”), pursuant to authority delegated to it by the Board. The Compensation Committee is responsible for determining the employees to whom awards will be made, the amounts of the awards, and the other terms and conditions of the awards. As of ~~March 31,~~September 30, 2019, the number of securities remaining available for future issuance is 19,421.

In addition to the 2011 Stock Incentive Plan, the Company grants stock warrants to officers, directors, employees and certain consultants to the Company from time to time as determined by the Board and, when appropriate, the Compensation Committee.

For the three and nine months ended September~~March 31,~~ 30, 2019 and 2018, there were no issuances of common stock options or warrants.

The following table summarizes the Company’s common stock option activity for the ~~three~~nine months ended ~~March 31,~~September 30, 2019:

	Number of Shares (000's)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (000's) ^(a)		Number of Shares (000's)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (000's)
Outstanding, December 31, 2018		15	$	47.77		5.4	$	—		15	$	47.77		5.4	$	—
Granted		—	$	—						—	$	—
Forfeited		—	$	—						—	$	—
Expired		—	$	—						—	$	—
Outstanding and Vested, March 31, 2019		15	$	47.77		5.1	$	—
Outstanding and Vested, September 30, 2019										15	$	47.77		4.6	$	—

The following table summarizes the common stock options outstanding and exercisable as of ~~March 31,~~September 30, 2019:

	Stock Options Outstanding						Options Exercisable				Stock Options Outstanding						Options Exercisable
Exercise Price	Number of Shares (000's)		Weighted Average Remaining Contractual Term (in years)		Weighted Average Exercise Price		Vested, March 31, 2019		Weighted Average Exercise Price		Number of Shares (000's)		Weighted Average Remaining Contractual Term (in years)		Weighted Average Exercise Price		Vested, September 30, 2019		Weighted Average Exercise Price
$15.72 - $47.99		10		5.4	$	46.84		10	$	46.84		10		5.0	$	46.84		10	$	46.84
$48.00 - $51.60		5		4.4	$	49.42		5	$	49.42		5		4.0	$	49.42		5	$	49.42
Total		15		5.1	$	47.77		15	$	47.77		15		4.6	$	47.77		15	$	47.77

The following table summarizes the Company’s common stock warrant activity for the ~~three~~nine months ended ~~March 31,~~September 30, 2019:

	Number of Warrants (000's)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in 000's)		Number of Warrants (000's)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in 000's)
Outstanding, December 31, 2018		85	$	45.53		3.7	$	—		85	$	45.53		3.7	$	—
Granted		—	$	—						—	$	—
Forfeited		—	$	—						—	$	—
Expired		—	$	—						—	$	—
Outstanding and Vested, March 31, 2019		85	$	45.53		3.4	$	—
Outstanding and Vested, September 30, 2019										85	$	45.53		2.9	$	—

The following table summarizes the common stock warrants outstanding and exercisable as of ~~March 31,~~September 30, 2019:

	Warrants Outstanding						Warrants Exercisable				Warrants Outstanding						Warrants Exercisable
Exercise Price	Number of Shares (000's)		Weighted Average Remaining Contractual Term (in years)		Weighted Average Exercise Price		Vested, March 31, 2019		Weighted Average Exercise Price		Number of Shares (000's)		Weighted Average Remaining Contractual Term (in years)		Weighted Average Exercise Price		Vested, September 30, 2019		Weighted Average Exercise Price
$0.00- $23.99		9		0.6	$	23.16		9	$	23.16		9		0.1	$	23.16		9	$	23.16
$24.00 - $35.99		9		0.6	$	30.84		9	$	30.84		9		0.1	$	30.84		9	$	30.84
$36.00 - $47.99		23		2.1	$	44.50		23	$	44.50		23		1.7	$	44.50		23	$	44.50
$48.00 - $59.99		42		5.2	$	52.99		42	$	52.99		42		4.8	$	52.99		42	$	52.99
$60.00 - $70.80		2		4.1	$	70.80		2	$	70.80		2		3.6	$	70.80		2	$	70.80
Total		85		3.4	$	45.53		85	$	45.53		85		2.9	$	45.53		85	$	45.53

The following table summarizes the Company’s restricted stock activity for the ~~three~~nine months ended ~~March 31,~~September 30, 2019:

	Number of Shares (000's)			Weighted Avg. Grant Date Fair Value		Number of Shares (000's)			Weighted Avg. Grant Date Fair Value
Unvested, December 31, 2018		48		$	6.20		48		$	6.20
Granted		—		$	—		—		$	—
Vested		(19	)	$	8.65		(19	)	$	8.65
Forfeited		—		$	—		—		$	—
Unvested, March 31, 2019		29		$	4.63
Unvested, September 30, 2019							29		$	4.63

For restricted stock unvested at ~~March 31,~~September 30, 2019, $0.1 million in compensation expense will be recognized over the next ~~1.5~~1.1 years.

Laws and regulations governing federal Medicare and state Medicaid programs are complex and subject to interpretation. Compliance with such laws and regulations can be subject to future governmental review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from certain governmental programs. As of ~~March 31,~~September 30, 2019, all of the Company’s facilities leased and subleased to third-party operators and managed for third-parties are certified by the U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services (“CMS”) and are ~~operational (see~~operational. See Note 7 - Leases).

The Company is party to various legal actions and administrative proceedings and is subject to various claims arising in the ordinary course of business, including claims that the services the Company provided during the time it operated skilled nursing facilities resulted in injury or death to the patients of the Company’s facilities and claims related to professional and general negligence, employment, staffing requirements and commercial matters. Although the Company intends to vigorously defend itself in these matters, there is no assurance that the outcomes of these matters will not have a material adverse effect on the Company’s business, results of operations and financial condition.

The Company previously operated, and the Company’s tenants now operate, in an industry that is extremely regulated. As such, in the ordinary course of business, the Company’s tenants are continuously subject to state and federal regulatory scrutiny, supervision and control. Such regulatory scrutiny often includes inquiries, investigations, examinations, audits, site visits and surveys, some of which are non-routine. In addition, we believe that there has been, and will continue to be, an increase in governmental investigations of long-term care providers, particularly in the area of Medicare/Medicaid false claims, as well as an increase in enforcement actions resulting from these investigations. Adverse determinations in legal proceedings or governmental investigations against or involving the Company, for the Company’s prior operations, or the Company’s tenants,

whether currently asserted or arising in the future, could have a material adverse effect on the Company’s business, results of operations and financial condition.

Professional and General Liability Claims. As of ~~March 31,~~September 30, 2019, the Company is a defendant in 13a total of 12 professional and general liability actions, primarily commenced on behalf of three of our former patients and nine of our current or prior tenant’s former patients. These actions generally seek unspecified compensatory and punitive damages for former patients ~~of the Company~~ who were allegedly injured or died while patients of our facilities ~~operated by the Company~~ due to professional negligence or understaffing. ~~Two~~One such ~~actions are~~action, on behalf of the Company’s former patient, is covered by insurance, except that any award of punitive damages would be excluded from such coverage and ~~three~~nine of such actions relate to events which occurred after the Company transitioned the operations of the facilities in question to a third-party operator and which are subject to such operators’ indemnification obligations in favor of the Company.

During the three months ended March 31, 2019: (i) one action was dismissed, ~~however~~and because the plaintiffs ~~have until~~did not re-file on or before September 12, 2019, ~~to re-file the action and;~~may not re-file; and (ii) one additional action was filed on ~~February 21,~~January 25, 2019 for a medical injury and improper care and treatment in the Circuit Court of Pulaski County, State of Arkansas on behalf of a deceased patient, who received care after the Transition, against the then operator affiliated with Skyline Healthcare, LLC (“Skyline”) ~~and~~, the Company and CIBC Bancorp USA, Inc. The plaintiff (Montgomery) is seeking unspecified compensatory damages for the actual losses and unspecified punitive damages. The Company believes that this action lacks merit and the Company intends to take action most favorable to the Company. There is no guarantee that the Company will prevail in the action that has been filed against it.

~~Subsequent to March 31,~~During the three months ended June 30, 2019, ~~the Company was notified of two additional~~three professional and general liability ~~actions, one~~claims as detailed below were filed against the Company.

On May 9, 2019, a complaint was filed in the State Court of ~~which is subject to the relevant operators’ indemnification obligations in favor~~Bibb County, State of Georgia by a patient, who received care outside Regional’s date of service (post Transition), against three different unrelated facilities and companies associated with those facilities. One of our tenants, their operator affiliated management company (Beacon) and the Company ~~(the~~are among the named defendants. The plaintiff (Goodrum) alleges personal injury, pain and suffering, medical bills and expenses, and loss of consortium and is seeking unspecified compensatory damages to be determined by jury ~~trial and~~trial. The complaint claims that medical expenses to date amount to $3.0 ~~million)~~million. The Company is indemnified in this action by Beacon and ~~one additional~~believes that this action lacks merit. The Company intends to take action most favorable to the Company. There is no guarantee that the Company will prevail in the action that has been filed against it.

On May 15 2019, a complaint was filed in the Circuit Court of Pulaski County, the State of Arkansas on behalf of a patient, who received care outside Regional’s date of service (post-Transition), against the then operator Skyline, the Company and CIBC Bancorp USA, Inc. The plaintiff (McFadden) alleges medical injury, improper care and treatment and is seeking unspecified compensatory damages for the actual losses and unspecified punitive damages. The Company believes that this action lacks merit, the Company intends to take action most favorable to the Company. There is no guarantee that the Company will prevail in the action that has been filed against it.

On June 17, 2019, a complaint was filed in Jackson County, General Court of Justice Superior Court Division, in the State of ~~Arkansas (the~~North Carolina by the estate of a patient (Medlin) who died in August 2016, against one of our prior tenants, their operator affiliated management company (Symmetry), the Company and our new tenant who began operations on March 1, 2019. The plaintiff isalleged wrongful death and gross medical malpractice and was seeking unspecified amounts to recover medical and funeral expenses, compensatory ~~damages). Both~~damages for pain and suffering, legal expenses and compensation in excess of $25,000 for wrongful death, to be determined by jury trial. The action against the Company was dismissed on August 19, 2019.

During the three months ended September 30, 2019, three professional and general liability actions ~~are on behalf patients who received care after~~were dismissed, one of which was indemnified by our former tenant and one of which was insured. Additionally the ~~Transition, see Note 15~~ ~~- Subsequent Events~~ Company settled one professional and general liability action (our former patient), for ~~further information.~~ a total of $200,000, payable in 12 monthly installments of $14,500 with an initial payment of $26,000 commencing November 2019.

On March 12, 2018, the Company entered into a separate mediation settlement agreement with respect to 25 actions filed in the State of Arkansas which were pending on such date, pursuant to which the Company paid a specified settlement amount. The aggregate settlement amount for all such 25 actions before related insurance proceeds was $5.2 million. The settlement of each such action was individually approved by the probate court. Under the settlement and release agreement with respect to a particular action, the Company was released from any and all claims arising out of the applicable plaintiff’s care while the plaintiff was a resident of one of the Company’s facilities.

In connection with a dispute between the Company and the Company’s former commercial liability insurance provider regarding, among other things, the Company’s insurance coverage with respect to the 25 actions filed in the State of Arkansas, the former insurer filed a complaint in May 2016 against the Company seeking, among other things, a determination that the former insurer had properly exhausted the limits of liability of certain of the Company’s insurance policies issued by the former insurer, and the Company subsequently filed a counterclaim against the former insurer regarding such matters (collectively, the “Coverage Litigation”). On March 12, 2018, the former insurer and the Company entered into a settlement agreement (the “Coverage Settlement Agreement”), providing for, among other things, a settlement payment by the former insurer in the amount of approximately $2.8 million (the “Insurance Settlement Amount”), the dismissal with prejudice of the Coverage Litigation, a customary release of claims by the former insurer and the Company, and agreement that the former insurer has exhausted the policies’ respective limits of liability and has no further obligations under the policies. Pursuant to the Coverage Settlement Agreement: (i) on March 16, 2018, the former insurer deposited the Insurance Settlement Amount into the trust account of the mediator with respect to the 25 actions; and (ii) on March 20, 2018, the former insurer and the Company caused the Coverage Litigation, including the counterclaim, to be dismissed with prejudice.

The Company paid, net of the Insurance Settlement Amount, an aggregate of approximately $2.4 million in settlement of all 25 actions filed in the State of Arkansas. The probate court approved settlements with respect to 315 of the 25 Arkansas actions during the quarter ended ~~March 31,~~June 30, 2018 (having approved three in the first quarter of 2018) and approximately $3.3 million and $0.5 million, respectively, was paid from the mediator’s trust account in such settlements.

In the first quarter of 2018, the Company settled four professional and general liability actions (other than those subject to mediation settlement agreements as discussed above) for the total of $670,000. ~~The outstanding balance~~

In the second quarter of 2018, the Company settled one professional and general liability action (other than those subject to mediation settlement agreements as discussed above) for a total of ~~March 31, 2019~~$50,000, paid in 10 monthly installments commencing July 2018.

In the second quarter of 2018, the Company was notified of one employment related action filed against the Company related to ~~be paid~~one of the Company’s discontinued operations. On August 1, 2018 the Company responded requesting dismissal without prejudice on multiple grounds, including being barred by ~~July 31, 2019 is $106,667.~~ the applicable statute of limitation. On October 4, 2018, the case against the Company was dismissed with prejudice.

The Company established a self-insurance reserve for these professional and general liability claims, included within “Accrued expenses and other” in the Company’s consolidated balance sheets of ~~$1.0~~$0.8 million and $1.4 million at ~~March 31,~~September 30, 2019 and December 31, 2018, respectively. Additionally as of ~~March 31,~~September 30, 2019 and December 31, 2018, ~~$0.6~~$0.4 million and $0.6 million, respectively, was reserved for settlement amounts in “Accounts payable” in the Company’s consolidated balance sheets. For additional information regarding the Company’s self-insurance reserve, see Part II, Item 8, “Financial Statements and Supplementary Data”, Note 15 – Commitments and Contingencies included in the Annual Report.

Aria Bankruptcy Proceeding. On May 31, 2016, Highlands Arkansas Holdings, LLC (“HAH”), an affiliate of Aria Health Group, LLC (“Aria”) and nine affiliates of HAH (collectively with HAH, the “Debtors”), filed petitions in the United States Bankruptcy Court for the District of Delaware for relief under Chapter 7. Following venue transfer from the Delaware court, these cases have been settled in the United States Bankruptcy Court for the Eastern District of Arkansas (the “Bankruptcy Court”).

On July 17, 2015, the Company made a short-term loan to HAH, for working capital purposes, and, in connection therewith, HAH executed a promissory note (the “HAH Note”) in favor of the Company. Since July 17, 2015, the HAH Note has been amended from time to time and had an outstanding principal balance of approximately $1.0 million that matured on December 31, 2015. On October 6, 2015, HAH and the Company entered into a security agreement, whereby HAH granted the Company a security interest in all accounts arising from the business of the Debtors, and all rights to payment from patients, residents, private insurers and others arising from the business of the Debtors (including any proceeds thereof), as security for payment of the HAH Note, as amended, and certain rent and security deposit obligations of the Debtors under their respective subleases with the Company (the “Aria Subleases”).

On April 21, 2017, the Company moved for relief from the automatic stay seeking release of its collateral, the Debtors’ accounts and their proceeds, which the trustee has represented as a total of approximately $0.8 million. The Company’s motion was opposed by the Chapter 7 trustee and another creditor, in May 2017. In its objection, the Chapter 7 trustee ~~asserts~~asserted that the Company iswas not entitled to any of the $0.8 million with respect to the HAH Note. In addition to opposing the Company’s claim to the $0.8 million, the Chapter 7 trustee ~~has~~ also indicated he was investigating avoidance claims against the Company with respect to funds the Company received from the Debtors prior to the bankruptcy filings. On March 28, 2018, such avoidance case was filed, requesting relief in an amount of $4.7 million. The Company ~~has~~ charged approximately $0.3 million and $0.6 million to “Provision for doubtful accounts” in the Company’s consolidated statement of operations on the HAH Note as of December 31,

2018, and December 31, 2017, respectively. On March 13, 2019, the Company and the Chapter 7 bankruptcy trustee entered into a settlement agreement to settle all existing and potential claims, including such avoidance claim. The Company has received $0.1 million with respect to the $1.0 million HAH Note.

Hardin & Jesson Action. On ~~February 25,~~August 5, 2019, the Company ~~was served notice of~~received notification from Hardin & Jesson that they had executed a settlement agreement with the Company pursuant to an action filed in Sebastian County Circuit Court - Fort Smith Division, Arkansas by Hardin & Jesson ~~& Terry, PLC~~on February 25, 2019, requesting financial documents from the Company’s predecessor issuer and seeking relief of outstanding amounts for legal services provided to the Company (and certain of its subsidiaries) in the State of Arkansas in relation to professional and general liability claims of approximately $0.5 million. On April 18, 2019, Hardin ~~Jesson~~ & ~~Terry, PLC~~Jesson amended their filing to correct their initial filing to clarify the claim is against the Company. On May 8, 2019, the Company provided a response denying the allegations. ~~There~~The settlement agreement provides for an agreed net outstanding liability of $0.3 million and provides for monthly payments of $13,888 beginning July 1, 2019, and continuing on the first day of each month thereafter until the $0.3 million liability is ~~no guarantee that~~paid in full. As of the date of filing this Quarterly Report the Company ~~will prevail in the action that~~ has ~~been filed against it.~~

~~Pinecone Credit Facility Contingent Finance Fees.~~ ~~Pursuant to the Second A&R Forbearance Agreement, the Company and Pinecone agreed to amend certain provisions~~made five of the ~~Loan Agreement. The Second A&R Forbearance Agreement, among other things accelerates~~required payments, in accordance with the ~~previously disclosed 3% finance “tail fee”, 1% prepayment penalty, and 1% break up fee so that such fees and penalties became part~~terms of the ~~principal as of April 15, 2019. For further information, see Note 3~~agreement. ~~– Liquidity,~~ ~~Note~~ ~~9 – Notes Payable and Other Debt and~~ ~~Note~~ ~~15 – Subsequent Events.~~

Ohio Attorney General Action. On October 27, 2016, the Ohio Attorney General (the “OAG”) filed in the Court of Common Pleas, Franklin County, Ohio a complaint against The Pavilion Care Center, LLC, Hearth & Home of Greenfield, LLC (each a subsidiary of the Company), and certain other parties (including parties for which the Company provides or provided management services). The lawsuit alleges that defendants submitted improper Medicaid claims for independent laboratory services for glucose blood tests and capillary blood draws and further alleges that defendants (i) engaged in deception, (ii) willfully received Medicaid payments to which they were not entitled or in a greater amount than that to which they were entitled, and (iii) obtained payments under the Medicaid program to which they were not entitled pursuant to their provider agreements and applicable Medicaid rules and regulations. The OAG is seeking, among other things, triple the amount of damages proven at trial (plus interest) and not less than $5,000 and not more than $10,000 for each deceptive claim or falsification. As previously disclosed, the Company received a letter from the OAG in February 2014 offering to settle its claims against the defendants for improper Medicaid claims related to glucose blood tests and capillary blood draws for a payment of approximately $1.0 million. The Company responded to such letter in July 2014 denying the allegations and did not receive further communication from the OAG until the above referenced lawsuit was filed. The Company filed an answer to the complaint on January 27, 2017 in which it denied the allegations. An order granting a motion to stay this proceeding was granted in the Court of Common Pleas, Franklin County, Ohio on July 12, 2017. Although there is no assurance as to the ultimate outcome of this matter or its impact on the Company’s business or its financial condition, the Company believes it has meritorious defenses and intends to vigorously defend the claim.

During the three and nine months ended ~~March 31,~~September 30, 2019, the Company paid $39,082 and $117,247, respectively to Mr. McBride, the Company’s former Chief Executive Officer and a former director, ~~pursuant to~~in full satisfaction of the McBride Settlement Agreement.

On May 13, 2019, the Company entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”), with Allan J. Rimland, our former Chief Executive Officer, Chief Financial Officer, President and director, who voluntarily resigned his employment effective October 17, 2017, pursuant to which, among other things, and in lieu of any other rights or obligations under Mr. Rimland’s employment agreement, the Company agreed to pay Mr. Rimland $85,000 in cash for claimed breach of employment agreement and for certain compensation alleged to be due and owing and Mr. Rimland released the Company from all claims and liabilities, including those arising out of his employment, and his employment agreement, with the Company (but excluding claims to enforce the provisions of the Settlement Agreement). The Settlement Agreement provided for two monthly payments of $25,000 paid by June 30, 2019, followed by three monthly payments of $11,667, paid during July 2019, August 2019 and September 2019.

For additional information regarding the Company’s related party transactions, see Note – 15 Subsequent Events and Part II, Item 8, “Financial Statements and Supplementary Data”, Note 18 – Related Party Transactions included in the Annual Report.

The Company has evaluated all subsequent events through the date the consolidated financial statements were issued and filed with the SEC.

On April 15, 2019, certain subsidiaries of Regional entered into a Purchase and Sale Agreement (the “PSA”) with affiliates of MED Healthcare Partners LLC (collectively “MED” or “Buyer”), with respect to four (4) skilled nursing facilities owned by the Seller.

Subject to the terms of the PSA, the Seller agreed to sell, and the Buyer agreed to purchase, all of the Seller’s right, title and interest in: (a) that certain 182-bed skilled nursing facility commonly known as Attalla Health & Rehab located in Attalla, AL; (b) that certain 100-bed skilled nursing facility commonly known as Healthcare at College Park located in College Park, GA; (c) the Quail Creek Facility; and (d) that certain 100-bed skilled nursing facility commonly known as Northwest Nursing Center located in Oklahoma City, OK (collectively, the “PSA Facilities”). The Buyer’s obligation to complete such purchase and sale is subject to specified closing conditions, which included a thirty (30) day due diligence period (the “Due Diligence Period”). In consideration therefor, Buyer shall pay to Seller the sum of approximately $28.5 million in cash.

On June 11, 2019, the Seller and Buyer entered into an amendment (the “PSA Amendment”) to the PSA, pursuant to the PSA Amendment, Seller and Buyer agreed to the following, that the due diligence period has thus expired as of June 3, 2019, at 5:00 p.m. Eastern Time (“EST”) and that the scheduled closing date, subject to satisfaction or waiver of customary terms and conditions, will occur on August 1, 2019, but may be extended by up to fifteen (15) days if Buyer notifies Seller in writing by July 29, 2019 at 5:00 p.m. EST. In accordance with the PSA and PSA Amendment the Buyer deposited the first deposit of $0.15 million and the second deposit of $0.15 million into an escrow account. There is no assurance that the scheduled closing date, will be August 1, 2019, or up to fifteen (15) days later or that the sale will occur at all.

~~Filing Delinquency Notices from the NYSE American with respect to this Form 10-Q and the Annual Report~~

On April 17, 2019, the Company received a letter from NYSE American stating that the Company was not in compliance with certain NYSE American continued listing standards because the Company failed to timely file its Annual Report on Form 10-K for the period ended December 31, 2018 (“Filing Delinquency Notification”). As a result, the Company became subject to the procedures and requirements set forth in Section 1007 of the Company Guide. Within five days of the Filing Delinquency Notification, the Company (a) contacted the Exchange to discuss the status of the delinquent report and (b) issued a press release disclosing the occurrence of the filing delinquency. The Company was provided a six-month cure period, with an option additional six-month cure period at the discretion of the NYSE American, who reserved the right at any time to immediately truncate the cure period or immediately commence suspension and delisting procedures.

On May 17, 2019, the Company received a letter from NYSE American stating that the Company had regained compliance with the Exchange’s continued listing standards set forth in Part 10 of the Company Guide. Specifically, the Company resolved the continued listing deficiency with respect to sections 134 and 1011 of the Company Guide since the Company filed its Annual Report Form 10-K for the period ended December 31, 2018 with the SEC on May 17, 2019.

~~By filing this Quarterly Report, the Company has now filed the Delayed Form 10-Q.~~

On April 30, 2019, the Company and a wholly owned subsidiary of the Company (the “Borrower”) and Congressional Bank, a Maryland chartered commercial bank (the “Quail Creek Lender”), amended a term loan agreement dated September 27, 2013, as amended from time to time, with an aggregate principal of $5.0 million (the “Quail Creek Loan Agreement”), to extend the maturity date of the Quail Creek Credit Facility, with a principal balance of approximately $4.0 million as of March 31, 2019, bearing interest at LIBOR + 4.75%, to June 30, 2019 (the “Maturity Date”), with an option to further extend to July 31, 2019, as discussed below. The Quail Creek Credit Facility is secured by a mortgage on the Quail Creek Facility.

As discussed above, on April 15, 2019, certain wholly owned subsidiaries of Regional entered into the PSA pursuant to which Seller agreed to sell four (4) skilled nursing facilities owned by Seller, including the Quail Creek Facility, subject to the terms and conditions set forth in the PSA.

The option to further extend the Maturity Date of the Quail Creek Credit Facility to July 31, 2019 (the “Extension Option”), was subject to the Borrower’s satisfaction of the following conditions: (i) Borrower shall have delivered to the Quail Creek Lender written notice of its intent to exercise the Extension Option no earlier than forty-five (45) days and no later than thirty (30) days prior to the Maturity Date; (ii) no default or event of default shall have occurred and be continuing; (iii) the closing under the PSA shall have been extended and the PSA shall otherwise still be in full force and effect (including with respect to the Quail Creek Facility); (iv) Quail Creek Lender shall have received such additional information or costs as Quail Creek Lender may request; and (v) Quail Creek Lender shall have approved such extension in its commercially reasonable discretion. The Quail Creek Loan Agreement also provides that the termination of the PSA will constitute an immediate event of default

under the Quail Creek Loan Agreement. As of the date of filing this Quarterly Report the Company is in the process with the Quail Creek Lender to extend the Maturity Date. There is no assurance that the Company will be able to further extend the maturity date of the Quail Creek Credit Facility.

On May 14, 2019, the Company was served notice of a personal injury, pain and suffering, medical bills and expenses, and loss of consortium action filed in the State of Georgia by a patient, who received care outside Regional’s date of service (post Transition), against three different unrelated facilities and companies associated with those facilities. One of our tenants, their operator affiliated management Company (Beacon) and the Company are among the named defendants. The plaintiff is seeking unspecified compensatory damages to be determined by jury trial. The complaint claims that medical expenses to date amount to $3.0 million. The Company is indemnified in this action by Beacon and believes that this action lacks merit. The Company intends to take action most favorable to the Company. There is no guarantee that the Company will prevail in the action that has been filed against it.

On May 31, 2019, the Company was served notice of a second medical injury, improper care and treatment case filed in the State of Arkansas on behalf of a patient, who received care outside Regional’s date of service (post Transition), against the then operator Skyline and the Company and CIBC Bancorp USA, Inc. The plaintiff is seeking unspecified compensatory damages for the actual losses and unspecified punitive damages. The Company believes that this action lacks merit, the Company intends to take action most favorable to the Company. There is no guarantee that the Company will prevail in the action that has been filed against it.

On May 13, 2019, the Company entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”), with Allan J. Rimland, our former Chief Executive Officer, Chief Financial Officer, President and director, who voluntarily resigned his employment effective October 17, 2017, pursuant to which, among other things, and in lieu of any other rights or obligations under Mr. Rimland’s employment agreement, the Company agreed to pay Mr. Rimland $85,000 in cash for claimed breach of employment agreement and for certain compensation alleged to be due and owing and Mr. Rimland released the Company from all claims and liabilities, including those arising out of his employment, and his employment agreement, with the Company (but excluding claims to enforce the provisions of the Settlement Agreement). The Settlement Agreement provides for two (2) monthly payments of $25,000, followed by three (3) monthly payments of $11,667, commencing within ten (10) days of the execution of the agreement and due on the 15^th ~~day of each month thereafter.~~

On June 13, 2019, (the “Effective Date”), the Company and certain of its subsidiaries entered into a first amendment (the “Pinecone Amendment”) to the Second A&R Forbearance Agreement, pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the Pinecone Amendment, to extend the timeline to complete the Asset Sale to August 15, 2019.

Pursuant to the Pinecone Amendment, the Company agreed that the Company will pay an additional non-refundable payment, payable in kind, on the Effective Date, by increasing the outstanding principal amount owed to Pinecone up to approximately 0.5 million, which replaces approximately $0.2 million of payable in kind fees, under the Second A&R Forbearance Agreement.

The forbearance period under the Second A&R Forbearance Agreement remains unchanged by the Pinecone Amendment and may terminate at any time in accordance with the Second A&R Forbearance Agreement. There is no assurance such period will extend through October 1, 2019.

This Quarterly Report and certain information incorporated herein by reference contain forward-looking statements and information within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, and management’s plans and objectives. In addition, certain statements included in this Quarterly Report, in the Company’s future filings with the SEC, in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “seek,” “plan,” “project,” “continue,” “predict,” “will,” and other words or expressions of similar meaning are intended by us to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company’s current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. The Company’s actual results may differ materially from those projected, stated or implied in these forward-looking statements as a result of many factors, including the Company’s critical accounting policies and risks and uncertainties related to, but not limited to, the operating results of the Company’s tenants, the overall industry environment and the Company’s financial condition. These and other risks and uncertainties are described in more detail in the Annual Report and in Part II, Item 1A of this Quarterly Report, as well as other reports that the Company files with the SEC.

Forward-looking statements speak only as of the date they are made and should not be relied upon as representing the Company’s views as of any subsequent date. The Company undertakes no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur, except as required by applicable laws, and you are urged to review and consider disclosures that the Company makes in this Quarterly Report and other reports that the Company files with the SEC that discuss factors germane to the Company’s business.

Regional Health, through its subsidiaries, is a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. Our business primarily consists of leasing and subleasing healthcare facilities to third-party tenants. As of ~~March 31,~~September 30, 2019, the Company owned, leased, or managed for third parties 2824 facilities primarily in the Southeast.

On April 15, 2019 the Company entered into a purchase and sale agreement with respect to four (4) owned skilled nursing facilities, with a scheduled closing date, subject to satisfaction or waiver of customary terms and conditions, of August 1, 2019, but may be extended by up to fifteen (15) days. For further information, see Note 15 – ~~Subsequent Events, Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)” in this Quarterly Report.~~

The operators of the Company’s facilities provide a range of health care and related services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for both long-term and short-stay patients and residents.

On April 15, 2019, the Company entered into the PSA with MED providing for the sale of four of the Company’s skilled nursing facilities, with substantially all of the fixtures, equipment, furniture, leases and other assets relating to such facilities, on August 1, 2019, subject to satisfaction or waiver of customary terms and conditions.

Under the PSA, the Company sold to MED: (i) on August 28, 2019, the Northwest Facility; and (ii) on August 1, 2019 (a) the Attalla Facility, (b) the College Park Facility, and (c) the Quail Creek Facility.

On August 1, 2019, the Company used a portion of the proceeds from the Asset Sale to repay approximately $21.3 million to Pinecone to extinguish all indebtedness owed by the Company under the Pinecone Credit Facility, and to repay approximately $3.8 million to Congressional Bank to extinguish all indebtedness owed by the Company under the Quail Creek Credit Facility. On September 30, 2019, the Company and Pinecone entered into a waiver and release agreement, and the Company paid approximately $0.4 million to Pinecone to fully extinguish the Surviving Obligations under the Pinecone Credit Facility. For further information, see Note 10 – Discontinued Operations and Dispositions, Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)” in this Quarterly Report.

~~For the three months ended and as~~As of ~~March 31,~~September 30, 2019, we had negative working capital of approximately ~~$34.3 million.~~$1.6 million which excludes $6.1 million of current operating lease obligation (with the corresponding right of use asset classified as long term). At ~~March 31,~~September 30, 2019, we had ~~$1.5~~$3.4 million in unrestricted cash and ~~$80.1~~$55.8 million in indebtedness, including current maturities of ~~$25.7~~$1.7 million. The current portion of such indebtedness is comprised of: (i) $19.4 million of long term-debt (including a $0.5 million “tail fee” and a $0.5 million “repayment or acceleration fee”) under the Pinecone Credit Facility, classified as current due to the Company’s short-term forbearance agreement regarding the Company’s noncompliance with certain covenants under the Pinecone Credit Facility, pursuant to which Pinecone may exercise its default-related rights and remedies, including the acceleration of the maturity of the debt, upon the termination of the forbearance period under such forbearance agreement (as further discussed below in this note); (ii) $4.0 million of mortgage indebtedness under the Quail Creek Credit Facility maturing in June 2019; and (iii) other debt of approximately $2.3 million, which includes senior debt and bond and mortgage indebtedness.

~~The~~Prior to August 1, 2019, the continuation of our business iswas dependent upon our ability: (i) to comply with the terms and conditions under the Pinecone Credit Facility and the Second A&R Forbearance Agreement (as amended by the Pinecone Amendment); and (ii) to refinance or obtain further debt maturity extensions on the Quail Creek Credit Facility, neither of which iswas entirely within the Company’s control. ~~These~~Those factors ~~create~~had created substantial doubt about the Company’s ability to continue as a going concern.

The Company ~~is following a strategy to repay~~repaid the Pinecone Credit Facility and Quail Creek Credit Facility ~~within~~on August 1, 2019 using proceeds from the ~~next few months.~~Asset Sale. If ~~these~~ efforts ~~are~~to make such repayment had been unsuccessful, the Company ~~may be~~would have been required to seek relief through ~~a number of~~ other available ~~routes, which may include~~alternatives, including a filing under the U.S. Bankruptcy Code. The consolidated financial statements do not include any adjustments that might behave been necessary if the Company iswas unable to continue as a going concern. See Note – 1510 ~~Subsequent Events,~~Discontinued Operations and Dispositions, to our consolidated financial statements in Part I, Item 1, “Financial Statements (unaudited)” in this Quarterly Report for details onregarding the ~~PSA with respect to~~Asset Sale. The Asset Sale, and the ~~sale~~repayment of all amounts due under the ~~PSA Facilities, which transaction, if successfully completed, is intended to address~~Pinecone Credit Facility and the Quail Creek Credit Facility, have addressed certain factors ~~creating~~that had created substantial doubt regarding the Company’s ability to continue as a going concern. ~~There~~

As a result of such repayment, the Company is ~~no assurance however,~~able to conclude that ~~these efforts~~it is probable that the Company will be ~~successful.~~

able to meet its obligations arising within one year of the date of issuance of these consolidated financial statements within the parameters set forth in the accounting guidance.

Management anticipates access to several sources of liquidity, including cash on hand, cash flows from operations, and debt refinancing during the twelve months from the date of this filing. At ~~March 31,~~September 30, 2019, the Company had ~~$1.5~~$3.4 million in unrestricted cash. During the ~~three~~nine months ended ~~March 31,~~September 30, 2019, the Company generated positive cash flow from continuing operations of ~~$0.1~~$2.2 million.

The following table provides summary information regarding the number of facilities and related ~~operational~~licensed beds/units as of ~~March 31,~~September 30, 2019:

Owned

Leased

Managed for Third
Parties

Total

Facilities

Beds/Units

Facilities

Beds/Units

Facilities

Beds/Units

Facilities

Beds/Units

State

Alabama ⁽¹⁾

3

410

—

—

—

—

3

410

Georgia ⁽¹⁾

4

463

8

869

—

—

12

1,332

North Carolina

1

106

—

—

—

—

1

106

Ohio

4

279

1

94

3

332

8

705

Oklahoma ⁽¹⁾

2

197

—

—

—

—

2

197

South Carolina

2

180

—

—

—

—

2

180

Total

16

1,635

9

963

3

332

28

2,930

Facility Type

Skilled Nursing ⁽¹⁾

14

1,449

9

963

2

249

25

2,661

Assisted Living

2

186

—

—

—

—

2

186

Independent Living

—

—

—

—

1

83

1

83

Total

16

1,635

9

963

3

332

28

2,930

⁽¹⁾

On April 15, 2019 the Company entered into the PSA with respect to four owned skilled nursing facilities, which PSA was amended on June 11, 2019. The scheduled closing date, subject to satisfaction or waiver of customary terms and conditions, will occur on August 1, 2019, but may be extended by up to fifteen (15) days. See Note 15 – ~~Subsequent Events, Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)” in this Quarterly Report.~~

	Owned				Leased				Managed for Third Parties				Total
	Facilities		Beds/Units		Facilities		Beds/Units		Facilities		Beds/Units		Facilities		Beds/Units
State
Alabama		2		230		—		—		—		—		2		230
Georgia		3		395		8		884		—		—		11		1,279
North Carolina		1		106		—		—		—		—		1		106
Ohio		4		291		1		99		3		332		8		722
South Carolina		2		180		—		—		—		—		2		180
Total		12		1,202		9		983		3		332		24		2,517
Facility Type
Skilled Nursing		10		1,016		9		983		2		249		21		2,248
Assisted Living		2		186		—		—		—		—		2		186
Independent Living		—		—		—		—		1		83		1		83
Total		12		1,202		9		983		3		332		24		2,517

The following table provides summary information regarding the number of facilities and related ~~operational~~licensed beds/units by operator affiliation as of ~~March 31,~~September 30, 2019:

Operator Affiliation	Number of Facilities ⁽¹⁾		Beds / Units		Number of Facilities ⁽¹⁾		Beds / Units
C.R. Management⁽³⁾		8		936		6		689
Aspire		5		373		5		390
Wellington Health Services		2		342		2		342
Peach Health		3		252		3		266
Symmetry Healthcare ⁽²⁾		2		180		2		180
Beacon Health Management		2		212		2		212
Southwest LTC⁽³⁾		2		197
Vero Health ⁽²⁾		1		106		1		106
Subtotal		25		2,598		21		2,185
Regional Health Managed		3		332		3		332
Total		28		2,930		24		2,517

The following table provides summary information regarding our portfolio facility-level occupancy rates for the periods shown:

For the Three Months Ended

Operating Metric ⁽¹⁾

June 30,

2018

September 30,

2018

December 31,

2018

March 31,

2019

December 31,

2018

March 31,

2019

June 30,

2019

September 30,

2019

Occupancy (%) ⁽²⁾

76.2

79.2

79.1

79.4

79.7

80.8

80.7

80.1

The following table provides summary information regarding our lease expirations for the years ~~shown:~~shown as of September 30, 2019:

			Operational Beds					Annual Lease Revenue ⁽¹⁾							Licensed Beds					Annual Lease Revenue ⁽¹⁾
	Number of Facilities		Amount		Percent (%)			Amount '000's		Percent (%)			Number of Facilities		Amount		Percent (%)			Amount '000's		Percent (%)
2023		1		50		1.9	%	$	263		1.3	%		1		62		2.8	%		263		1.6	%
2024		1		126		4.8	%		965		4.9	%		1		126		5.8	%		965		5.8	%
2025		5		534		20.6	%		4,068		20.5	%		2		269		12.3	%		2,221		13.3	%
2026		—		—		0.0	%		—		0.0	%		—		—		0.0	%		—		0.0	%
2027		8		869		33.4	%		7,748		39.1	%		8		884		40.4	%		7,748		46.4	%
2028		4		323		12.4	%		2,352		11.9	%		4		328		15.0	%		2,352		14.1	%
2029		1		106		4.1	%		538		2.7	%		1		106		4.9	%		538		3.2	%
Thereafter		5		590		22.8	%		3,884		19.6	%		4		410		18.8	%		2,601		15.6	%
Total		25		2,598		100.0	%	$	19,818		100.0	%		21		2,185		100.0	%	$	16,688		100.0	%

There were no acquisitions during the three and nine months ended ~~March 31,~~September 30, 2019. For historical information regarding the Company’s acquisitions, see Part II, Item 8, “Financial Statements and Supplementary Data”, Note 10 – Acquisitions and Dispositions included in the Annual Report.

Effective January 15, 2019, and as contemplated by the A&R New Forbearance Agreement, the Company’s lease for the Omega Facilities (two facilities located in Georgia), which leases were due to expire August 2025 and which Omega Facilities the Company subleased to third party subtenants, were terminated by mutual consent of the Company and the lessor of the Omega Facilities.

On August 1, 2019, the Company and MED completed the sale of three of the PSA Facilities, together with substantially all of the fixtures, equipment, furniture, leases and other assets relating to such facilities, pursuant to the PSA, as amended. The aggregate purchase price paid to the Company for the three facilities was $26.1 million, net of $0.175 million from the first and second deposits held in escrow (the remaining earned $0.125 million deposit was applied to the remaining facility sale upon closing), and the Company paid a $0.4 million sale commission. The proceeds from the sale were used to repay the Pinecone Credit Facility and Quail Creek Credit Facility in full.

On August 28, 2019, the Company, sold the Northwest Facility, together with substantially all of the fixtures, equipment, furniture, leases and other assets relating to the Northwest Facility, to MED, pursuant to the PSA, as amended. In connection with the sale, MED paid to the Company a cash purchase price for the Northwest Facility equal to $2.4 million, and the Company incurred approximately $0.1 million for a building improvement credit and sales commission expenses. For further information on the above transactions, see Note 9 – Notes Payable and Other Debt and Note 10 – Discontinued Operations and Dispositions to the Company's Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”, of this Quarterly Report.

For historical information regarding the Company’s divestitures, see Part II, Item 8, “Financial Statements and Supplementary Data”, Note 10 – Acquisitions and Dispositions and Note 11 – Discontinued Operations included in the Annual Report.

We prepare our financial statements in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Article 8 of Regulation S-X. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amount of assets, liabilities, revenues and expenses. On an ongoing basis, we review our judgments and estimates, including, but not limited to, those related to doubtful accounts, income taxes, stock compensation, intangible assets and loss contingencies. We base our estimates on historical experience, business knowledge and on various other assumptions that we believe to be reasonable under the circumstances at the time. Actual results may vary from our estimates. These estimates are evaluated by management and revised as circumstances change.

For a discussion of our critical accounting policies and recent accounting pronouncements not yet adopted by the Company, see Note 1 – Organization and Significant Accounting Policies to the Company's Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”, of this Quarterly Report.

The following table sets forth, for the periods indicated, unaudited statement of operations items and the amounts and percentages of change of these items. The results of operations for any particular period are not necessarily indicative of results for any future period. The following data should be read in conjunction with our consolidated financial statements and the notes thereto, which are included herein.

	Three Months Ended March 31,									Three Months Ended September 30,									Nine Months Ended September 30,
(Amounts in 000’s)	2019			2018			Percent Change (*)			2019			2018			Percent Change (*)			2019			2018			Percent Change (*)
Revenues:
Rental revenues	$	5,138		$	5,705			(9.9	)%	$	4,590		$	4,972			(7.7	)%	$	14,746		$	15,706			(6.1	)%
Management fees		239			234			2.1	%		239			235			1.7	%		716			703			1.8	%
Other revenues		47			48			(2.1	)%		1			49			(98.0	)%		93			148			(37.2	)%
Total revenues		5,424			5,987			(9.4	)%		4,830			5,256			(8.1	)%		15,555			16,557			(6.1	)%
Expenses:
Facility rent expense		1,726			2,171			(20.5	)%		1,640			2,171			(24.5	)%		5,006			6,512			(23.1	)%
Cost of management fees		159			157			1.3	%		148			137			8.0	%		467			448			4.2	%
Depreciation and amortization		1,023			1,221			(16.2	)%		797			1,126			(29.2	)%		2,661			3,507			(24.1	)%
General and administrative expenses		926			879			5.3	%		730			984			(25.8	)%		2,551			2,751			(7.3	)%
Provision for doubtful accounts		(172	)		1,938		NM				32			(48	)	NM				(214	)		3,934		NM
Other operating expenses		408			343			19.0	%		191			255			(25.1	)%		821			823			(0.2	)%
Total expenses		4,070			6,709			(39.3	)%		3,538			4,625			(23.5	)%		11,292			17,975			(37.2	)%
Income (loss) from operations		1,354			(722	)	NM				1,292			631			104.8	%		4,263			(1,418	)	NM
Other expense:
Other (income) expense:
Interest expense, net		1,654			1,275			29.7	%		1,157			1,783			(35.1	)%		4,535			4,595			(1.3	)%
Loss on extinguishment of debt		333			441			(24.5	)%		924			3,514			(73.7	)%		2,478			3,955			(37.3	)%
Gain on disposal of assets		(690	)		—		NM				(6,451	)		—		NM				(7,141	)		—		NM
Other expense		7			9			(22.2	)%
Total other expense, net		1,304			1,725			(24.4	)%
Other (income) expense											(48	)		—		NM				6			10		NM
Total other (income) expense, net											(4,418	)		5,297			(183.4	)%		(122	)		8,560			(101.4	)%
Income (loss) from continuing operations before income taxes		50			(2,447	)	NM				5,710			(4,666	)		(222.4	)%		4,385			(9,978	)		(143.9	)%
Income tax expense		44			26			69.2	%		—			—		NM				44			33			33.3	%
Income (loss) from continuing operations		6			(2,473	)	NM				5,710			(4,666	)		(222.4	)%		4,341			(10,011	)		(143.4	)%
Income (loss) from discontinued operations, net of tax		178			(55	)		(423.6	)%		101			157			(35.7	)%		411			(242	)		(269.8	)%
Net income (loss)	$	184		$	(2,528	)		(107.3	)%	$	5,811		$	(4,509	)		(228.9	)%	$	4,752		$	(10,253	)		(146.3	)%

Rental revenues—Rental revenue decreased by approximately ~~$0.6~~$0.4 million, or ~~9.9%~~7.7%, to ~~$5.1~~$4.6 million for the three months ended ~~March 31,~~September 30, 2019, compared with ~~$5.7~~$5.0 million for the same period in 2018. The decrease reflects approximately ~~$0.5~~$0.6 million related to the Omega Lease Termination, $0.5 million related to the sale of the PSA Facilities and approximately $0.1 million due to an amendment to the Wellington Subleases ~~and~~off-set by approximately ~~$0.2~~$0.7 million rent received in ~~aggregate lower rent~~the current year by affiliates of Aspire for ~~our~~the facilities ~~where we have changed operator compared to~~operated by Ohio Beacon Affiliates in the prior year ~~partially off-set by~~who stopped paying rent and the recognition of ~~$0.2~~$0.1 million of property tax income as a result of the Company’s adoption on ASC 842. The Company recognizes all rental revenues on a straight line rent accrual basis, except with respect to the Ohio Beacon Affiliates in the prior year and the Mountain Trace Facility while operated by an affiliate of Symmetry for January and February 2019 and the PSA Facilities sold during the current quarter, for which rental revenue was recognized based on cash received.

Facility rent expense—Facility rent expense decreased by ~~$0.5~~approximately $0.6 million, or ~~20.5%~~24.5%, to ~~$1.7~~$1.6 million for the three months ended ~~March 31,~~September 30, 2019, compared with $2.2 million for the same period in 2018. The net decrease is due to the Omega Lease Termination and Covington Forbearance Agreement.

Depreciation and amortization—Depreciation and amortization expense decreased by approximately $0.3 million, or 29.2%, to $0.8 million for the three months ended September 30, 2019, compared with $1.1 million for the same period in 2018. The decrease is mainly due to equipment and computer related assets being fully depreciated and the cessation of depreciation and amortization on assets sold in the current quarter.

General and administrative—General and administrative costs decreased by approximately $0.3 million, or 25.8%, to $0.7 million for the three months ended September 30, 2019, compared with $1.0 million for the same period in 2018. The decrease is due to approximately $0.4 million lower business consulting and legal expenses incurred in relation to the Pinecone forbearance agreements, a continued decrease in auditing, accounting and other expenses of approximately $0.1 million off-set by a non-recurring increase in employee related expenses of approximately $0.2 million.

Interest expense, net—Interest expense decreased by approximately $0.6 million, or 35.1%, to $1.2 million for the three months ended September 30, 2019, compared with $1.8 million for the same period in 2018. The decrease is due to the August 1, 2019, repayment of all amounts due under the Pinecone Credit Facility and the Quail Creek Credit Facility.

Loss on extinguishment of debt—The loss from extinguishment of debt decreased by approximately $2.6 million, or 73.7%, to $0.9 million for the three months ended September 30, 2019, compared with $3.5 million for the same period in 2018. The current period expense is due to $0.4 million in settlement of the Surviving Obligations and $0.5 million in fees related to provisions in the Second A&R Forbearance Agreement, the Pinecone Amendment and the full repayment of the Pinecone Credit Facility. The prior year expenses were due to a substantial change in debt terms pursuant to the New Forbearance Agreement with Pinecone.

Gain on disposal of Assets— The gain on disposal of assets of $6.4 million for the three months ended September 30, 2019, is due to the sale of four of the Company’s facilities.

Income (loss) Discontinued operations, net of tax— The income (loss) from discontinued operations decreased by $0.1 million, or 35.7%, to a benefit of $0.1 million for the three months ended September 30, 2019, compared with a benefit of $0.2 million expense for the same period in 2018. The decrease is due to approximately a $0.1 million workers compensation insurance prior year’s premium and deposit refund.

Rental revenues—Rental revenue decreased by approximately $1.0 million, or 6.1%, to $14.7 million for the nine months ended September 30, 2019, compared with $15.7 million for the same period in 2018. The decrease reflects approximately $1.7 million related to the Omega Lease Termination, $0.5 million related to the sale of the PSA Facilities, approximately $0.3 million due to an amendment to the Wellington Subleases and approximately $0.1 million in aggregate lower rent for our facilities where we have changed operator compared to the prior year, partially off-set by approximately $1.2 million rent received in the current year by affiliates of Aspire for the facilities operated by Ohio Beacon Affiliates in the prior year who stopped paying rent and the recognition of approximately $0.4 million of property tax income as a result of the Company’s adoption on ASC 842. The Company recognizes all rental revenues on a straight line rent accrual basis, except with respect to the Ohio Beacon Affiliates in the prior year and the Mountain Trace Facility while operated by an affiliate of Symmetry for January and February 2019 and the PSA Facilities held for sale during the current quarter, for which rental revenue was recognized based on cash received.

Facility rent expense—Facility rent expense decreased by approximately $1.5 million, or 23.1%, to $5.0 million for the nine months ended September 30, 2019, compared with $6.5 million for the same period in 2018. The net decrease is due to the Omega Lease Termination and Covington Forbearance Agreement.

Depreciation and amortization—Depreciation and amortization expense decreased by approximately ~~$0.2~~$0.8 million, or ~~16.2%~~24.1%, to ~~$1.0~~$2.7 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2019, compared with ~~$1.2~~$3.5 million for the same period in 2018. The decrease is mainly due to equipment and computer related assets being fully ~~depreciated.~~depreciated and the cessation of depreciation and amortization on assets sold in the current quarter.

General and administrative—General and administrative costs ~~increased~~decreased by ~~5.3%~~approximately $0.2 million, or 7.3%, to ~~$0.9~~$2.6 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2019, compared with ~~$0.9~~$2.8 million for the same period in 2018. The ~~net increase~~decrease is due to approximately ~~$0.25~~$0.3 million inlower business consulting and legal expenses incurred in relation to the Pinecone forbearance agreements, ~~partially offset by~~ a continued decrease in auditing, accounting and other expenses of approximately $0.1 million, off-set by a non-recurring increase in employee related expenses of approximately $0.2 million.

Provision for doubtful accounts—Provision for doubtful accounts expense decreased by approximately ~~$2.1~~$4.1 million, to ~~$(0.2)~~a benefit of $0.2 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2019, compared with ~~$1.9~~$3.9 million for the same period in 2018. The current year gain is related to the collection of the Ohio Beacon Affiliates lease termination payment plan, while the prior year expense is due to the Ohio Beacon Affiliates notifying the Company of their plan to cease operating our properties on June 30, 2018 and, the Company recording allowances for balances owed by the Ohio Beacon Affiliates and Mountain Trace Tenant, and the associated write-off of the straight-line rent receivable. During the three months ended September 30, 2019, the Company released all of the remaining provision for the Ohio Beacon Affiliates’ payment plan due to their timely monthly payments, which was off-set by fully providing for the outstanding balances on the Symmetry Tenants’ payment plan due to non-payment. The Company had also recorded an allowance of approximately ~~$0.5~~$2.0 million on a $3.0 million note issued to Skyline in relation to their purchase of nine former facilities of the Company located in Arkansas, due to Skyline’s bankruptcy.

~~Other operating expenses~~Interest expense, net—~~Other operating expenses increased~~Interest expense decreased by approximately $0.1 million, or ~~19.0%~~1.3%, to ~~$0.4~~$4.5 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2019, compared with ~~$0.3~~$4.6 million for the same period in 2018. The ~~increase~~decrease is due to ~~$0.2 million incurred in legal fees~~the August 1, 2019, repayment of all amounts due under the Pinecone Credit Facility and ~~other partially off-set by $0.1 million in lower property tax accruals related to transitioning operators for~~ the ~~Ohio Beacon Facilities and Mountain Trace Facility.~~

~~Interest expense, net~~—Interest expense increased by approximately $0.4 million, or 29.7%, to $1.7 million for the three months ended March 31, 2019, compared with $1.3 million for the same period in 2018. The increase is mainly due to the net increase of debt principal year over year and increased interest rates related to the PineconeQuail Creek Credit Facility.

Loss on extinguishment of debt—The loss from extinguishment of debt decreased by approximately ~~$0.1~~$1.5 million, ~~or (24.5)%,~~ to ~~$0.3~~$2.5 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2019, compared with ~~$0.4~~$4.0 million for the same period in 2018. The current period expense is due to the Second A&R Forbearance Agreement, the repayment of all amounts due under the Pinecone Credit Facility and related expenses amounting to approximately $2.1 million and $0.4 million in settlement of the Surviving Obligations, while the prior period expense is due to approximately $3.6 million due to the substantial change in debt terms pursuant to the New Forbearance Agreement with Pinecone, and pre-payment penalties of $0.2 million and $0.2 million in expensed deferred financing fees from the repayment of debt in connection with the Pinecone Credit Facility.

Gain on disposal of Assets— The gain on disposal of assets of $7.1 million for the nine months ended September 30, 2019, is comprised of $6.4 million due to the sale of four of the Company’s facilities in the current quarter and $0.7 million from the Omega Lease Termination in the first quarter.

Income (loss) Discontinued operations, net of tax— The income (loss) from discontinued operations decreased by $0.6 million, or 269.8%, to a benefit of $0.4 million for the nine months ended September 30, 2019, compared with $0.2 million expense for the same period in 2018. The decrease is due to net favorable adjustments to bad debt expense and lower professional and general legal expenses as the ~~Omega Lease Termination.~~Company nears completion of its legacy professional and general liability claims and Transition vendor settlements and approximately a $0.1 million workers compensation insurance prior year’s premium and deposit refund.

As of ~~March 31,~~September 30, 2019, the Company had total current liabilities of ~~$39.3~~$14.1 million and total current assets of ~~$5.0~~$6.4 million, resulting in a working capital deficit of approximately ~~$34.3 million.~~$1.6 million after excluding $6.1 million of current operating lease obligation (with the corresponding right of use asset classified as long term). Included in current liabilities at ~~March 31,~~September 30, 2019 is the ~~$25.7~~$1.7 million current portion of the Company’s ~~$80.1~~$55.8 million in indebtedness. The current portion of such indebtedness is comprised ~~of: (i) $19.4 million~~ of long term-debt (including a $0.5 million “tail fee” and a $0.5 million “repayment or acceleration fee” ) under the Pinecone Credit Facility, classified as current due to the Company’s short-term forbearance agreement with Pinecone regarding the Company’s noncompliance with certain covenants under the Pinecone Credit Facility pursuant to which Pinecone may exercise its default-related rights and remedies, including the acceleration of the maturity of the debt, upon the termination of the forbearance period under such forbearance agreement (as further discussed below in this note); (ii) $4.0 million mortgage indebtedness under the Quail Creek Credit Facility maturing in June 2019; and (iii) other debt of approximately $2.3 million, which includes senior debt, ~~and~~ bond and mortgage ~~indebtedness.~~indebtedness and other debt. The Company anticipates net principal repayments of approximately ~~$25.8~~$1.7 million during the next twelve-month period, which includes ~~the $19.4 million debt under the Pinecone Credit Facility,~~ approximately ~~$4.0 million of payments under the Quail Creek Credit Facility,~~ $1.5 million of routine debt service amortization, ~~approximately $0.8~~$0.1 million payments on other non-routine debt and a $0.1 million payment of bond debt. On August 1, 2019, the Company used a portion of the proceeds from the Asset Sale to repay approximately $21.3 million to Pinecone to extinguish all indebtedness owed by the Company under the Pinecone Credit Facility, and to repay approximately $3.8 million to Congressional Bank to extinguish all indebtedness owed by the Company under the Quail Creek Credit Facility. For further information see Note – 10 Discontinued Operations and Dispositions to the Company's Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”, of this Quarterly Report.

On February 15, 2018, the Company entered into the Pinecone Credit Facility with Pinecone, with an aggregate principal amount of $16.25 million, which refinanced existing mortgage debt in an aggregate amount of $8.7 million on the Pinecone Facilities, and provided additional surplus cash flow of $6.3 million for general corporate needs (see Note 9 – Notes Payable and Other Debt, Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)” of this Quarterly Report) after deducting approximately $1.25 million in debt issuance costs and prepayment penalties. Regional Health iswas a guarantor of the Pinecone Credit Facility. Certain of the notes under the Pinecone Credit Facility ~~are~~were also guaranteed by certain wholly-owned subsidiaries of Regional Health. The surplus cash flow from the Pinecone Credit Facility was used to fund $2.4 million of self-insurance reserves for professional and general liability claims with respect to 25 professional and general liability actions, and to fund repayment of $1.5 million in convertible debt. The remaining $2.4 million in surplus cash proceeds from the Pinecone Credit Facility was used for general corporate purposes.

On May 10, 2018, Pinecone sent the ~~Default Letter,~~Company a default letter (the “Default Letter”), notifying the Company that it was in default under certain financial covenants of the Pinecone ~~Loan Documents.~~Credit Facility. On May 18, 2018, the Company and certain of its subsidiaries entered the Original Forbearance Agreement with respect to the specified events of default set forth therein, pursuant to which, among other things, additional fees in the amount of $0.4 million were added to the outstanding principal balance under the Pinecone Credit Facility. The forbearance period under the Original Forbearance Agreement terminated on July 6, 2018, because the Company did not satisfy conditions in the Original Forbearance Agreement that required the Company to enter into an agreement with Pinecone to support a transaction or series of transactions to remedy the defaults specified in the Default Letter and the Original Forbearance Agreement.

On September 6, 2018, the Company and certain of its subsidiaries entered into a the New Forbearance Agreement with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the New Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to the Specified Defaults under the Pinecone ~~Loan Documents.~~Credit Facility.

Pursuant to the New Forbearance Agreement, the Company and Pinecone amended certain provisions of the Pinecone ~~Loan Documents.~~Credit Facility. Such amendments, among other things: (i) removed the restriction on prepaying the loans during the ~~thirteen (13)~~13 month-period after the Closing Date; (ii) provided a ~~thirty (30)-day~~30-day cure period for certain events of default and a ~~fifteen (15)-day~~15-day cure period for certain failures to provide information or materials pursuant to the Pinecone ~~Loan Documents;~~Credit Facility; (iii) increased the finance fee payable on repayment or acceleration of the loans, depending on the time at which the loans are repaid ($0.25 million prior to December 31, 2018, and $0.5 million thereafter); and (iv) increased the outstanding principal balance owed by (a) approximately $0.7 million to reimburse Pinecone for its accrued and unpaid expenses and to pay outstanding interest payments for prior interest periods and (b) $1.5 million fee described as a non-refundable payment of additional interest. During the forbearance period under the New Forbearance Agreement, the interest rate reverted from the default rate of 18.5% per annum to the ongoing rate of 13.5% per annum.

The New Forbearance Agreement terminated on December 31, 2018, because the Company did not satisfy certain conditions set forth therein.

Pursuant to the A&R New Forbearance Agreement, the Company and Pinecone amended certain provisions of the ~~Loan Agreement.~~Pinecone Credit Facility. In addition Pinecone consented to the Omega Lease Termination. The leases of the Omega Facilities were to expire in August 2025, and the A&R New Forbearance Agreement required that the Omega Lease Termination be completed by February 1, 2019.

Pursuant to the A&R New Forbearance Agreement, the Company reimbursed Pinecone by February 1, 2019, for certain unpaid expenses and prepaid the AdCare Holdco Loan. In connection with the Omega Lease Termination, the Company realized gross proceeds (including a $1.2 million termination fee payable by the landlord to the Company, which approximated future forgone cash flow from the Company’s related sublease) to contribute to the Company’s required payment to Pinecone of approximately $1.4 million, of which $0.2 million was paid to Pinecone on January 4, 2019, for Pinecone’s expenses and the balance of $1.2 million was paid on January 28, 2019, of which $0.3 million was for Pinecone’s expenses, which included a 1% prepayment penalty, and the balance of $0.9 million was applied to pay down the principal amount of the AdCare Holdco Loan, which at March 31, 2019, was approximately $4.5 million.

The A&R New Forbearance Agreement amended the Loan Agreement to, among other things: (i) add a $0.35 million fee (paid in kind) to the loans on a pro rata basis; (ii) provide for the PIK Rate (3.5%), with such interest to be paid in kind in arrears by increasing the outstanding principal amount of loans held by the Pinecone on the first ~~(1st)~~ day of each month; provided that interest accruing at the PIK Rate on each loan and any overdue interest on each loan was paid in cash (a) on the maturity of the loans, whether by acceleration or otherwise, or (b) in connection with any repayment or prepayment of the loans; and (iii) modify the default rate of interest to add an additional 2.5% to the PIK Rate, in addition to the ongoing rate of 13.5%. During the forbearance period under the A&R New Forbearance Agreement, the interest rate paid in cash on the first (1st) day of each month was the ongoing rate of 13.5% per annum. See Note – 10 Discontinued Operations and Dispositions, to our consolidated financial statements located in Part I, Item 1, “Notes to consolidated financial statements (unaudited)” for further information on the Omega Lease Termination and subsequent AdCare Holdco Loan partial repayment completed on January 28, 2019. The forbearance period under the A&R New Forbearance Agreement expired according to its terms on March 14, 2019.

On March 29, 2019, the Company and certain of its subsidiaries entered the Second A&R Forbearance Agreement (as amended by the Pinecone Amendment) with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the Second A&R Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to the Specified Defaults under the ~~Loan Agreement.~~Pinecone Credit Facility. The forbearance period under the Second A&R Forbearance Agreement commenced on March 29, 2019, and ~~may extend~~could have extended as late as October 1, 2019, unless the forbearance period iswas earlier terminated as a result of specified termination events, including a default or event of default under the ~~Loan Agreement~~Pinecone Credit Facility (other than any Specified Defaults) or any failure by the Company or its subsidiaries to comply with the terms of the Second A&R Forbearance Agreement, including, without limitation, the Company’s obligation to progress with an Asset Sale (as defined below) in accordance with the timeline specified therein. See Note ~~-15~~-9 ~~Subsequent Events~~Notes Payable and Other Debt located in Part I. Item 1, “Notes to consolidated financial statements (unaudited)” in this Quarterly Report, for details of an amendment to the Second A&R Forbearance Agreement with respect to such timeline. ~~Accordingly, the forbearance period under the Second A&R Forbearance Agreement may terminate at any time and there is no assurance such period will extend through October 1, 2019.~~

Pursuant to the Second A&R Forbearance Agreement, the Company and Pinecone amended certain provisions of the ~~Loan Agreement.~~Pinecone Credit Facility. The Second A&R Forbearance Agreement ~~requires,~~required, among other things (i) that the Company pursue and complete Asset Sale which ~~would result~~resulted in the repayment in full of all of the Company’s indebtedness to Pinecone and, in connection therewith, the Company pay not less than $0.3 million and not more than $0.55 million in forbearance fees, as well as certain other expenses of Pinecone, or (ii) Pinecone’s other disposition of the ~~Loan Agreement~~Pinecone Credit Facility as contemplated by the Second A&R Forbearance Agreement. Additionally the Second A&R Forbearance Agreement ~~accelerates~~accelerated the previously disclosed 3% finance “tail fee”, 1% prepayment penalty, and 1% ~~break up~~breakup fee so that such fees and penalties became part of the principal as of April 15, 2019.

Upon the occurrence of an event of default (other than the Specified Defaults), or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement, Pinecone ~~may declare~~could have declared the entire unpaid principal balance under the Pinecone Credit Facility, together with all accrued interest and other amounts payable to Pinecone thereunder, immediately due and payable. Subject to the terms of the Pinecone ~~Loan Documents,~~Credit Facility, Pinecone ~~may foreclose~~could have foreclosed on the ~~Collateral.~~collateral. The ~~Collateral includes,~~collateral included, among other things, the Pinecone Facilities and all assets of the borrowers owning the Pinecone Facilities, the leases associated with the Pinecone Facilities and all revenue generated by the Pinecone Facilities, and rights under a promissory note in the amount of ~~$4.5~~$5.0 million, issued by Regional Health pursuant to the Pinecone Credit Facility in favor of one of its subsidiaries, which subsidiary is a borrower and guarantor under the Pinecone Credit Facility.

In addition, the equity interests in substantially all of Regional Health’s direct and indirect, wholly-owned subsidiaries ~~have been~~were pledged to Pinecone as part of the ~~Collateral.~~collateral (the “Pledged Subsidiaries”). The assets and operations of the Pledged Subsidiaries constitute substantially all of the Company’s assets and operations. Upon the occurrence of an event of default (other than the Specified Defaults) or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement, Pinecone may, in addition to its other rights and remedies, remove any or all of the managers of the Pledged Subsidiaries and appoint its own representatives as managers of such Pledged Subsidiaries. If Pinecone elects to appoint its own representatives as managers of the Pledged Subsidiaries, then such managers would control such subsidiaries and their assets and operations and could potentially restrict or prevent such subsidiaries from paying dividends or distributions to Regional Health. As a holding company with no significant operations, Regional Health relies primarily on dividends and distributions from the Pledged Subsidiaries to meet its obligations and pay dividends on its capital stock (when and as declared by the Board.)

The Pinecone Loan Documents provide that Pinecone’s rights and remedies upon an event of default are cumulative, and that Pinecone may exercise (although it is not obligated to do so) all or any one or more of the rights and remedies available to it under the Pinecone Loan Documents or applicable law. The Company does not know which rights and remedies, if any, Pinecone may choose to exercise under the Pinecone Loan Documents upon the occurrence of an event of default (other than the Specified Defaults) or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement. If Pinecone elects to appoint its own representatives as managers of the Pledged Subsidiaries, to accelerate the indebtedness under the Pinecone Credit Facility, or to foreclose on significant assets of the Company (such as the Facilities and/or the equity interests in the Pledged Subsidiaries), then it will have a material adverse effect on the Company’s liquidity, cash flows, financial condition and results of operations, and whether or not the Company will be able to continue as a going concern.

The forbearance period under the Second A&R Forbearance Agreement ~~commenced on March 29, 2019~~remained unchanged by the Pinecone Amendment and may ~~extend as late as~~have continued until October 1, 2019, unless earlier terminated ~~upon the occurrence of specified termination events under~~in accordance with the Second A&R Forbearance Agreement. As of such date or earlier termination, Pinecone will no longer be required to forbear from exercising its default-related rights and remedies with respect to the Specified Defaults and may exercise all of its rights and remedies with respect toThe Company repaid the Pinecone ~~Loan Documents at that time.~~

As of March 31, 2019, the Company is in compliance with its debt covenants other than those in the Quail Creek Credit Facility. The Company was not in compliance with the monthly operator minimum EBITDAR required under the Quail Creek Credit Facility ~~as of March 31, 2019. The Quail Creek Credit Facility requires~~on August 1, 2019 from the Company maintain an operator minimum EBITDAR of $400 thousand, and the Company’s operator minimum EBITDAR was equal to $294 thousand as of March 31, 2019. The Company is currently in the process to obtain a waiver for such violation in anticipationproceeds of the ~~sale of the Quail Creek Facility, the sale of which is contemplated by the PSA disclosed in~~Asset Sale. For further information see Note 15 – 9 ~~Subsequent Events~~Notes Payable and Other Debt and Dispositions and Note – 10 Discontinued Operationslocated in Part I. Item 1, “Notes to consolidated financial statements (unaudited)” in this Quarterly ~~Report. The Quail Creek Credit Facility is secured by~~Report.

As of September 30, 2019, the ~~Quail Creek Facility.~~Company was in compliance with the various covenants for the Company’s outstanding credit related instruments.

On ~~January 15,~~August 1, 2019 ~~but effective February 1,~~and August 28, 2019, the Company ~~agreed to a 10% reduction in base rent, or an aggregate average of approximately $31,000 per month cash rent reduction for~~completed the ~~year ending December 31, 2019, and $48,000 per month decrease in straight-line revenue, respectively, for two~~Asset Sale. The sale of the ~~Company’s eight facilities located in Georgia, which are subleased to~~Quail Creek Facility, the ~~Wellington Sublessees under the Wellington Subleases. The Wellington Subleases due to expire August 31, 2027, relate to the Tara~~Attalla Facility and the ~~Power Springs Facility. Additionally~~College Park Facility occurred on August 1, 2019, and the sale of the Northwest Facility occurred on August 28, 2019. In connection with the Asset Sale: (i) MED paid to the Company ~~modified~~a cash purchase price for the ~~annual~~PSA Facilities equal to $28.5 million in the aggregate; (ii) the Company incurred approximately $0.4 million in sales commission expenses and $0.1 million for a building improvement credit; and (iii) the Company transferred approximately $0.1 million in lease security deposits to MED. The expected 2019 annualized rent ~~escalator to 1% per year~~receivable for the sold PSA Facilities was approximately $3.0 million and estimated 2019 annualized interest expense for the Pinecone Credit Facility and Quail Creek Credit Facility, paid off on August 1, 2019, from the ~~prior scheduled increase from 1% to 2% previously due to commence on the 1st day of the sixth lease year.~~Asset Sale proceeds, was approximately $3.8 million. See Note – 710 ~~Leases,~~Discontinued Operations and Dispositions, located in Part I. Item 1, “Notes to consolidated financial statements (unaudited)” in this Quarterly Report.

On August 28, 2018, the Company received a deficiency letter from NYSE American stating that the Company was not in compliance with the continued listing standards set forth in the Company Guide regarding the low selling price. On February 28, 2019, the Company regained compliance with the continued listing standards set forth in the Company Guide regarding the low selling price by completing the Reverse Stock Split. The proposal to amend the Charter to effect a reverse stock split of the common stock at a ratio of between one-for-six and one-for-twelve, as determined by the Board in its sole discretion, was approved at the Company’s 2018 annual meeting of shareholders, and the Reverse Stock Split became effective on December 31, 2018. If the Company is again determined to be noncompliant with any of the continued listing standards of the NYSE American within twelve months of February 28, 2019, the Exchange will examine the relationship between the Company’s previous noncompliance with the continued listing standards with respect to the low selling price and such new event of noncompliance in accordance with Section 1009(h) of the Company Guide. In connection with such new event of noncompliance, the Exchange may, among other things, truncate the compliance procedures described in the continued listing standards or initiate immediate delisting proceedings.

On April 17, 2019, the Company received a letter from NYSE American stating that the Company was not in compliance with the Exchange’s continued listing standards under the timely filing criteria outlined in Section 1007 of the Company Guide because the Company failed to timely file its Annual Report on Form 10-K for the period ended December 31, 2018. As a result, the Company became subject to the procedures and requirements set forth in Section 1007 of the Company Guide. The Company was provided a six-month cure period (until October 17, 2019) during which the Exchange monitored the Company and the status of the initial delinquent report and any subsequent delinquent reports.

On May 17, 2019, the Company received a letter from NYSE American stating that the Company had regained compliance with the Exchange’s continued listing standards set forth in Part 10 of the Company Guide. Specifically, the Company resolved the continued listing deficiency with respect to sections 134 and 1011 of the Company Guide since the Company filed its Form 10-K for the period ended December 31, 2018 with the SEC on May 17, 2019.

On May 21, 2019, the Company received a letter of noncompliance from the NYSE American stating that the Company is not in compliance with the Exchange’s continued listing standards under the timely filing criteria outlined in Section 1007 of the Company Guide because of the Company’s Filing Delinquency related to the Delayed Form 10-Q, which was due to be filed with the SEC no later than May 20, 2019. As a result of the foregoing, the Company has become subject to the procedures and requirements of Section 1007 of the Company Guide. During the Initial Cure Period, the Exchange will monitor the Company and the status of the Delayed Form 10-Q and any subsequent reports until the Filing Delinquency is cured. If the Company fails to cure the Filing Delinquency within the Initial Cure Period, the Exchange may, in its sole discretion, allow the Company’s securities to be traded during an Additional Cure Period, depending on the Company’s specific circumstances. If the Exchange determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set forth in Section 1010 of the Company Guide.

Notwithstanding the foregoing, however, the Exchange may in its sole discretion decide (i) not to afford the Company any Initial Cure Period or Additional Cure Period, as the case may be, at all or (ii) at any time during the Initial Cure Period or Additional Cure Period, to truncate the Initial Cure Period or Additional Cure Period, as the case may be. Furthermore, the Exchange may immediately commence suspension and delisting procedures if the Company is subject to delisting pursuant to any other provision of the Company Guide, including if the Exchange believes, in its sole discretion, that continued listing and trading of the Company’s securities on the Exchange is inadvisable or unwarranted in accordance with Sections 1001-1006 of the Company Guide. In the interim, the Company’s securities will continue to be listed on the Exchange, subject to the Company’s compliance with other continued listing requirements, and the Company’s common stock and preferred stock will continue to trade under the symbols “RHE” and “RHE PA,” respectively. The Exchange will make a late filer (“.LF”) indicator available on the consolidated tape. Each data vendor that disseminates the quotes and trades of Exchange-listed issuers may append this indicator to the ticker symbols of the Company. Each vendor is free to use an indicator of its own choosing so the letter or symbol used to indicate this status may differ from vendor to vendor. The Exchange also publishes a list of noncompliant issuers and displays the .LF indicator on its website.

~~By filing this Quarterly Report, the Company has now filed the Delayed Form 10-Q.~~

In applying applicable accounting guidance, management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company’s obligations due over the next twelve months, including the Quail Creek Credit Facility maturing in June 2019, the likelihood that the Company will be able to comply with the requirements in the Pinecone Loan Documents, including the Second A&R New Forbearance Agreement, and Pinecone’s remedies in the event of non-compliance, as well as the Company’s recurring business operating expenses.

~~There is no assurance that~~As the Company will be able to refinance or obtain further debt maturity extensions on the Quail Creek Credit Facility, or comply with all of the requirements under the Pinecone Loan Documents, including the Second A&R Forbearance Agreement, which requires, among other things, that the Company complete the Asset Sale in accordance with the timeframe set forth therein. Such compliance depends, in part, on the Company’s ability to work with outside parties, which is not within the Company’s exclusive control. If the Company is unable to refinance or obtain further debt maturity extensions on the Quail Creek Credit Facility, the Quail Creek Lender may exercise its default-related rights, or if the Company is unable to comply with all the requirements under the Pinecone Loan Documents, including the Second A&R Forbearance Agreement, and Pinecone were to accelerate all obligations under the Pinecone Loan Documents or otherwise exercise its default-related rights or foreclose on the Collateral, then it would have a material adverse consequence on the Company’s ability to meet its obligations arising within one year of the date of issuance of these consolidated financial statements.

~~The Company is pursuing a strategy to repay~~fully repaid the Pinecone Credit Facility and ~~the~~ Quail Creek Credit Facility ~~by means~~on August 1, 2019 from the proceeds of the Asset Sale, ~~and to streamline its cost infrastructure. See Note – 9~~ ~~Notes Payable and Other Debt~~ ~~and Note – 15~~ ~~Subsequent Events~~, to the Company’s Notes to unaudited consolidated financial statements located in Part I, Item 1, Financial Statements (unaudited), of this Quarterly Report, for a further discussion of the conditions of the extension of the Quail Creek Credit Facility and a purchase and sale transaction to effectuate the Asset Sale, which if completed, would permit us to repay the Pinecone Credit Facility and the Quail Creek Credit Facility in full. There is no assurance that we will be able to successfully execute this strategy or otherwise repay the Pinecone Credit Facility and the Quail Creek Credit Facility. Due to the inherent risks, unknown results, and significant uncertainties associated with each of these matters along with the direct correlation between these matters and the Company’s ability to satisfy the financial obligations that may arise over the applicable one-year period, the Company is ~~unable~~able to conclude that it is probable that the Company will be able to meet its obligations arising within one year of the date of issuance of these consolidated financial statements within the parameters set forth in the accounting guidance.

These factors create substantial doubt about the Company’s ability to continue as a going concern. If the Company’s efforts to repay the Pinecone Credit Facility and the Quail Creek Credit Facility are unsuccessful, the Company may be required to seek relief through a number of other available routes, which may include a filing under the U.S. Bankruptcy Code. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern

For additional information regarding the Company’s liquidity, see Note 3 – Liquidity and Note 9 – Notes Payable and other debt~~and Note 15~~ ~~– Subsequent Events~~, to the Company’s consolidated financial statements located in Part I, Item 1, Notes to Consolidated Financial Statements”, of this Quarterly Report.

The following table presents selected data from our consolidated statement of cash flows for the periods presented:

	Three Months Ended March 31,						Nine Months Ended September 30,
(Amounts in 000’s)	2019			2018			2019			2018
Net cash provided by operating activities - continuing operations	$	117		$	732		$	2,165		$	1,321
Net cash used in operating activities - discontinued operations		(282	)		(735	)		(980	)		(1,264	)
Net cash provided by (used in) investing activities – continuing operations		1,105			(163	)
Net cash (used in) provided by financing activities – continuing operations		(2,119	)		1,894
Net cash provided by (used in) investing activities - continuing operations								3,636			(266	)
Net cash (used in) provided by financing activities - continuing operations								(4,183	)		661
Net cash used in financing activities - discontinued operations		(34	)		(90	)		(34	)		(188	)
Net change in cash and restricted cash		(1,213	)		1,638			604			264
Cash and restricted cash at beginning of period		6,486			5,359			6,486			5,359
Cash and restricted cash at end of period	$	5,273		$	6,997
Cash and restricted cash (excluding restricted cash held for sale), ending							$	7,090		$	5,623

Net cash provided by operating activities—continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 was approximately ~~$0.2~~$2.2 million, consisting primarily of our income from operations less changes in working capital, and noncash charges (primarily ~~depreciation and amortization,~~ gain on disposal of assets, depreciation and ~~accounts payable, accrued expenses~~amortization, loss on debt extinguishment, and ~~other)~~lease revenue in excess of cash received). The ~~$0.6~~$0.8 million ~~decrease~~increase primarily reflects the decrease in interest payments, legal and consulting expenses related to the Pinecone Credit Facility and increase in ~~interest payments.~~bad debt collections partially offset by lower rent receipts.

Net cash used in operating activities—discontinued operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 was approximately ~~$0.3~~$1.0 million, excluding non-cash proceeds and payments. This amount was to fund legal and associated settlement costs related to our legacy professional and general liability claims.

Net cash provided by investing activities—continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 was approximately ~~$1.1~~$3.6 million. This is the result of receipt of approximately $2.6 million net proceeds (excluding non-cash proceeds and payments) from the sale of the PSA Facilities in the current quarter and the $1.2 million Omega Lease Termination fee offset by ~~$0.1~~$0.2 million capital expenditures on building improvements.

Net cash used in financing activities—continuing operations was approximately ~~$2.1~~$4.2 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2019. Excluding non-cash proceeds and payments, this is the result of routine repayments of approximately ~~$1.4~~$2.6 million of other existing debt obligations, ~~$0.2~~$0.3 million repayment of bonds principal and ~~$0.5~~approximately $1.3 million in relation to expenses and fees related to Pinecone forbearance ~~expense fees.~~agreements, repayment of the Pinecone Credit Facility and settlement of the Surviving Obligations.

Net cash used in financing activities—discontinued operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 was for Medicaid and vendor note payments.

Net cash provided by operating activities—continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2018 was approximately ~~$0.7~~$1.3 million, consisting primarily of our ~~income~~loss from operations less changes in working capital, and noncash charges (primarily bad debt expense, loss on extinguishment of debt, depreciation and amortization and rent revenue in excess of cash received). The $3.2 million decrease compared to the same period in 2017 was primarily reflects the non-payment of rent related to the Ohio Beacon Facilities (approximately $1.8 million), approximately $0.7 million (of which $0.2 million has been forgiven) of rent in arrears related to Symmetry Tenants and approximately $0.9 million increase in interest payments, partially offset by miscellaneous other amounts netting to $0.2 million.

Net cash used in operating activities—discontinued operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2018 was approximately ~~$0.7~~$1.3 million, excluding non-cash proceeds and payments. This amount was to fund legal and associated settlement costs related to our legacy professional and general liability claims.

Net cash used in investing activities—continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2018 was approximately ~~$0.2~~$0.3 million. This is the result of capital expenditures on building improvements for three of the Company’s properties.

Net cash provided by financing activities—continuing operations was approximately ~~$1.9~~$0.7 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2018. Excluding non-cash proceeds and payments, this is primarily the result of $2.4 million new financing from Pinecone offset by routine repayments of ~~$0.5~~approximately $1.7 million of other existing debt obligations.

Net cash used in financing activities—discontinued operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2018 was approximately ~~$0.1~~$0.2 million payments for Medicaid and vendor notes.

The Company repaid the Pinecone Credit Facility and Quail Creek Credit Facility on August 1, 2019, from the proceeds of the Asset Sale. For information regarding the Company’s debt financings, see Note 9 – Notes Payable and Other Debt, to the Company’s Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”, of this Quarterly Report and Note 9 – Notes Payable and Other Debt to our audited consolidated financial statements included in Part II, Item 8., “Financial Statements and Supplementary Data” in the Annual Report.

Our operations could be adversely affected if we experience significant delays in receipt of rental income from our tenants.

As of September 30, 2019 and December 31, 2018, the Company reserved for approximately $0.7 million and approximately $1.4 million, respectively, of receivables. Accounts receivable, net totaled ~~$1.0~~$0.9 million at ~~March 31,~~September 30, 2019 and $1.0 million at ~~December 31, 2018, with all uncollected patient care receivables fully allowed at March 31, 2019 and~~ December 31, 2018.

For information regarding the Company’s operating leases, see Note 7 – Leases, to the Company’s Notes to consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”, of this Quarterly Report, and Note 7 – Leases located in Part II, Item 8, “Financial Statements and Supplementary Data”, included in the Annual Report.

Disclosure in response to Item 3. of Form 10-Q is not required to be provided by smaller reporting companies.

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed pursuant to the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Interim Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, with the participation of our Chief Executive Officer and Interim Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report (the “Evaluation Date”). Based on such evaluation, our Chief Executive Officer and Interim Chief Financial Officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective.

There has been no change in the Company’s internal controls over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

The Company is a defendant in various legal actions and administrative proceedings arising in the ordinary course of business, including claims that the services the Company provided during the time it operated skilled nursing facilities resulted in injury or death to patients. Although the Company settles cases from time to time when settlement can be achieved on a reasonable basis, the Company vigorously defends any matter in which it believes the claims lack merit and the Company has a reasonable chance to prevail at trial or in arbitration. Litigation is inherently unpredictable and there is risk in the Company's strategy of aggressively defending these cases. There is no assurance that the outcomes of these matters will not have a material adverse effect on the Company’s financial condition. Although arising in the ordinary course of the Company's business, certain of these matters are described below under "Professional and General Liability Claims."

Except as set forth in this Item 1, Legal Proceedings, there have been no new material legal proceedings and no material developments in the legal proceedings reported in Part I, Item 3, Legal Proceedings, in the Annual Report. For further information with respect to legal proceedings, see Note 13 - Commitments and Contingencies, to the Company’s Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”, of this Quarterly Report.

During the three months ended ~~March 31, 2019: (i) one action was dismissed, however the plaintiffs have until~~ September ~~12,~~30, 2019, to re-file the action and; (ii) one additional action was filed on February 21, 2019 for a medical injury and improper care and treatment in the State of Arkansas on behalf of a deceased patient, who received care after the Transition, against the then operator affiliated with Skyline Healthcare, LLC (“Skyline”) and the Company and CIBC Bancorp USA, Inc. The plaintiff is seeking unspecified compensatory damages for the actual losses and unspecified punitive damages. The Company believes that this action lacks merit and the Company intends to take action most favorable to the Company. There is no guarantee that the Company will prevail in the action that has been filed against it.

~~Subsequent to March 31, 2019, the Company was notified of two additional~~three professional and general liability actions were dismissed, one of which ~~is subject to the relevant operators’ indemnification obligations in favor~~was indemnified by our former tenant and one of which was insured. Additionally the Company ~~(the plaintiff is seeking unspecified compensatory damages to be determined by jury trial~~settled one professional and ~~claims that medical expenses to date amount to $3.0 million) and one additional~~general liability action (our former patient), for a total of $200,000, payable in ~~the State~~12 monthly installments of ~~Arkansas (the plaintiff is seeking unspecified compensatory damages). Both actions are on behalf patients who received care after the Transition. For additional information~~$14,500 with ~~respect to legal proceedings, also see Note 13 -~~ ~~Commitments and Contingencies~~ ~~and Note 15 –~~ ~~Subsequent Events~~ ~~to the Company’s Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”,~~an initial payment of ~~this Quarterly Report.~~$26,000 commencing November 2019.

The Company established a self-insurance reserve for these professional and general liability claims, included within “Accrued expenses and other” in the Company’s consolidated balance sheets of ~~$1.0~~$0.8 million and $1.4 million at ~~March 31,~~September 30, 2019 and December 31, 2018, respectively. Additionally as of ~~March 31,~~September 30, 2019 and December 31, 2018, ~~$0.6~~$0.4 million and $0.6 million, respectively, was reserved for settlement amounts in “Accounts payable” in the Company’s consolidated balance sheets. For additional information regarding the Company’s self-insurance reserve, see Part II, Item 8, Financial Statements and Supplementary Data, Note 15 – Commitments and Contingencies included in the Annual Report.

~~Aria Bankruptcy Proceeding. On May 31, 2016, HAH and the Debtors filed petitions in the United States Bankruptcy Court for the District of Delawarefor relief under Chapter 7. Following venue transfer from the Delaware court, these cases have been settled in the Bankruptcy Court.~~

On July 17, 2015, the Company made a short-term loan to HAH, for working capital purposes, and, in connection therewith, HAH executed the HAH Note in favor of the Company. Since July 17, 2015, the HAH Note has been amended from time to time and had an outstanding principal balance of $1.0 million that matured on December 31, 2015. On October 6, 2015, HAH and the Company entered into a security agreement, whereby HAH granted the Company a security interest in all accounts arising from the business of the Debtors, and all rights to payment from patients, residents, private insurers and others arising from the Debtors (including any proceeds thereof), as security for payment of the HAH Note, as amended, and certain rent and security deposit obligations of the Debtors under Aria Subleases.

On April 21, 2017, the Company moved for relief from the automatic stay seeking release of its collateral, the Debtors’ accounts and their proceeds, which the trustee has represented as a total of approximately $0.8 million. The Company’s motion was opposed by the Chapter 7 trustee and another creditor, in May 2017. In its objection, the Chapter 7 trustee asserts that the Company is not entitled to any of the $0.8 million with respect to the HAH Note. In addition to opposing the Company’s claim to the $0.8 million, the Chapter 7 trustee has also indicated he was investigating avoidance claims against the Company with respect to funds the Company received from the Debtors prior to the bankruptcy filings. On March 28, 2018, such avoidance case was filed, requesting relief in an amount of $4.7 million. The Company has charged approximately $0.3 million and $0.6 million to “Provision for doubtful accounts” in the Company’s consolidated statement of operations on the HAH Note as of December 31, 2018, and December 31, 2017, respectively. On March 13, 2019, the Company and the Chapter 7 bankruptcy trustee entered into a settlement agreement to settle all existing and potential claims, including such avoidance claim. The Company has received $0.1 million with respect to the $1.0 million HAH Note.

Hardin & Jesson Action. On ~~February 25,~~August 5, 2019, the Company ~~was served notice of~~received notification from Hardin & Jesson that they had executed a settlement agreement with the Company pursuant to an action filed in Sebastian County Circuit Court - Fort Smith Division, Arkansas by Hardin ~~Jesson~~ & ~~Terry, PLC~~Jesson requesting financial documents from the Company’s predecessor issuer and seeking relief of outstanding amounts for legal services provided to the Company (and certain of its subsidiaries) in the State of Arkansas in relation to professional and general liability claims of approximately $0.5 million. On April 18, 2019, Hardin ~~Jesson~~ & ~~Terry, PLC~~Jesson amended their filing to correct their initial filing to clarify the claim is against the Company. On May 8, 2019, the Company provided a response denying the allegations. ~~There~~The settlement agreement provides for an agreed net outstanding liability of $0.3 million and provides for monthly payments of $13,888 beginning July 1, 2019, and continuing on the first day of each month thereafter until the $0.3 million liability is ~~no guarantee that~~paid in full. As of the date of filing this Quarterly Report the Company ~~will prevail in the action that~~ has ~~been filed against it.~~

~~Ohio Attorney General Action.~~ On October 27, 2016, the Ohio Attorney General (the “OAG”) filed in the Court of Common Pleas, Franklin County, Ohio a complaint against The Pavilion Care Center, LLC, Hearth & Home of Greenfield, LLC (each a subsidiarymade five of the ~~Company), and certain other parties (including parties for which~~required payments, in accordance with the Company provides or provided management services). The lawsuit alleges that defendants submitted improper Medicaid claims for independent laboratory services for glucose blood tests and capillary blood draws and further alleges that defendants (i) engaged in deception, (ii) willfully received Medicaid payments to which they were not entitled or in a greater amount than that to which they were entitled, and (iii) obtained payments underterms of the Medicaid program to which they were not entitled pursuant to their provider agreements and applicable Medicaid rules and regulations. The OAG is seeking, among other things, triple the amount of damages proven at trial (plus interest) and not less than $5,000 and not more than $10,000 for each deceptive claim or falsification. As previously disclosed, the Company received a letter from the OAG in February 2014 offering to settle its claims against the defendants for improper Medicaid claims related to glucose blood tests and capillary blood draws for a payment of approximately $1.0 million. The Company responded to such letter in July 2014 denying the allegations and did not receive further communication from the OAG until the above referenced lawsuit was filed. The Company filed an answer to the complaint on January 27, 2017 in which it denied the allegations. An order granting a motion to stay this proceeding was granted in the Court of Common Pleas, Franklin County, Ohio on July 12, 2017. Although there is no assurance as to the ultimate outcome of this matter or its impact on the Company’s business or its financial condition, the Company believes it has meritorious defenses and intends to vigorously defend the claim.agreement.

For a detailed description of certain risk factors that could affect our business, operations and financial condition, see Part I, Item 1A., Risk Factors, included in the Annual Report, as supplemented and modified by the risk factors set forth below in this Item 1A. The risk factors described in the Annual Report and this Quarterly Report (collectively, the “Risk Factors”) do not describe all risks applicable to our business, and we intend it only as a summary of certain material factors. The Risk Factors should be considered in connection with evaluating the forward-looking statements contained in this Quarterly Report because the Risk Factors could cause the actual results and conditions to differ materially from those projected in forward-looking statements. If any of the risks actually occur, our business, financial condition or results of operations could be negatively affected. In that case, the trading price of the common stock and Series A Preferred Stock could decline.

We are pursuing a strategy to repay certain current maturities of debt. If these efforts are unsuccessful, then we may be required to seek relief through a number of other available alternatives, which may include a filing under the U.S. Bankruptcy Code. Seeking relief under the U.S. Bankruptcy Code could have a material adverse effect on one or more classes of Regional stakeholders.

~~As described in Note 1 –~~ ~~Organization and Significant Accounting Policies~~ ~~and Note 3 –~~ ~~Liquidity~~ in Part I, Item 1, “Business – Going Concern” in this Quarterly Report, Regional is pursuing a strategy to repay the Pinecone Credit Facility and Quail Creek Credit Facility within the next few months through the sale of certain of Regional’s assets. We cannot assure you we will successfully execute this strategy or what the impact might be on us or on any of our stakeholders, whether individually or in the aggregate, if such strategy is not successfully executed.

If we are unable to repay these current maturities of debt, we may conclude that it is necessary to initiate Chapter 11 proceedings under the U.S. Bankruptcy Code to implement a restructuring of our obligations. Seeking relief under Chapter 11 would likely have a material adverse effect on our business, financial condition, results of operations, liquidity and returns to some or all of our stakeholders, depending on their respective interests in Regional. If we were to elect a bankruptcy proceeding, it is possible that holders of our common stock and/or claims and interests with respect to, or rights to acquire, our common stock, and possibly holders of our Series A preferred stock as well, would be entitled to little or no recovery, and those equity interests could be canceled for little or no consideration. Moreover, because we have a significant amount of indebtedness as well as Series A preferred stock that is senior to our common stock in our capital structure, we believe that if we were to seek bankruptcy relief under Chapter 11, it could cause our outstanding common stock to be canceled, or otherwise result in a very limited recovery, if any, and would place our common stock shareholders, and possibly our Series A preferred stock shareholders, at significant risk of losing their entire investment. If we were to elect to file a Chapter 11 proceeding, our senior management would be required to spend significant amounts of time and effort dealing with the proceeding instead of focusing on business operations. Bankruptcy relief also may make it more difficult to retain management and other key personnel necessary to our success.

There is no assurance that the Company will be able to comply with, or otherwise modify, the requirements in the Pinecone Loan Documents, including the Second A&R Forbearance Agreement (as amended by the Pinecone Amendment). If Pinecone elects to exercise its rights and remedies under the Pinecone Loan Documents with respect to any event of default, then it will have a material adverse effect on us and create substantial doubt about the Company’s ability to continue as a going concern.

On March 29, 2019, the Company and certain of its subsidiaries entered into the Second A&R Forbearance Agreement (as amended by the Pinecone Amendment) with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the Second A&R Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to the Specified Defaults under the Loan Agreement. The forbearance period under the Second A&R Forbearance Agreement commenced on March 29, 2019 and may extend as late as October 1, 2019, unless the forbearance period is earlier terminated as a result of specified termination events, including a default or event of default under the Loan Agreement (other than any Specified Defaults) or any failure by the Company or its subsidiaries to comply with the terms of the Second A&R Forbearance Agreement, including, without limitation, the Company’s obligation to progress with an Asset Sale in accordance with the timeline specified therein. Accordingly, the forbearance period under the Second A&R Forbearance Agreement may terminate at any time and there is no assurance such period will extend through October 1, 2019. The forbearance period under the Company’s prior forbearance agreement with Pinecone expired according to its terms on March 14, 2019.

As of such date, Pinecone will no longer be required to forbear from exercising its default-related rights and remedies with respect to the Specified Defaults and may exercise all of its rights and remedies with respect to the Pinecone Loan Documents at that time.

Upon the occurrence of an event of default (other than the Specified Defaults), or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement, Pinecone may declare the entire unpaid principal balance under the Pinecone Credit Facility, together with all accrued interest and other amounts payable to Pinecone thereunder, immediately due and payable. Subject to the terms of the Pinecone Loan Documents, Pinecone may foreclose on the Collateral. The Collateral includes, among other things, the Facilities and all assets of the borrowers owning the Facilities, the leases associated with the Facilities and all revenue generated by the Facilities, and rights under a promissory note in the amount of $5.4 million, issued by Regional Health pursuant to the Pinecone Credit Facility in favor of one of its subsidiaries, which subsidiary is a borrower and guarantor under the Pinecone Credit Facility.

In addition, the equity interests in substantially all of Regional Health’s direct and indirect, wholly-owned subsidiaries have been pledged to Pinecone as part of the Collateral. The assets and operations of the Pledged Subsidiaries constitute substantially all of the Company’s assets and operations. Upon the occurrence of an event of default (other than the Specified Defaults) or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement, Pinecone may, in addition to its other rights and remedies, remove any or all of the managers of the Pledged Subsidiaries and appoint its own representatives as managers of such Pledged Subsidiaries. The assets and operations of the Pledged Subsidiaries constitute substantially all of the company’s assets and operations. If Pinecone elects to appoint its own representatives as managers of the Pledged Subsidiaries, then such managers would control such subsidiaries and their assets and operations and could potentially restrict or prevent such subsidiaries from paying dividends or distributions to Regional Health. As a holding company with no significant operations, Regional Health relies primarily on dividends and distributions from the Pledged Subsidiaries to meet its obligations and pay dividends on its capital stock (when ~~and as declared by the Board.)~~

The Pinecone Loan Documents provide that Pinecone’s rights and remedies upon an event of default are cumulative, and that Pinecone may exercise (although it is not obligated to do so) all or any one or more of the rights and remedies available to it under the Pinecone Loan Documents or applicable law. The Company does not know which rights and remedies, if any, Pinecone may choose to exercise under the Pinecone Loan Documents upon the occurrence of an event of default (other than the Specified Defaults) or the expiration or termination of the forbearance period under the Second A&R Forbearance Agreement. If Pinecone elects to appoint its own representatives as managers of the Pledged Subsidiaries, to accelerate the indebtedness under the Pinecone Credit Facility, or to foreclose on significant assets of the Company (such as the Facilities and/or the equity interests in the Pledged Subsidiaries), then it will have a material adverse effect on the Company’s liquidity, cash flows, financial condition and results of operations, and the Company’s ability to continue operations will be materially jeopardized.

There is no assurance that the Company will be able to comply with the requirements in the Pinecone Loan Documents, including the Second A&R Forbearance Agreement (as amended by the Pinecone Amendment), or otherwise modify the requirements thereof. Such compliance depends, in part, on the Company’s ability to obtain the cooperation of outside parties, which is not within the Company’s control. If Pinecone were to exercise its default-related rights and remedies under the Pinecone Credit Facility, then it will have a material adverse consequence on the Company’s ability to meet its obligations arising within the next twelve months, and create substantial doubt about the Company’s ability to continue as a going concern.

We have substantial indebtedness, which may have a material adverse effect on our business and financial condition.

As of ~~March 31,~~September 30, 2019, we had approximately ~~$80.1~~$55.8 million in ~~indebtedness, including current maturities of debt.~~indebtedness. We may also obtain additional short-term and long-term debt to meet future capital needs, subject to certain restrictions under our existing indebtedness, which would increase our total debt. Our substantial amount of debt could have negative consequences to our business. For example, it could:

In addition, our ability to borrow funds in the future will depend in part on the satisfaction of the covenants in our debt agreements. If we are unable to satisfy the financial covenants contained in those agreements, or are unable to generate cash sufficient to make required debt payments, the lenders and other parties to those arrangements could accelerate the maturity of some or all of our outstanding indebtedness.

For the three months ended and as of March 31, 2019, we had negative working capital of approximately $34.3 million. At March 31, 2019, we had $1.5 million in unrestricted cash and $80.1 million in indebtedness, including current maturities of $25.7 million. The current portion of such indebtedness is comprised of: (i) $19.4 million of long term-debt (including a $0.5 million “tail fee” and a $0.5 million “repayment or acceleration fee”) under the Pinecone Credit Facility, classified as current due to the Company’s short-term forbearance agreement regarding the Company’s noncompliance with certain covenants under the Pinecone Credit Facility, pursuant to which Pinecone may exercise its default-related rights and remedies, including the acceleration of the maturity of the debt, upon the termination of the forbearance period under such forbearance agreement; (ii) $4.0 million of mortgage indebtedness under the Quail Creek Credit Facility maturing in June 2019 (there is no assurance that the Company will be able to further extend the maturity date of the Quail Creek Credit Facility); and (iii) other debt of approximately $2.3 million, which includes senior debt and bond and mortgage indebtedness.

We continue to undertake measures to grow our operations and streamline our operations and cost infrastructure by (i) increasing future lease revenue through acquisitions and investments in existing properties; (ii) modifying the terms of existing leases; (iii) refinancing or repaying debt to reduce interest costs and mandatory principal repayments; and (iv) reducing general and administrative expenses.

Management anticipates both access to and receipt of several sources of liquidity, including cash from operations and cash on hand. We have routine ongoing discussions with existing and potential new lenders to refinance current debt on a longer-term basis and, in recent periods, have refinanced short-term acquisition-related debt with traditional long-term mortgage notes, some of which have been executed under government guaranteed lending programs.

In order to satisfy the Company’s capital needs, the Company seeks to: (i) refinance debt where possible to obtain more favorable terms (including via asset sales); (ii) raise capital through the issuance of debt securities and convertible securities; and (iii) increase operating cash flows through acquisitions. The Company anticipates that these actions, if successful, will provide the opportunity to maintain its liquidity, thereby permitting the Company to better meet its operating and financing obligations. However, there is no guarantee that such actions will be successful.

If we fail to meet all applicable continued listing requirements of the NYSE American and the NYSE American determines to delist the common stock and Series A Preferred Stock, then the delisting could adversely affect the market value and liquidity of such securities, adversely affect our ability to raise needed funds and subject us to additional trading restrictions and regulations.

On May 17, 2019, the Company received a letter from NYSE American stating that the Company had regained compliance with the Exchange’s continued listing standards set forth in Part 10 of the Company Guide. Specifically, the Company resolved the continued listing deficiency with respect to sections 134 and 1011 of the Company Guide since the Company filed its Form 10-K for the period ended December 31, 2018 with the SEC on May 17, 2019.

~~By filing this Quarterly Report, the Company has now filed the Delayed Form 10-Q.~~

We give no assurance that the Company will be to maintain compliance with the NYSE American continued listing standards. If the common stock and Series A Preferred Stock are delisted from the NYSE American, then such securities may trade in the over-the-counter market. If our securities were to trade on the over-the-counter market, selling the common stock and Series A Preferred Stock could be more difficult because smaller quantities of shares would likely be bought and sold, transactions could be delayed, and any security analysts’ coverage of us may be reduced. In addition, in the event the common stock and Series A Preferred Stock are delisted, broker-dealers have certain regulatory burdens imposed upon them, which may discourage broker-dealers from effecting transactions in such securities, further limiting the liquidity of the common stock and Series A Preferred Stock. These factors could result in lower prices and larger spreads in the bid and ask prices for our securities. Such delisting from the NYSE American and continued or further declines in our share price could also greatly impair our ability to raise additional necessary capital through equity or debt financing and could significantly increase the ownership dilution to shareholders caused by our issuing equity in financing or other transactions. Any such limitations on our ability to raise debt and equity capital could prevent us from making future investments and satisfying maturing debt commitments.

We depend on affiliates of C.R Management, Wellington and Aspire for a significant portion of our revenues and any inability or unwillingness by such entities to satisfy their obligations to us could have a material adverse effect on us.

~~Our 25~~As of the date of filing this Quarterly Report, our 21 properties (excluding the three facilities that are managed by us) are operated by a total of 2521 separate tenants, with each of our tenants being affiliated with one of ~~eight~~seven local or regionally-focused operators. We refer to our tenants who are affiliated with the same operator as a group of affiliated tenants. Each of our operators operate (through a group of affiliated tenants) between ~~two~~one and ~~eight~~six of our facilities, with our most significant operators, C.R Management, Wellington and Aspire, each operating (through a group of affiliated tenants) ~~eight,~~six, two and five facilities, respectively. We, therefore depend, on tenants who are affiliated with C.R Management, Wellington and Aspire for a significant portion of our revenues. We cannot assure you that the tenants affiliated with C.R Management, Wellington and Aspire will have sufficient assets, income and access to financing to enable them to make rental payments to us or to otherwise satisfy their obligations under the applicable leases and subleases, and any inability or unwillingness by such tenants to do so could have a material adverse effect on us.

The Board suspended dividend payments with respect to the Series A Preferred Stock, commencing with the fourth quarter of 2017, and determined to continue such suspension indefinitely in June 2018. No dividends were declared or paid with respect to the Series A Preferred Stock for such dividend periods. As a result of such suspension, the Company has ~~$12.1~~$16.6 million of undeclared preferred stock dividends in arrears, whose annual dividend rate has increased to 12.875% commencing with the fourth quarter of 2018, with respect to the Series A Preferred Stock as of the date of filing of this Quarterly Report. See Note 11 – Common and Preferred Stock, “Preferred Stock Offerings and Dividends”, to the Company’s Notes to our consolidated financial statements located in Part I, Item 1, “Financial Statements (unaudited)”, of this Quarterly ~~Report,~~Report.

The agreements included as exhibits to this Quarterly Report are included to provide information regarding the terms of these agreements and are not intended to provide any other factual or disclosure information about the Company, its business or the other parties to these agreements. These agreements may contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time, and should not be relied upon by investors.

Exhibit No.	Description	Method of Filing

3.1	Amended and Restated Articles of Incorporation of Regional Health Properties, Inc., effective September 21, 2017	Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K12B filed on October 10, 2017

3.2	Certificate of Merger, effective September 29, 2017	Incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K12B filed on October 10, 2017

3.3	Amended and Restated Bylaws of Regional Health Properties, Inc., effective September 21, 2017	Incorporated by reference to Exhibit 3.3 of the Registrant’s Current Report on Form 8-K12B filed on October 10, 2017

4.1	Form of Common Stock Certificate of Regional Health Properties, Inc.	Incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K12B filed on October 10, 2017

4.2	Description of Regional Health Properties, Inc. Capital Stock	Incorporated by reference to Exhibit 4.2 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

4.3*	2005 Stock Option Plan of AdCare Health Systems, Inc.	Incorporated by reference to Exhibit 4.2 of the Registrant’s Registration Statement on Form S-8 (Registration No. 333-131542) filed October 27, 2011

4.4*	AdCare Health Systems, Inc. 2011 Stock Incentive Plan	Incorporated by reference to Exhibit 4.3 of the Registrant’s Registration Statement on Form S-8 (Registration No. 333-131542) filed October 27, 2011

4.5*	Form of Non-Statutory Stock Option Agreement	Incorporated by reference to Exhibit 4.4 of the Registrant’s Registration Statement on Form S-8 (Registration No. 333-131542) filed October 27, 2011

4.6*	Form of Incentive Stock Option Agreement	Incorporated by reference to Exhibit 4.5 of the Registrant’s Registration Statement on Form S-8 (Registration No. 333-131542) filed October 27, 2011

4.7	Form of Warrant to Purchase Common Stock of the Company	Incorporated by reference to Exhibit 4.3 to the Registrant’s Registration Statement on Form S-3 (File No. 333-175541)

4.8	Warrant to Purchase 50,000 Shares of Common Stock, dated December 28, 2012, issued by AdCare Health Systems, Inc. to Strome Alpha Offshore Ltd.	Incorporated by reference to Exhibit 4.21 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2012

4.9	Form of Warrant, dated March 28, 2014, issued by AdCare Health Systems, Inc. to the placement agent and its affiliates in connection with the offering of 10% Subordinated Convertible Notes Due April 30, 2015	Incorporated by reference to Exhibit 4.3 of the Registrant’s Quarterly Report on Form 10-Q for the three months ended March 31, 2014

4.10	Form of Warrant granted to management to Purchase Shares of AdCare Health Systems, Inc. dated November 20, 2007	Incorporated by reference to Exhibit 10.23.2 of the Registrant’s Annual Report on Form 10-KSB as amended March 31, 2008

10.1	Second Amended and Restated Forbearance Agreement dated March 29, 2019 among CP Property Holdings, LLC, Northwest Property Holdings, LLC and Attalla Nursing ADK, LLC as Borrowers, Hearth & Home of Ohio, Inc., as Guarantor, AdCare Property Holdings, LLC, as Guarantor and Borrower, Regional Health Properties, Inc., as Guarantor, and Pinecone Reality Partners II, LLC as Lender	Incorporated by reference to Exhibit 10.203 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused the report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Page Number
Part I.	FINANCIAL INFORMATION

Item 1.	Financial Statements (unaudited)	3
	Consolidated Balance Sheets as of ~~March 31,~~September 30, 2019 and December 31, 2018	3
	Consolidated Statements of Operations for the three and nine months ended ~~March 31,~~September 30, 2019 and 2018	4
	Consolidated ~~Statement~~Statements of Stockholders' Equity for the three and nine months ended ~~March 31,~~September 30, 2019 and 2018	5
	Consolidated Statements of Cash Flows for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 and 2018	6
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3937
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	5148
Item 4.	Controls and Procedures	5148

Part II.	OTHER INFORMATION

Item 1.	Legal Proceedings	5249
Item 1A.	Risk Factors	5349
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	5851
Item 3.	Defaults upon Senior Securities	5851
Item 4.	Mine Safety Disclosures	5851
Item 5.	Other Information	5851
Item 6.	Exhibits	5952

Signatures		6356

Exhibit No.	Description	Method of Filing

10.2	Eighth Amendment to Loan and Security Agreement and Fourth Amendment to Promissory Note dated April 30, 2019 by and between QC Property Holdings, LLC, a Georgia limited liability company and Congressional ~~Bank.~~Bank.	Incorporated by reference to Exhibit 10.205 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.3	Forbearance Agreement, dated as of January 11, 2019, by and between Covington Realty, LLC and Regional Health Properties, Inc.	Incorporated by reference to Exhibit 10.212 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.4	Lease Termination Agreement, dated as of January 15, 2019, by and between Bonterra/Parkview Inc. and ADK Bonterra/Parkview, LLC	Incorporated by reference to Exhibit 10.213 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.5	Second Amendment to Sublease Agreement, dated as of February 15, 2019, by and between ADK Georgia, LLC. and 3460 Powder Springs Road Associates, L.P.	Incorporated by reference to Exhibit 10.214 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.6	Second Amendment to Sublease Agreement, dated as of February 15, 2019, by and between ADK Georgia, LLC. and 3223 Falligant Avenue Associates, L.P.	Incorporated by reference to Exhibit 10.215 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.7	Lease Agreement, dated as of February 28, 2019, by and between Mountain Trace Nursing ADK, LLC and Vero Health X, LLC.	Incorporated by reference to Exhibit 10.216 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.8	Third Amendment to Sublease Agreement, dated as of March 13, 2019, by and between ADK Georgia, LLC. and 3460 Powder Springs Road Associates, L.P.	Incorporated by reference to Exhibit 10.217 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.9	Third Amendment to Sublease Agreement, dated as of February 15, 2019, by and between ADK Georgia, LLC. and 3223 Falligant Avenue Associates, L.P.	Incorporated by reference to Exhibit 10.218 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.10	Settlement Agreement and Release, dated as of March 13, 2019, by and between Regional Health Properties, Inc. and Chapter 7 Trustee	Incorporated by reference to Exhibit 10.219 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2018

10.11	Purchase and Sale Agreement dated as of April 15, 2019, by and between Northwest Property Holdings, LLC, QC Property Holdings, LLC, Attalla Nursing ADK, LLC, and CP Property Holdings, LLC, and Attalla Realty LLC, College Park Realty LLC, Quail Creek Realty LLC, and Northwest Realty LLC	Incorporated by reference to Exhibit 2.0 of the Registrant’s Current Report on Form 8-K filed August 7, 2019

10.11	First Amendment to Second Amended and Restated Forbearance Agreement dated June 12, 2019 among CP Property Holdings, LLC, Northwest Property Holdings, LLC and Attalla Nursing ADK, LLC as Borrowers, Hearth & Home of Ohio, Inc., as Guarantor, AdCare Property Holdings, LLC, as Guarantor and Borrower, Regional Health Properties, Inc., as Guarantor, and Pinecone Reality Partners II, LLC as Lender	Incorporated by reference to Exhibit 10.11 of the Registrant’s Quarterly Report on Form 10-Q for the three months ended March 31, 2019

10.12	Second Amendment to Purchase and Sale Agreement dated as of July 31, 2019, by and between Northwest Property Holdings, LLC, QC Property Holdings, LLC, Attalla Nursing ADK, LLC, and CP Property Holdings, LLC, and Attalla Realty LLC, College Park Realty LLC, Quail Creek Realty LLC, and Northwest Realty LLC	Incorporated by reference to Exhibit 2.2 of the Registrant’s Current Report on Form 8-K filed August 7, 2019

10.13	Third Amendment to Purchase and Sale Agreement dated as of July 31, 2019, by and between Northwest Property Holdings, LLC, QC Property Holdings, LLC, Attalla Nursing ADK, LLC, and CP Property Holdings, LLC, and Attalla Realty LLC, College Park Realty LLC, Quail Creek Realty LLC, and Northwest Realty LLC	Incorporated by reference to Exhibit 2.3 of the Registrant’s Current Report on Form 8-K filed August 7, 2019

Exhibit No.	Description	Method of Filing

10.14	Fourth Amendment to Purchase and Sale Agreement dated as of July 31, 2019, by and between Northwest Property Holdings, LLC, QC Property Holdings, LLC, Attalla Nursing ADK, LLC, and CP Property Holdings, LLC, and Attalla Realty LLC, College Park Realty LLC, Quail Creek Realty LLC, and Northwest Realty LLC	Incorporated by reference to Exhibit 2.4 of the Registrant’s Current Report on Form 8-K filed August 7, 2019

10.15	Fifth Amendment to Purchase and Sale Agreement dated as of July 31, 2019, by and between Northwest Property Holdings, LLC, QC Property Holdings, LLC, Attalla Nursing ADK, LLC, and CP Property Holdings, LLC, and Attalla Realty LLC, College Park Realty LLC, Quail Creek Realty LLC, and Northwest Realty LLC	Incorporated by reference to Exhibit 2.5 of the Registrant’s Current Report on Form 8-K filed August 7, 2019

10.16	Sixth Amendment to Purchase and Sale Agreement dated as of July 31, 2019, by and between Northwest Property Holdings, LLC, QC Property Holdings, LLC, Attalla Nursing ADK, LLC, and CP Property Holdings, LLC, and Attalla Realty LLC, College Park Realty LLC, Quail Creek Realty LLC, and Northwest Realty LLC	Incorporated by reference to Exhibit 2.6 of the Registrant’s Current Report on Form 8-K filed August 7, 2019

10.17	Waiver and Release Agreement dated September 30, 2019 among CP Property Holdings, LLC, Northwest Property Holdings, LLC and Attalla Nursing ADK, LLC as Borrowers, Hearth & Home of Ohio, Inc., as Guarantor, AdCare Property Holdings, LLC, as Guarantor and Borrower, Regional Health Properties, Inc., as Guarantor, and Pinecone Reality Partners II, LLC as Lender	Filed herewith

31.1	Certification of CEO pursuant to Section 302 of the Sarbanes-Oxley Act	Filed herewith

31.2	Certification of CFO pursuant to Section 302 of the Sarbanes-Oxley Act	Filed herewith

32.1	Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act	Filed herewith

32.2	Certification of CFO pursuant to Section 906 of the Sarbanes-Oxley Act	Filed herewith

~~Exhibit No.~~	~~Description~~	~~Method of Filing~~

101	The following financial information from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended ~~March 31,~~September 30, 2019, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets as of ~~March 31,~~September 30, 2019 (unaudited) and December 31, 2018; (ii) Consolidated Statements of Operations for the three and nine months ended ~~March 31,~~September 30, 2019 and 2018 (unaudited); (iii) Consolidated Statements of Stockholders’ Equity (Deficit) for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 (unaudited); (iv) Consolidated Statements of Cash Flows for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 and 2018 (unaudited); and (v) the Notes to Consolidated Financial Statements (unaudited).	Filed herewith

		REGIONAL HEALTH PROPERTIES, INC.
		(Registrant)

Date:	~~June 18,~~November 12, 2019	/s/ Brent Morrison
		Brent Morrison
		Chief Executive Officer and Director (Principal Executive Officer)

Date:	~~June 18,~~November 12, 2019	/s/ E. Clinton Cain
		E. Clinton Cain
		Interim Chief Financial Officer, Senior Vice President and Chief Accounting Officer (Principal Financial and Accounting Officer)

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

(Amounts in 000’s)
Facility Name	Revenue Recognition	Straight- Line Rent Asset		Other Receivables		2018 Original Cash Annual Rent**		% of Total Original Expected 2018 Cash Annual Rent**			Annualized Rent Concession Granted*
North Carolina
Mountain Trace⁽¹⁾	Cash basis	$	—	$	—	$	742		3.3	%	$	382
South Carolina
Sumter	Straight-line		571		381		836		3.8	%		236
Georgetown	Straight-line		237		73		338		1.5	%		26
		$	808	$	454	$	1,916		8.6	%	$	644

		December 31,
(Amounts in 000's)		2018
Lease deposits	$	375
Straight-line rent receivable		704
Buildings and improvements, net		352
Equipment and computer related, net		97
Intangible assets—lease rights, net		676
Assets of disposal group	$	2,204

Accounts payable	$	100
Other liabilities -lease deposits		170
Other liabilities -accrued straight-line rent		1,221
Liabilities of disposal group	$	1,491

						Principal indebtedness repaid		Purchase Price		Gain/(loss) on Sale
Facility Name	Lender	Interest Rate (a)				(Amounts in 000’s)		(Amounts in 000’s)		(Amounts in 000’s)
Attalla	Pinecone	Fixed		13.50	%	$	9,696	$	13,000	$	3,739
College Park	Pinecone	Fixed		13.50	%		3,043		7,000		3,050
Quail Creek	Congressional Bank	LIBOR + 4.75%		7.15	%		3,878		6,100		524
Northwest	Pinecone	Fixed	13.50		%		3,011		2,400		(862	)
AdCare Property Holdings	Pinecone	Fixed		13.50	%		5,009		—		—
Total						$	24,637	$	28,500	$	6,451